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The chemo-enzymatic synthesis of triaryl P-chiral ligands was achieved from 
readily available starting materials using the metallo-induced 1,4-
rearrangement of phosphonates to produce pro-chiral phosphine oxides which 
could be enzymatically desymmetrized in good yield and high enantiomeric 
excess using CAL-A. The chiral phosphine oxide could then be derivatized 
further to produce ligand like structures. A chiral phosphine oxide could be 
selectively reduced to give an oxidatively stable P-chiral phosphine, with 
minimal loss in enantiomeric excess.  Although the synthesised P-chiral ligand 
displayed configurational instability, slight alterations to the structure predicted 
by our molecular modelling results could potentially give both oxidatively and 
configurationally stable P-chiral phosphine ligands. Furthermore, based on 
unpublished results using an achiral monodentate ligand we believe that our 
P-chiral ligands would find application in copper-catalysed asymmetric 1,6-






2,6-DHBD 2,6-Dihydroxybenzoic acid decarboxylase 
AIBN  Azobisisobutyronitrile 
BINAP 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl 
BREP-  Butanol rinsed enzyme preparation 
CAL-A Candida antarctica Lipase A 
CAL-B Candida antarctica Lipase B 
CAMP  Cyclohexylanisylmethyl phosphine 
CMCR Candida magnoliae carbonyl reductase 
Cod  Cyclooctadiene 
Cy  Cyclohexyl 
DCM  Dichloromethane 
DFT  Density functional theory 
DHP  3,4-Dihydropyran 
DIPAMP Di-Phenylanisylmethylphosphine 
DIPEA Diisopropylethyl amine 
DKR  Dynamic kinetic resolution 
DMAP  Dimethyl aminopyridine 
DMSO Dimethyl sulfoxide 
EA  Ethyl acetate 
e.e.   Enantiomeric excess 
Eqv  Equivalents 
FAD   Flavin adenine dinucleotide 
GOase Galactose Oxidase 
HPLC  High performance liquid chromatography 
HOMO Highest occupied molecular orbital 
HRP   Horse radish peroxidase 
ISPA  Isopropenyl Acetate 
IR   Infra-red Spectroscopy 
Imid  Imidazole 
LDA  Lithium diispropylamide 
LAS  Lipase AS Amano 
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LUMO  Lowest unoccupied molecular orbital 
m-CPBA meta-Chloroperbenzoic acid 
MS  Mass Spectrometry 
Ms-Cl  Mesyl Chloride 
NAD  Nicotinamide adenine dinucleotide 
NADP  Nicotinamide adenine dinucleotide phosphate 
NMR  Nuclear magnetic resonance 
NR  No reaction 
PAMP  Phenylanisylmethylphosphine 
PCC  Pyridinium Chlorochromate 
Pin  Pinacol 
PMHS  Polymethyl hydrogen siloxane 
PPL  Pancreatic Porcine Lipase 
PTE  Phosphotriesterase 
p-TSA  p-Toluene sulfonic acid 
Pyr  Pyridine 
R.F.   Retention Factor 
RT   Room temperature 
RPM  Revolutions per minute 
TBAF  Tetrabutyl ammonium fluoride 
TBAI  Tetrabutyl ammonium iodide 
TBDPS-Cl tButyl diphenyl silyl chloride 
TEP   Tolmans electronic parameter 
THF  Tetrahydrofuran  
THP  Tetrahydropyranyl ether 
TLC  Thin layer Chromatography 
TMDS  Tetramethyldisiloxane 
TPO  Triphenylphosphine oxide 
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1.1 – Phosphines in organic synthesis 
 
Phosphines and phosphine oxides have undeniably played a pivotal part in 
organic chemistry throughout the years, however, the application of chiral 
phosphine and phosphorus containing ligands in asymmetric catalysis has 
become one of the most effective routes for the construction of chiral building 
blocks for synthesis[1-5]. With a rise in the need for enantiomerically pure 
pharmaceuticals and fine chemicals, asymmetric catalysis remains at the 
forefront of synthetic organic chemistry to meet this demand in both, academia 
and industry. The first application of a chiral phosphine ligand was in the 
asymmetric hydrogenation of alkenes, Knowles et al. pioneered this work 
using several different tertiary phosphines for the rhodium catalysed 
hydrogenation. Initially, the dialkyl aryl phosphine ligand (3) shown in Scheme 
1, was applied to the reduction of alkene 1 which gave the desired product 
with an e.e. of only 15%. However, the ligand used for the reaction was only 
at 69% e.e. [6] 
 
 
Scheme 1 – Rhodium-catalysed asymmetric hydrogenation of 1 using a P-chiral 




The asymmetric methodology was largely improved upon in the hydrogenation 
of the precursor to L-DOPA, 4 to give 6, where the chiral mono-dentate ligand, 
CAMP gave an e.e. of 85%.[7] In 1972, Knowles et al. improved on this even 
further with the use of the bi-dentate,  di-Phenylanisylmethylphosphine (Di-
PAMP) ligand 5 (Scheme 2) which gave the same product in 96% e.e.[8] 
Furthermore, this process has been scaled up to produce over 250 tons per 
year of L-DOPA, a treatment for Parkinson’s disease. 
 
 
Scheme 2 – Industrial Monsanto synthesis of L-DOPA precursor using the rhodium 
catalysed asymmetric hydrogenation of 4. 
 
1.2 – Phosphines structure and bonding 
 
1.2.1 – Structure of phosphines 
 
Phosphines span a broad range of structures, but they can be broadly 
categorized to be either, primary (PRH2), secondary (PRR’H) or tertiary 
(PRR’R’’), which relates to the level of substitution around the phosphorus 
atom.[9] The simplest phosphine structure is phosphine gas with the formula 
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PH3, consisting of three P-H bonds with a H-P-H angle of 93.5o in the trigonal 
pyramidal shape with a singular lone pair which is perpendicular to the 
phosphorus atom, as shown in Figure 1. Due to the low H-P-H angle of 93.5o, 
PH3 can be described as a Drago molecule, which states that there is no 
hybridization of the phosphorus orbitals (i.e. sp3) to form the P-H bonds which 
are therefore formed entirely of pure p orbitals which are orthogonal to the 
central phosphorus and the s orbital of the hydrogen atoms. Furthermore, this 
means that the lone pair is made almost entirely of the s orbital of the 
phosphorus atom. This contrasts with structures such as ammonia (NH3) 
which show a pyramidal or distorted tetrahedral structure due to sp3 
hybridization, with larger bond angles of 107o. The lone pair of ammonia, 




Figure 1 – Structure of phosphine and ammonia displaying the difference in bond 
angle. 
 
As we move to a tertiary phosphine such as PMe3, the C-P-C angle increases 
to approximately 98.6o and whilst this angle is still lower than the 109o angle 
approximated by sp3 hybridized, tetrahedral structures, it can be argued that 
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PMe3 has more sp3 hybridized character.[11] The use of hybridization in 
phosphines can also be used to better explain the mechanism of the inversion 
of phosphines, which will be covered in more detail. 
 
1.2.2 - Phosphines bonding to metals 
 
The properties of phosphines as ligands have been extensively studied over 
the last few decades[12-16], especially tertiary phosphines, to the point where 
the tuning of both steric and electronic effects can be carried out with a large 
amount of predictability. Phosphines bind to transition metals through the 
contribution of two electrons from the phosphorus lone pair to an empty 
metallic d orbital and the level of donation depends on the substituents 
attached to the phosphorus atom. In alkyl phosphines, such as trimethyl 
phosphine 9, the alkyl sp3 bonds tend to be better electron donors than those 
that possess sp2 bonds such as triphenyl phosphine 10 (Figure 2). This 
progresses further, as electron-withdrawing or releasing groups attached to 
the substituents can also have a remarkable effect on the electron density on 
the phosphorus atom.   
 
 





The electron-withdrawing and donating ability of a ligand can be explained 
further using the Tolman’s electronic parameter (TEP), where the electronic 
effects of a ligand can be defined through the effect on the vibrational 
frequency of carbon monoxide in a metal species. A common metal species 
to measure the TEP is [LNi(CO)3] (Scheme 3), where L relates to the ligand 
of interest. The three carbonyl molecules bind to the metal causing a decrease 
in the vibrational frequency of free C-O at 2143 cm-1.[12] 
 
 
Scheme 3 – Characterisation of the electronics of phosphine ligands by Tolman 
through measurement of the IR of C-O bonds. 
 
The shift in the IR frequency of the C-O bond can be explained through the pi 
back bonding which occurs when the nickel atom donates electrons from its d 
orbitals into the empty pi* anti-bonding orbitals on the CO. This strengthens 
the metal-carbon bond but subsequently weakens the C-O bond resulting in 
the lower vibrational frequency observed. When a phosphine binds to the 
nickel which increases the density of the pi electrons on the metal, the degree 
of back bonding to the metal-carbon bond increases too, weakening the C-O 
bond even further. Tolman et al. used a series of phosphine ligands with 
varying withdrawing and donating effects to show this phenomenon; as 
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expected the most electronegative ligand, PF3, showed the smallest decrease 
in the frequency of the C-O bond as it removes electron density from the nickel 
atom. Inversely, the trialkyl phosphines such as PMe3 and PtBu3 showed the 
greatest decrease in the frequency of the C-O bond (Table 1), due to the 
increased electron donation into the metal.[12,13] 
 
Table 1 – Tolman’s electronic parameter for several different phosphine ligands and 
their effect on the v(CO) of the carbonyl bond. 



















Phosphines can also participate in back bonding in metal complexes, 
however, the electronics of back bonding from the metals d orbitals to the 
phosphines orbitals is fundamentally different to molecules such as carbon 
monoxide, which undergoes back bonding into the pi antibonding C=O orbital 
as described above. Traditionally, back bonding in phosphines was attributed 
to the interaction between the metallic dπ orbital and the empty 3d orbital on 
the phosphorus atom, however this was disproved through a series of 
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experiments in which the bond lengths of the metal to the phosphine (P-M) 
and the bond lengths of the phosphorus and attached group (P-R) were 
measured. Oxidation of the metal centre, which decreases the ability of the 
metal to back bond to the phosphorus, led to the lengthening of the P-M bond 
due to the lesser amount of bonding between the two atoms. Oxidation of the 
metal centre also led to the shortening of the P-R bond of the phosphine which 
shows that the back bonding must involve participation from the δ* P-R orbitals 
to account for the shortening of this bond. This can be further proved through 
the changing of substituents on the phosphorus atom, as the inclusion of more 
electronegative atoms on the phosphorus atoms decreases the energy of the 
sigma antibonding orbital (increasing the pi acidity) allowing for greater 
contribution to the LUMO from the phosphorus as well as greater back bonding 
from the metal, a phenomenon shown in Figure 3. The level of pi acidity in 
cases such as PF3 becomes as great as that found for carbon monoxide which 




Figure 3 – Formation of the metal-phosphine complex and pi back bonding from the 




Inversely, when a phosphine binds to an electron-rich metal you would expect 
the P-C, anti-bonding orbitals to become more populated increasing the P-C 
bond length however, this effect is often hidden by an opposing effect in which 
the donation of the lone pair into the metal also decreases the P(lone pair) – 
R(bonding pair) repulsion which in turn decreases P-R bond length.  
 
The tuning of metal catalysed reactions often comes from the use of different 
sized phosphine ligands and in addition to the Tolman’s electronic parameter, 
the Tolman’s cone angle can be used to identify ligands which are suitable 
based on sterics. This parameter is particularly useful as the phosphine 
ligands are often what provide the asymmetric induction in metal reactions and 
when used correctly can control the co-ordination around the metal centre. 
The Tolman’s cone angle is defined through measurement of the angle which 
encompasses the structure of the whole ligand where the apex of the cone is 
the metal (Figure 4).  
 
 
Figure 4 – Calculation of Tolman’s cone angle for metal-phosphine complexes. 
 
Tolman et al. calculated the cone angle of a variety of different phosphines 
(Table 2) using a zerovalent nickel complex and as expected the smallest 
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ligands such as PH3, PF3 and PMe3 gave much smaller cone angles than the 
bulkier ligands such as PtBu3 and PPh3.[14,15] 
 
Table 2 – Calculated Tolman’s cone angle for phosphines with varying size 
substituents. 






















Whilst the calculation of the cone angle is relatively simple with symmetrical 
ligands such as PMe3 and PPh3, this calculation can still be applied to 
asymmetric ligands where the substituents half angles are averaged and then 
doubled to find the total cone angle. This allows the characterisation of the 
properties of chiral ligands in asymmetric catalysis to better understand the 







1.3 – Inversion of phosphines 
 
Phosphines show remarkably different inversion properties compared to their 
second-row amine counterparts. Amines which contain three different 
substituents do not show any optical activity due to the rapid inversion of the 
nitrogen. Whilst this rapid stereo isomerization exists in amines, phosphines 
do not always display this trait. The activation energy for the inversion of 
phosphines is typically in excess of 30 kcal/mol compared to the activation 
energy of 5-10 kcal/mol for amines which means that individual enantiomers 
of phosphines can be isolated.[17] The most general, recognised mechanism 
of inversion of phosphines and amines occurs through an ‘umbrella’ type or 
vertex mechanism (Scheme 4) in which the centre atom (N or P) changes from 
an sp3 hybridized, trigonal pyramidal shape (C3v) to the sp2 hybridized, trigonal 
planar (D3h) and the orbital which contains the lone pair on the central atoms 
changes from sp3 to a p orbital on the phosphorus atom.[18-21] Whilst this 
mechanism does explain the inversion of many phosphines, it does not 
describe the mechanism of inversion for all phosphines, as the edge inversion 






Scheme 4 – Inversion pathway for both ammonia and PMe3, showing the movement 
from the sp3 hybridized trigonal pyramidal structure to the trigonal planar transition 
state. 
 
Whilst many phosphines display stability to inversion, this stability is 
determined by several factors. Most importantly, the electronegativity of the 
substituents, the steric demands of the substituents and conjugation of the 
phosphorus lone pair have the greatest effect. However, the presence of lone 
pairs in proximity to the phosphorus atom and the angular constraints within 
the molecule can also affect inversion barrier. 
 
1.3.1 - Effects of electronegativity on inversion energy 
 
Beginning with electronegativity, both DFT and ab initio calculations[21] have 
shown that moving from the simplest phosphine, PH3, with increasing 
substitution with electronegative fluorine atoms (PH2F to PF3) leads to an 
increase in the inversion barrier. This trend is also observed in the trihalide 
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phosphines where moving from PBr3 to PCl3 to the most electronegative, PF3, 
shows incremental increases in the inversion barrier. Creve and Nguyen used 
DFT calculations to find the barrier and the pathway of inversion for several 
substituted halogenated phosphines,[22] as shown in Table 3. 
 
Table 3 – Inversion pathway and energies of several halogenated phosphines. 
 
Species Inversion Pathway Inversion Barrier (kJ/mol) 
PH3 Vertex 141.3 
PH2F Vertex 215.3 
PHF2 Edge 210.9 
PF3 Edge 221.1 
PH2Cl Vertex 185.6 
PHCl2 Edge 203.1 
PCl3 Edge 211.5 
PH2Br Vertex 179.6 
PHBr2 Edge 164.4 
PBr3 Edge 165.9 
PMe3 Vertex 171.0 
 
A simplistic explanation of the observed increase in inversion barrier can be 
attributed to the shortening of the gap between the HOMO and the LUMO 
orbital in the more electronegative phosphines, as shown in Figure 3. This 
depopulates the phosphines p orbital, which is required for inversion, in favour 
of the fluorine P-orbital which ultimately destabilizes the trigonal planer 
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transition state, due to the large energy gap between the HOMO and the 
LUMO in the planar transition state.[22]  
 
1.3.2 - Effects of sterics on inversion energy 
 
The steric bulk of the substituents also have a profound effect on the inversion 
barrier of phosphines but also greatly influences the properties of the 
phosphines when acting as a ligand. As steric bulk of the substituents 
increases the repulsions between these substituents in a trigonal pyramidal 
structure also increases, therefore, increasing the planarity of the trigonal 
geometry decreasing the barrier to inversion. This is highlighted when viewing 
the sum of the angles around the phosphorus centre, in which the trend shows 
that a higher internal sum of the C-P-C bonds leads to a lower energy barrier 
for inversion.[23,24] Whilst this same argument could be applied to the planar 
trigonal transition state, the angles in this planar geometry are larger at 120o, 
compared to those of approximately 109o (depending on substituents) of the 
trigonal pyramidal configuration, meaning that the planar transition state is not 









Table 4 – Inversion barrier of tertiary phosphines highlighting the negative effects 
























As shown by the calculations in Table 4, moving from the less sterically 
demanding trimethyl amine/phosphine to the more sterically demanding 
isopropyl substituents or phenyl containing substituents there is a significant 
drop in the inversion barrier energy of both the amine and phosphine centered 
compounds.[23,25] This trend is further cemented through the work by Holz et 
al. in which triaryl phosphines were shown to have a relatively low inversion 
barrier, highlighted through both experimental work and DFT calculations. The 
inversion barrier energy and half-life were increased dramatically through the 
substitution of an anisyl group for a lesser sterically demanding methyl or n-
butyl chain.[24]  
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1.3.3 - Effects of conjugation on inversion energy 
 
Conjugation is another factor which has been shown to affect the inversion 
barrier as delocalization of the lone pair of the phosphorus atom would allow 
for stabilization of the transition state, decreasing activation energy. Aryl 
substituents or heteroatoms which contain available d orbitals, allow for 
conjugation and therefore display this trend as they show activation energies 
lower than that of non-conjugated phosphine such as trialkyl phosphines, as 
shown by Mislow et al.[26] Furthermore, the presence of heteroatoms which 
contain lone pairs adjacent to the phosphorus atom also destabilizes the 
planar transition state due to the repulsion between lone pairs of the 
heteroatom and the phosphorus. This is highlighted in the study by Holz et 
al. in which the half-life for molecules which contain groups, such as phenolic 
derivatives in the ortho- or para- position, disrupt the conjugation of the 





Scheme 5 – A) Stabilization of the phosphorus lone pair through conjugation into 
the aromatic ring. B) Delocalization of phosphorus lone pair into the aromatic ring 





1.4 – Stability of phosphines to oxidation 
 
In addition to configurational stability, the stability of phosphine ligands 
towards oxidation under atmospheric conditions depends on several factors, 
however and steric effects are likely to be the most important factor.[27,28] The 
Buchwald group reported the varying stability of phosphines to oxidation in 
toluene through exposing a variety of different phosphine structures to three 
different conditions for 65 hours; an oxygen atmosphere at room temperature, 
an oxygen atmosphere at 100oC and under air at 100oC. The least bulky, 
tricyclohexyl phosphine, showed almost complete oxidation under all three 
conditions, whereas the bulkier, triphenyl phosphine showed complete stability 
at room temperature but a large amount of oxidation in air and oxygen 
atmospheres at the elevated temperature of 100oC.[27]  The oxidation under all 
three conditions could be decreased to under 8% when moving to phosphines 
which contain extremely bulky, biaryl substituents which also contain isopropyl 
groups in the 2,4,6- positions of the non-phosphorus containing aryl ring, as 











Table 5 – Observed oxidation of 4 different tertiary phosphines in 3 different oxidative 
conditions. 
 % of oxidation seen after 65 h 
Compound Condition A Condition B Condition C 
 
99% 99% 99% 
 
0% 72% 73% 
 
<5% 34% 69% 
 
0% 5% 7% 
Condition A - Oxygen atmosphere at room temperature. Condition B – Air atmosphere 
at 100oC. Condition C – Oxygen atmosphere at 100oC[27]. 
 
1.5 – Chirality in phosphines 
 
There are two main categories of chiral phosphine ligands, those where the 
chirality lies on the phosphorus atoms itself and those where the chirality is 
located elsewhere in the phosphines structure. The latter structures include 
those with axial chirality. Both types of chiral phosphines have their 
advantages and disadvantages in catalysis as well as their ease of synthesis 
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and stability. Historically, P-chiral ligands have been neglected due to certain 
prejudices surrounding their configurational stability. However, it can be 
argued that the for the greatest asymmetric induction from the ligands 
surrounding the metal it would be preferential for the chirality to lie on the 
phosphorus atom, due to the proximity of the phosphorus to the metal. Due to 
these prejudices, the number of P-chiral ligands is greatly outnumbered by 
chiral phosphines which contain the chirality elsewhere in the structure.  
 
1.5.1 - C-2 Symmetry 
 
C-2 symmetry can be advantageous in both P-chiral ligands and ligands such 
as (R)-BINAP and (R,R)-DIOP and accounts for the high enantioselectivity in 
a large number of catalytic asymmetric reactions. It is often thought that 
increased symmetry within asymmetric catalysts would be detrimental to 
selectivity, however, asymmetric induction only requires the ligand to be chiral. 
C-2 symmetry improves selectivity as it decreases the number of unique 
approaches and transition states (Figure 5) as rotation of the ligand leads to 







Figure 5 – Explanation of C-2 symmetric where the C-2 symmetric structure on the 
left shows only 2 unique points of reaction (red + blue) where the asymmetric 
molecule on the right shows 4 unique points of reaction. 
 
1.5.2 – Non-P* stereogenic phosphines 
 
As mentioned previously, the number of non-P-stereogenic ligands vastly 
outnumbers that of the P-stereogenic phosphine ligands. Some of these 
ligands have been applied to multiple areas of catalysis and are known as 






Figure 6 – Structures of ‘privileged’ chiral phosphine ligands which do not contain a 
P-stereogenic centre. 
 
One of the most widely known and used phosphine ligands is 2,2′-
bis(diphenylphosphino)-1,1′-binaphthyl (BINAP) (13), which unlike DIPAMP 
and CAMP, BINAP does not contain a stereogenic phosphorus or carbon as 
its chirality lies axially within the backbone of its structure. BINAP has been 
applied as a ligand in both rhodium[31-33] and ruthenium[34-37] catalysis. Some 
of the most pioneering work with BINAP was shown by Nobel prize winning 
chemist, Noyori, who developed the rhodium-BINAP catalysed asymmetric 







Scheme 6 – Use of Rhodium-BINAP complex (16) for the asymmetric reduction of 
an α-ketoester to give the chiral alcohol 17. 
 
1.5.3 - P-Chiral phosphines 
 
Two of the most well-known P-chiral ligands are cyclohexylanisylmethyl 
phosphine (CAMP) and DIPAMP, which were mentioned previously (Section 
1.1) in the asymmetric hydrogenation of L-DOPA were inspiration for many 
modern P-chiral asymmetric ligands.[6-8] Since then the spectrum of P-chiral 
ligands has grown to include a vast range of structures (Figure 7) which have 





Figure 7 – Examples of P-chiral ligands used in asymmetric catalysis. 
 
Imamoto et al. used the air-stable, (R,R)-QuinoxP* (19) ligand in the 
enantioselective rhodium-catalysed 1,4-addition of arylboronic acids to α,β-
unsaturated ketones (Scheme 7), to give the chiral product 26 in both high 
yield and enantiomeric excess.[40] 
 
 
Scheme 7 – Rhodium-catalysed 1,4-addition of arylboronic acids to α,β-




Alternatively, Cao et al. demonstrated the use of the P-chiral ligand, (S)-
Antphos 28, in the total synthesis of the biologically active molecule 
triptoquinone H (30). The palladium-catalysed cyclization of intermediate 27 
afforded the tricyclic, chiral molecule 29 in an e.e. of 85%, which included a 
carbon quaternary centre (Scheme 8).[43] 
 
 
Scheme 8 – Palladium-catalysed cyclization of 27 utilizing P-chiral ligand, (S)-
Antphos 28, to afford the tricyclic intermediate 29 in 85% e.e. 
 
Similarly, the P-chiral ligand, MeO-BoqPhos (32) was utilized in the total 
synthesis of a potent 11β-HSD-1 inhibitor (34), used in the treatment of 
metabolic diseases such as diabetes, through the iridium-catalysed 
asymmetric hydrogenation of the pyridinium ring in precursor 31 (Scheme 9). 
This proceeded to give the tricyclic intermediate 33 in high diastereoselectivity 
and modest enantioselectivity. This was scaled up to multi kilogram reaction 





Scheme 9 – Iridium-catalysed asymmetric hydrogenation of the pyridinium ring of 
31 to produce chiral intermediate 33 in 70% e.e in high diastereomeric excess. 
 
 1.6 - Synthesis of chiral phosphines and phosphine oxides 
 
1.6.1 – Chemical routes to chiral phosphines 
 
There are several established synthetic routes to P-stereogenic phosphines, 
although these often require the use of chiral auxiliaries followed by 
crystallisation to separate the diastereomers, which can be both expensive 
and low yielding. In the 1960’s Mislow et al. demonstrated the synthesis of 
chiral phosphinates, using (-)-menthol as a chiral auxiliary, where the 
separation of a single diastereomer could be achieved through crystallization 
in which the other remained in the mother liquor. The yield could be increased 
further through the reaction of the mother liquor with thionyl chloride to yield 
the precursor, 38 which could be reacted with (-)-menthol to re-form the 
diastereomeric mixture. The resulting phosphinate (40b) can then be reacted 
with a Grignard reagent to yield the tertiary phosphine oxide.[45,46] This 
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procedure has been used by Knowles et al. to synthesise the oxide precursor, 
42, to the chiral bidentate ligand, DIPAMP (Scheme 10).[47] 
 
 
Scheme 10 – Synthesis of a chiral bis-phosphine oxide 50 using (-)-menthol as a 
chiral auxiliary.[47] 
 
More recent syntheses of P-chiral ligands include the use of bidentate, chiral 
auxiliaries such as amino alcohols or ephedrine.[48,49] Juge et al. used (+)-
ephedrine for the synthesis of a tertiary, P-chiral phosphine ligand starting with 
the condensation of bis(dimethylamino)phenyl phosphine with (+)-ephedrine 
and then trapping of the free phosphine with BH3.SMe2 to give the chiral 
oxazaphospholidine-borane complex 44 (Scheme 11). The alcohol group of 
the auxiliary can then be selectively displaced through the addition of a 
lithiated nucleophilic species, such as an aryl or alkyl group, with retention of 
the phosphorus centre. The next two steps both occur with inversion of the 
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phosphorus centre as the amine group of the auxiliary is then cleaved away 
from the phosphorus atom under acidic methanol conditions to give the 
phosphinite-borane, 46, which upon addition of another lithiated, nucleophilic 
species yields the chiral, tertiary phosphine-borane 47.[48,49] 
 
 
Scheme 11 – Enantioselective synthesis of phosphines and phosphine-boranes 
using (+)-ephedrine as a chiral auxiliary. 
 
The chiral phosphine-borane 47 was then decomplexed through the addition 
of a secondary amine to yield the P-chiral, tertiary phosphine 48 with an e.e. 
of 85%.[48,49] This route, however, suffers from several shortcomings, such as 
the size limitation of the nucleophiles which can be used in the displacements 
at the phosphorus centre as large, bulky groups gave drastically reduced 
yields. Furthermore, this route like other P-chiral synthetic routes also requires 
multiple recrystallization steps to achieve homochirality, which can have 




1.7 – Green chemistry 
 
Green chemistry is a broad discipline which encompasses and can be applied 
to almost all areas of chemistry but is mainly applied to the areas of synthesis, 
catalysis and chemical engineering.[50-54] Green chemistry is defined as “the 
design of chemical product and processes which reduce or eliminate the use 
or generation of hazardous substances” and there are 12 main principles[55,56] 
which can be considered when using the green chemistry approach which are 
defined as: 
 
1) Prevention of waste preferred over the treatment of waste 
2) Methods of synthesis should be atom efficient 
3) Synthetic products should not possess human/environmental toxicity 
4) Products should retain efficacy while reducing toxicity 
5) Solvents and other auxiliaries should be unnecessary where possible 
6) Reduction of energy requirements and use of ambient conditions 
7) Use of renewable feedstocks 
8) Reducing derivatives (i.e. protection/deprotection) 
9) Moving toward catalytic reagents from stoichiometric 
10) Design of biodegradable products 
11) Analytical methods for real-time hazard/pollutant prevention 
12) Use of safer reagents, which are benign in the event of an accidental spill 
 
Since 1990, when the US pollution prevention act was passed,[57] companies 
have aimed to reduce the level of pollutants produced through cost-effective 
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modifications to existing and new processes. This has led to the formation of 
E(nvironmental) factor for assessing the environmental impact of chemical 
processes and can be defined as the kg waste/kg product, where companies 
now strive for low E factors where zero equates to zero waste produced.[9] 
Journals such as Green Chemistry, first published by in 1999 by the Royal 
Society of Chemistry, have become a repository for all aspects of green 
chemistry in synthesis, catalysis and chemical engineering.[53,54,56,58] 
 
1.8 – Enzymes as biocatalysts 
 
Enzymes have been utilised for hundreds of years in the production of alcohol 
and other food products, mostly unbeknownst to the users of them. The first 
reported use of enzymes in synthetic chemistry was in the isolation of pure     
(-)-tartaric acid, by Louis Pasteur, where the opposite enantiomer, (+)-tartaric 
acid, was selectivity consumed by P. glaucum mould in a kinetic resolution.[59-
61] Since then, biocatalysis using enzymes has been at the forefront of green 
chemistry in recent years due to the chemo-, regio- and stereoselectivity 
(Scheme 12) shown by enzymes which allows for greater atom economy, as 
conventional protection and deprotection methods can be made redundant 








Scheme 12 – A) Lipase AS Amano catalysed chemo-selective hydrolysis of 49. B) 
2,6-dihydroxybenzoic acid decarboxylase catalysed regio-selective carboxylation of 
phenol 51. C) Candida m. carbonyl reductase catalysed stereo-selective reduction of 
53. 
 
Furthermore, enzymes allow for the move from stoichiometric reagents to 
catalytic reactions. Biocatalysts typically operate in neutral aqueous 
conditions, which is environmentally benign, as well as them being 






1.8.1 – Enzyme structure 
 
Enzymes are protein macromolecules which can split into a four-tier hierarchy 
of structure consisting of primary, secondary, tertiary and quaternary 
functions, which is summarised in Figure 8. The primary structure relates to 
the enzyme’s amino acid sequence, consisting of combinations of the 21 key 
amino acids, bonded through the strong amide bonds between each amino 
acid. Due to the nature of the amino acids’ hydrogen bonding donating and 
accepting ability, H-bonding between neighbouring amino acids leads to the 
secondary structure of enzymes which manifests most commonly as either α-




Figure 8 – The structural formation of proteins showing the primary, secondary, 
tertiary and quaternary structure to give the assembled macromolecular protein.[66] 
 
The secondary structures fold further into a more stable, tertiary structure, 
which is driven through the lower energy isolating alkyl and other non-polar 
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residues internally, away from the aqueous environment they are formed in. 
Inversely, the polar residues are situated towards the surface of the protein to 
interact with the aqueous environment and stabilise the structure of the 
protein. Furthermore, additional bonding interactions occur such as π-π 
stacking between aromatic residues, Van der Waals forces, disulfide bonds 
between cysteine residues and salt bridges to enforce the 3D shape of the 
tertiary structure. Finally, the quaternary structure is formed when any number 
of the additional interactions bring together separate tertiary structures to form 
the final, protein structure.[66,67] Enzymes may also contain tightly bound metal 
ions such as iron, copper or molybdenum to aid in catalysis or use fusible co-
factors such as FAD and NAD(P) (Scheme 13). These co-factors assist in 
processes such as metabolism and electron transfer, a function that an 
enzyme could not carry out without the aid of co-factors. More specifically, they 





Scheme 13 – Redox activity of both NAD(P) and FAD to NAD(P)H and FAD. 
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1.8.2 – Mechanisms of enzyme activity 
 
As enzymes act as nature’s catalysts, they function like other chemical 
catalysts in that they increase the rate of the reaction without being consumed 
and without affecting the equilibrium of the reaction. They achieve this through 
reduction of the activation energy in a reaction coordinate, either through 
stabilisation of a transition state or through providing a lower energy pathway 
for the reaction. An enzyme catalysed reaction can be described through the 
formula shown in Scheme 14, in which the enzyme and the substrate form an 




Scheme 14 – Generalised reaction of an enzyme (E) and substrate (S) leading to 
the enzyme-substrate complex (ES) to give the enzyme and product (P). 
 
A key feature of enzymes is that the reaction takes place inside the active site 
of the enzyme where certain amino acid residues bind to the substrate. Emil 
Fischer initially postulated that the binding of the substrate to the active site of 





Scheme 15 – The induced fit model postulated by Koshland in 1958.[71,72] 
 
However, the ‘lock and key’ theory has been disproven in favour of the induced 
fit model (Scheme 15), as the lock and key theory would lead to a stabilised 
enzyme-substrate complex of such low energy that it would be difficult to 
overcome the energy barrier to reach the transition state. Inversely, the 
induced fit hypothesis describes that upon binding of the substrate to the 
enzyme leads to a conformational shift in the active site which can stabilise 
the transition state instead of the enzyme-substrate complex.[71-73] 
 
1.9 – Enantioselective enzymatic transformations 
 1.9.1 – Enzymatic kinetic resolution 
 
The space, residues, and interactions of the substrate within the active site are 
what give enzymes their high degree of chemo-, regio- and 
stereoselectivity.[66,68,69] This high selectivity shown by enzymes has been 
utilized in the resolution of racemates in a process called kinetic resolution, 
where an enzyme displays an increase in rate when acting upon a favoured 
enantiomer. This effectively leads to a separation of enantiomers, through 
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chemical modification of the more reactive enantiomer and this process has 
been used extensively in organic synthesis, especially where enantiopure 
pharmaceuticals and chiral building blocks are vital.[74-76] Juaristi et al. used a 
kinetic resolution in the separation of (R/S)-ketorolac, a non-steroidal anti-
inflammatory, whose separate enantiomers show differing 
pharmacokinetics.[77,78] The kinetic resolution could be achieved via the lipase 
catalysed esterification of rac-57 to give enantiopure (R)-58 (Scheme 16) and 
(S)-57 in high e.e. or via the lipase catalysed hydrolysis of the propyl ester rac-




Scheme 16 – Enzyme-catalysed kinetic resolutions of rac-ketorolac (rac-57) and 
rac-59 to give enantiopure esters (R)-58/59 and (S)-57 in high e.e. 
 
1.9.2 – Enzymatic dynamic kinetic resolution 
 
Whilst use of enzymatic kinetic resolutions in synthetic routes provides a 
means to access enantiopure compounds, this is normally accompanied by a 
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maximum 50% yield. However, this can be offset by using a dynamic kinetic 
resolution (DKR) in which the unreacted starting material is able to epimerize 
throughout the reaction to allow complete consumption of the starting material. 
For example, this can be achieved through the addition of a metal complex 
which can catalyse the epimerization of a chiral alcohol via a redox process.[79] 
The metal catalyst catalyses the reversible interconversion of the enantiomeric 
alcohols while the enantioselective lipase is able to selectively acylate one 
enantiomer.  The first example of this type of chemo-enzymatic transformation 
was reported by Williams et al., who used the rhodium catalyst [Rh2(OAc)4] 
and a lipase from Pseudomonas fluorescens.[80] This methodology has been 
applied in the total synthesis of the natural product stagonolide-C (64) in which 
the two chiral building acetates 61 and 63 were made by dynamic kinetic 
resolution using Candida antarctica lipase (CAL-B) (Scheme 17).[81] 
 
 
Scheme 17 – Dynamic kinetic resolutions of precursor fragments 61 and 63 which 





1.9.3 – Enzymatic desymmetrization 
 
As with dynamic kinetic resolution, enzymatic desymmetrization also allows 
access to enantiopure molecules without the loss of yield associated with 
kinetic resolutions but also without the need for epimerisation of the substrate, 
which is not always possible. Alexander Ogston, in 1948, first highlighted the 
ability of enzymes to react asymmetrically on prochiral molecules with 
enantiotopic groups through selective interactions within the structure of the 
enzyme.[82-84] Although the incorporation of an enzymatic desymmetrization 
into a synthetic route can be challenging due to the need to incorporate a 
prochiral or meso molecule into the synthetic plan, this approach is often 
favoured over kinetic resolution due to the potential increased yield. Chen et 
al. reported the desymmetrization of the meso 1,4-ester 65 (Scheme 18) 
leading to an intermediate (66) in the synthesis of biotin 68, utilizing vinyl 
acetate and pig liver esterase (PLE).[85] 
 
 
Scheme 18 – Lipase-catalysed desymmetrization of meso diol 65, leading to biotin 




1.10 - Enzymatic synthesis of chiral phosphorus compounds 
 
The use of enzymes in the enantioselective synthesis of phosphorus 
containing compounds is much less explored than that of chemical methods. 
However, there is literature precedent for this type of transformation. The use 
of enzymes has been demonstrated on P(III) compounds[86-88] and numerous 
groups of P(V)  compounds[89-92], highlighting the broad spectrum of enzyme 
substrates. The kinetic resolution of tertiary phosphine oxides containing an 
ester group has been reported by Kazlauskas et al. where a lipase from 
Candida rugosa was used to resolve the phosphine oxide 69 to give the 
alcohol (R)-70 in 90% e.e. which could be methylated give the (R)-71 in 99% 
e.e. after recrystallisation (Scheme 19).[89] 
 
 
Scheme 19 – Hydrolytic resolution of 69 to give (R)-70 in 90% e.e. which was 
improved upon after methylation to give 71 and subsequent recrystallisation.[89] 
 
In addition to the kinetic resolution demonstrated by Kazlauskas et al., Xiang 
et al. reported complementary enzymes for the diastereoselective hydrolysis 
of phosphoramidate 72, which is a precursor to several anti-viral prodrugs. 
Utilizing two different mutants of the enzyme phosphotriesterase (PTE), Xiang 
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et al. was able to access both diastereoisomers of the drug precursor through 




Scheme 20 – Diastereoselective hydrolysis of 72 by two mutants of PTE to give 
each diastereosiomer of the phosphoamidate ((SP)-72 and (RP)-72). 
 
 
1.11 – Copper-catalysed asymmetric 1,6-boration 
 
Although phosphines and chiral phosphines have a multitude of different 
applications in catalysis, the asymmetric copper catalysed 1,6-boration of 
unsaturated compounds is one area which could benefit from the use of P-
chiral monodentate phosphines. The related copper catalysed 1,4-boration is 
well described in the literature with both applications and mechanistic insights 
having been published.[93-95] However, the analogous 1,6-boration is less 
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researched mainly due to the difficulties with both -regio and -stereoselectivity, 
further complicated by limited mechanistic understanding for the 1,6-addition. 
The 1,6-boration of α,β,γ,δ-unsaturated esters has been reported in the 
literature to give allyl borates in 4 different isomeric forms, as shown in Figure 





Figure 9 – The 4 possible products from the copper catalysed 1,6-boration of 
α,β,γ,δ-unsaturated ester or ketones. 
 
Kobyashi et al.  published the 1,6-boration of cyclic diene esters such as 73 to 
form E-homoallylic allyl borates in an aqueous, copper-catalysed reaction. The 
reaction was done using the chiral, bidentate, pyridine-based ligand 74 
(Scheme 21) along with several different copper (II) sources. Using these 
conditions, both the 1,4-boronate 75 and 1,6-boronate cyclic E-allyl borate 76 
could be accessed depending on the addition of acetic acid or on the copper 
salt used, with up to 99:1 regioselectivity for the 1,6-boration over the 1,4-
boration with relatively high e.e. Kobayashi et al. then went on to show that 
use of Cu(OH)2 led to a heterogeneous system, most likely due to the 
formation of an insoluble polymeric µ-hydroxide, which due to steric factors 
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disfavours the formation of 1,4-addition. Inversely, the use of Cu(OAc)2 led to 
a homogenous system in which the reactive species was found to be the less 
sterically demanding, (pin)B-Cu(OAc)-Lig (confirmed by ESI-MS), explaining 
why 1,4-addition is possible and in some examples heavily preferred.[96] 
 
 
Scheme 21 – Copper catalysed 1,6-boration of cyclic diene ketones using a bi-
dentate pyridine ligand. 
 
Lam et al. have shown the selective, controlled asymmetric copper catalysed 
1,6-boration to acyclic α,β,γ,δ-unsaturated ketones with the use of the bi-
dentate phosphine ligand, Josiphos 9 (Scheme 22). By switching the solvent, 
the concentration of the substrate, the equivalents of isopropanol and the 
steric bulk of the group alpha to the ketone either the chiral Z-homo allylic 
borate (78) or the E-allylic borate (79) can be accessed, shown in Scheme 22 




Scheme 22 – Copper catalysed 1,6-boration of acyclic α,β,γ,δ-unsaturated ketones 
with bidentate Josiphos ligand to give either the (Z)-α,β or (E)-γ,δ product depending 
on addition of isopropanol and solvent. 
 
Table 6 – Solvent conditions and reaction conditions which give access to the allylic 
and homo-allylic products. 
Solvents Concentration [M] (Z)-α,β-78:(E)-γ,δ-79 
iPrOH:THF (1:1) 0.1 1:14 
THF 0.1 1:1 
Cyclohexane/THF (4:1) 0.04 >19:1 
 
Lam et al. went on to apply this reaction to α,β,γ,δ-unsaturated esters using 
the Josiphos ligand on significant scale. This led predominately to the (E)-allyl 
borate with a high regioselectivity of > 19:1 for the 1,6-allyl borate over the 1,4-
allyl borate and progressed in 95% e.e. (Scheme 23). The chiral, E-allyl borate 
could then be selectively oxidized with NaBO3.4H2O to yield the corresponding 
allylic alcohol. More interestingly, Lam et al. showed that the 1,6-allylborate 
could also be used in a stereoselective allylboration with benzaldehyde and 
lewis acid, BF3, as shown in Scheme 23, lead to an inseparable mixture of a 
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23:1 ratio of the (E)-/(Z)- isomers of the anti- adduct proceeding through a 
Zimmerman-Traxler transition state.[97,98] 
 
 
Scheme 23 – Copper catalysed 1,6-boration with the chiral bidentate phosphine 9 to 
give the (E)-γ,δ product 81 which on allyl boration with benzaldehyde and BF3 gives 
the anti- adduct 82 in a 23:1 mixture of (E) to (Z) products. 
 
Lam et al.  and personal communication with Prof. Luo (Co-author Ref. [97,98]) 
have shown that if the same copper catalysed 1,6-boration is carried out with 
the use of an achiral mono-dentate, phosphine ligand, this leads to the (Z)-
allylborate with high selectivity, albeit a racemic mixture.[99] When this (Z)-
allylborate undergoes allylboration under the same conditions as above, this 
would lead to a racemic mixture of the syn-adduct with increased selectivity 




Scheme 24 - Copper catalysed 1,6-boration with the achiral mono-dentate phosphine 
to give the (Z)-γ,δ product 83 which on allyl boration with benzaldehyde and BF3 gives 
the syn- adduct 84 with high (E)- selectivity. 
 
Literature routes through to the acyclic, chiral 1,6-(Z)-allylborate are hitherto 
unknown, which is further complicated through the lack of mechanisms for the 
copper catalysed 1,6-boration. Based on the preliminary work by Luo et al., 
we believe a P-chiral, monodentate ligand would give access to the chiral (Z)-
γ,δ-allylborate with the same high (Z)-selectivity. On allylboration, this would 
give a single enantiomer of the syn-adduct with high (E)-selectivity, which can 
be rationalised through the Zimmerman-Traxler transition state shown in 




Scheme 25 – Proposed copper catalysed 1,6-boration with the mono-
dentate, P-chiral ligand which will allow for formation of the chiral (Z)-γ,δ 
















1.12 – Project aims 
 
Based on the preliminary work by Lam et al. and personal communications 
with Professor Yunfei Luo,[97-100] we hypothesised that a P-chiral tertiary triaryl 
phosphine such as the target ligands, shown in Figure 10,  would allow us to 
access the chiral (Z)-γ,δ-allylborate 85 (Schemes 24 and 25) via the copper-
catalysed 1,6-boration.  
 
 
Figure 10 – Target ligands for the copper-catalysed 1,6-boration reaction. 
 
Furthermore, we believed that tertiary triaryl phosphines 87 and 88 would also 
display oxidative stability, due to high steric demands, allowing them to be 
stored and used under atmospheric conditions, increasing potential 
application.[27,28]  We hypothesised that due to the large cone angle shown by 
tertiary triaryl phosphines, the target ligands would show good asymmetric 
induction during catalysis leading to high selectivity and enantiomeric excess 






We envisaged a chemo-enzymatic synthesis of P-chiral phosphines and 
phosphine oxides using the enantioselectivity of enzymes to introduce chirality 
(Scheme 26). Starting from commercially available halophosphines (89 and 
90), we planned to synthesise the phosphine substrates 91 and 92 which could 
be subjected to enzymatic kinetic resolution or desymmetrization respectively. 
The desymmetrization of 92 would be the quickest and most efficient route to 
install chirality since the substrate would require no prior derivatization. 
Furthermore, the implementation of a desymmetrization would give us the 
potential for a greater yield of over 50%, which is normally the limit of a kinetic 
resolution. Kinetic resolution could still give us access to P-chiral compounds 
albeit with a lower yield. However, access to P-chiral compounds was more 
important than the accompanying yield. In addition, any left-over material from 
a kinetic resolution could be recycled back into the enzymatic reactions. 
Chemical modifications of the P-chiral compounds would then allow us to fine 
tune the structure of the phosphine to produce stable ligands for the intended 




Scheme 26 – Proposed chemo-enzymatic route utilizing either enzymatic 
kinetic resolution or desymmetrization and chemical modifications to give 





2 – Results and discussion 
 
2.1 - 1st Generation synthesis of prochiral phosphines 
 
To gain access to a P-chiral monodentate ligand we first had to synthesise a 
racemic phosphine which could be enzymatically resolved, or a pro-chiral 
phosphine which could be enzymatically desymmetrized. Based on this we 
hypothesized that a prochiral, triaryl phosphine with ortho- substituents 
(Scheme 27) would allow for straight forward synthesis from simple, available 
halophosphines as well as options to more than one type of enzymatic 
transformation. 
 
Scheme 27 – Approach to the chemo-enzymatic synthesis of chiral phosphines. 
 
We chose a pro-chiral triarylphosphine with benzylic hydroxyl groups in the 
ortho- position, as this is a group which can be enzymatically acted upon. The 
hydroxyl group of 2-bromobenzyl alcohol was protected using DHP in DCM 
with p-TSA (Scheme 28). The choice of a THP protecting group was due to 
its inherent stability under basic and nucleophilic conditions, something which 
was needed for the upcoming steps, in addition to its straightforward removal 





Scheme 28 – Protection of 2-Bromobenzyl alcohol (96) with DHP under acidic 
conditions. 
 
The addition of 97 to dichlorophenyl phosphine to give the tertiary phosphine 
was initially attempted through the formation of the Grignard reagent 98 
(Scheme 29), a method which is prevalent in the literature for the synthesis of 
phosphines.[102-103] However, the initiation step in which magnesium is inserted 
across the C-Br bond to facilitate the formation of the Grignard reagent could 
not be replicated in similar conditions to that in the literature. 
 
 
Scheme 29 – Attempted synthesis of the triaryl phosphine 99 through Grignard 
formation and subsequent addition to dichlorophenyl phosphine which should yield 
the phosphine. 
 
Due to the lack of reactivity via the Grignard method, the THP protected 97 
was instead reacted with a slight excess (1.1 eqv.) of n-BuLi at -78oC in order 
to facilitate lithium-halogen exchange and the formation of the species 100 
(Scheme 30). Dichlorophenyl phosphine (0.5 eqv.) was then added dropwise 
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to the reaction, left to warm up to room temperature and subsequently stirred 
for 12 hours. After purification by column chromatography the desired 
phosphine 99 was obtained in quite a poor yield (<20%). The observed poor 
yield of the reaction may have been to be due to the less than optimal amount 
of lithium-halogen exchange occurring to form the nucleophilic species and 
then the competing nucleophilicity of any unreacted n-BuLi.  
 
 
Scheme 30 – Formation of the triaryl phosphine through lithium-halogen exchange 
of the -THP protected 2-bromobenzyl alcohol 97 which was subsequently added to 
dichlorophenyl phosphine. 
 
Deprotection of 99 was completed in methanol and catalytic p-TSA proceeded 
with a poor yield, which was unexpected. On further analysis of the 31P NMR 
of the product, it was shown that the phosphine 101 was spontaneously 
oxidizing in air to form the corresponding phosphine oxide 102 (Scheme 31). 
This oxidation was highly unexpected for a triaryl phosphine, since 
triphenylphosphine shows high stability to oxidation by atmospheric oxygen in 
air. Analysis by 31P NMR identified the corresponding phosphine oxide due to 
the different shift compared to the phosphine, with the phosphine displaying a 
31P NMR shift of δ -27.1 and the phosphine oxide showing a shift of δ 40.5. It 
was found that the phosphine was oxidizing at a rate of just over 25% per hour 
which shows that the phosphine is highly unstable in atmospheric oxygen even 
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at room temperature. The observed poor oxidative stability could be due to the 
proximal hydroxyl group which has the potential to stabilize a radical 
intermediate species in the mechanism of oxidation, an effect which has been 




Scheme 31 – Deprotection of -THP group in acidic methanol which also led to the 
phosphine oxide 102 through oxidation from in air at approximately 27% conversion 
in an hour. 
 
In parallel, the bis-aldehyde analogue 105 was also synthesised via a similar 
route, shown in Scheme 32. Protection of the aldehyde derivative 103 through 
acetal formation was achieved through the addition of either ethylene glycol or 
triethyl orthoformate under acidic conditions which progressed in >85% yield 
and was easily characterized by the loss of the downfield aldehyde proton 
peak. This was then reacted in the same manner as described previously, 
where a slight excess of n-BuLi (1.1 eqv.) was added to 104 at -78oC after 
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which 0.5 equivalents of dichlorophenyl phosphine was added dropwise, in 
half an equivalence with yields ranging from 27-40% (Scheme 32). 
 
 
Scheme 32 – Ethyl acetal protection of 2-bromo benzaldehyde (103) followed by 
lithium-halogen exchange, and addition of dichlorophenyl phosphine to yield the 
phosphine, 105. 
 
The removal of the acetal group was attempted in acidic acetone under reflux 
via acetal transfer to acetone. This deprotection step led to an unexpected 
product. Analysis of the crude material by 31P NMR highlighted three main 
peaks at δ -16.9, -37.1 and -42.7 and 1H NMR highlighted several peaks 
around 5 ppm which would not have been present in the expected aldehyde 
product 106. Purification of the crude material led to the identification of the 
phosphorus peak at δ -16.9 belonging to the expected product 106 and the 
two peaks at δ -38.1 and -43.9 belonging to a single compound.  Previous 
literature has highlighted that the under these conditions compound 106  has 
been shown to undergo an aldol reaction with acetone to give the intermediate 
107 which subsequently oxidised and cyclized to give the product, 108 
(Scheme 33).[104] Similar to compound 101, the poor oxidative stability shown 
by 106 under the deprotection conditions could be due to the formation of the 
proximal hydroxyl group in the intermediate 107, which again  may stabilize an 
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intermediate in the oxidation of the phosphorus centre.[28] Although we did not 
fully characterize the compound 108, the 1H and 31P NMR support the 
formation of the spirophosphorane as the preliminary data was in agreement 
with the literature.[104,105] 
 
 
Scheme 33 – Acetal transfer deprotection of 105 leading to the aldol reaction 
product 107 which subsequently cyclizes to yield 108. 
 
The deprotection of 105 did however proceed as expected using 1 M HCl in 
THF to give 106 in 83% yield without any observed cyclized product. The 
phosphine 106 also showed stability to oxidation. Although we did have a route 
to both phosphines, stability to oxidation was an issue for the phosphine 101 
and therefore any means to bypass the potential loss of yield through oxidation 




2.2 – Synthesis of the pro-chiral phosphine oxide 
 
In order to by-pass the problem of oxidation seen with phosphine 101, we 
hypothesised that the synthesis of the phosphine oxide 102 directly would 
simplify matters. The problem of oxidation stability could potentially be 
addressed later through the addition of groups that might increase stability. 
We could produce the chiral phosphine oxides through enzymatic reactions 
and then reduce the phosphine oxide to the phosphine prior to use in an 
oxygen-free atmosphere. However, bench top stability would be preferable for 
further application of any ligands synthesised. The phosphine oxide 102, was 
synthesised, initially following the same route as shown in Scheme 30. 
However, prior to purification the crude material 99 was dissolved in a 2:1 
mixture of DCM and water and excess hydrogen peroxide (Scheme 34) was 
added and left to stir at room temperature until the phosphine had been 
oxidised to 109. Crude 1H NMR of the reaction mixture showed that there was 
the possible presence of atropoisomers as the crude analysis contained an 
extra set of identical peaks and so the product was not fully characterized. The 
THP deprotection step was performed without purification of 109 and did not 








Scheme 34 – Synthesis of phosphine, 99, and subsequent oxidation to the 
corresponding phosphine oxide 109 with hydrogen peroxide in a DCM:water 
solution. 
 
The removal of the THP groups was attempted in methanol with 10% p-TSA. 
However, this reaction also gave an unexpected product as 31P NMR analysis 
showed a peak at δ -36.9 which was a phosphine-like shift, which did not 
correspond to the phosphine oxide product. A literature search showed that 
the under acidic conditions, the pro-chiral phosphine oxide 102 undergoes 
spontaneous cyclization to form the spirophosphorane 110, via the 
mechanism shown in Scheme 35,[104,105]  and was present in our reaction in 
73% yield compared to the 23% yield of the expected un-cyclized product, 






Scheme 35 – Acid catalysed cyclisation of 102 to give the spirophosphorane, 110. 
 
Fortunately, the spirophosphorane was much less polar and could be easily 
separated away from the product by column chromatography. 
Spirophosphorane 110 was then hydrolysed back to the desired product 102 
through refluxing in a mixture of 2:1 ethanol and water along with concentrated 
hydrochloric acid (Scheme 36).[105] 
 
 
Scheme 36 – Hydrolysis of 110 back to the diol 102 through refluxing in an acidic 
solution of ethanol and water. 
 
The spirophosphorane 110 showed an interesting splitting pattern in its 1H 
NMR spectrum as it displayed extensive splitting of the -CH2 groups adjacent 
to the P,O-phosphoether bond. These diastereotopic CH2 protons displayed 
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different small J3HP couplings of 5.7 and 2.2 Hz and then a larger, J2HH geminal 
coupling of 14.2 Hz (Figure 11). 
 
 
Figure 11 – 1H NMR splitting of methylene protons of the spirophosphorane, 110. 
 
The prochiral diol 102, was characterised by 1H NMR showing 4 methylene 
protons which resolved to two separate doublets at δ 4.67 and 4.58 (J = 12Hz), 
again due to them being diastereotopic, a broad peak for the -OH, which would 
sometimes resolve into a triplet depending on sample concentration, and an 
aromatic region containing 13 protons. Analysis by 31P NMR showed a single 
peak at δ 40.4 and HRMS identified a mass of 361.0964 m/z corresponding to 
the [M+Na]+ ion, all of which was in agreement with literature.[102] 
 
2.3 – 2nd Generation synthesis of the pro-chiral substrate  
 
Whilst the 5-step route to 102 was successful, the overall yield was modest 
(<20%). Therefore, any possible optimization of the route to produce the 
enzymatic substrate would allow for much higher throughput for the project. 
Literature searching revealed a route for the synthesis of a similar, phenolic 
tri-aryl phosphine from the corresponding phosphonate (111) via a lithium 
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mediated 1,3-rearrangement (Scheme 37).[106,107] This reaction proceeds 
through the deprotonation of the aromatic proton, -ortho to the phenoxy group 
by LDA, to form the carbanion which undergoes the intramolecular 
rearrangement to form a more stable phenoxide anion. This method would 
also allow us to synthesise the pro-chiral phenolic derivative 112, which could 
potentially be enzymatically desymmetrized to give a chiral phosphine oxide. 
 
 
Scheme 37 – LDA-induced 1,3-rearrangement of the phosphonate to the phosphine 
oxide. 
 
We hypothesised that the same rearrangement could be achieved on a 
benzylic phosphonate to form 102. Literature searching of this reaction 
showed that it had not previously been attempted on a benzylic phosphonate 
derivative and so conditions for the analogous 1,4-rearrangement reaction 
were unknown. In order to test the viability of this rearrangement, we 
attempted to synthesise the 2-bromoaryl phosphonate 114, which was 
achieved by two different methods.[108-111] The first method attempted to 
synthesise the phosphonate was the use of 2-bromobenzyl alcohol (96), with 
DIPEA and a catalytic amount of DMAP (Scheme 38). The mixture was stirred 
for an hour after which dichlorophenyl phosphine was added dropwise and the 
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reaction was left to stir for 18 hours at room temperature. After work up the 
resulting residue was dissolved in a 2:1 solution of DCM and water and an 
excess of hydrogen peroxide was added to oxidise the phosphorus from P(III) 
to the P(V), phosphonate. This led to the formation of the phosphonate 114 in 
a modest 32% yield. We then attempted a second approach for the synthesis 
of the phosphonate 114.  
 
 
Scheme 38 – Initial synthesis of the phosphonate 114 through the addition of 
DIPEA to the benzyl alcohol and then the addition of dichlorophosphine followed by 
oxidation to the phosphine oxide. 
 
Lithium diisopropyl amide (LDA) was added to 2-bromobenzyl alcohol 96 at -
78oC to form an alkoxide after which phenyl phosphinic dichloride was added 
to the reaction dropwise at room temperature to form the phosphonate 
(Scheme 39). This method ensured the deprotonation of the hydroxyl group 
and disposed of the need for a separate oxidation step, resulting in higher 
yields (75%) than the previously described method in Scheme 37. As with the 
spirophosphorane 110, the benzylic phosphonates displayed a similar 1H NMR 
-CH2 splitting pattern, but with a small, identical, J3HP coupling constant of 7.2 
Hz due to the proximity of the phosphorus atom and a large J2HH coupling 
constant of 12.7 Hz due to them being diastereotopic protons. The 31P NMR 
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also showed a single peak with a shift of δ 19.79 which is also in agreement 
with similar phosphonates shown in the literature.[109-111]  
 
 
Scheme 39 – Synthesis of the phosphonate 114 through the addition of LDA to 96 
and then addition of phenyl phosphinic dichloride. 
 
Now that we had access to the phosphonate 114, we probed conditions which 
would initiate the 1,4-rearrangement through metallo-exchange of the aryl 
halide bond creating the nucleophilic species. The first method attempted 
utilised Mg and I2, to form a Grignard reagent (Scheme 40). Unfortunately, 
initiation via this method did not occur at room temperature but only when the 
reaction was refluxed for an extended period, which ultimately led to 
degradation of the phosphonate. Interestingly, analysis of the crude material 
from the reaction by 31P NMR showed a small amount of spirophosphorane, 
110, at δ -36.8. For 110 to be present in the reaction mixture, there must have 
been the formation of a P-C bond, showing that there is some scope for 1,4-
rearrangement through initiation of the C-Br bond.  
 
 
Scheme 40 – Failed Grignard reaction leading to phosphoric acid and a small 




To further probe the initiation of the C-Br bond we attempted the use of 
iPrMgCl.LiCl (Turbo Grignard), which is commonly used to facilitate the 
metallo-exchange group from the isopropyl group to the carbon-halogen bond 
of another molecule.[112,113] Turbo Grignard was added at 0oC to the 
phosphonate and the reaction heated by 10oC every hour but no activation 
occurred. The reaction was again heated to reflux for 24 hours but, no reaction 
was observed, and the starting material was fully recovered (Scheme 41).  
 
 
Scheme 41 – A failed attempt of the rearrangement of the bromo-containing 
phosphonate 114 using Turbo Grignard reagent. 
 
Due to the lack of reactivity shown by the Grignard-based reactions, n-BuLi 
was used to facilitate lithium-halogen exchange, as with the initial attempts at 
the synthesis of the phosphines and phosphine oxides. A slight excess of n-
BuLi was added at -78oC to the phosphonate in THF and left to warm up to 
room temperature overnight which lead to the formation of the pro-chiral 
phosphine oxide diol 102, in 5% yield as well as the product (116) resulting 





Scheme 42 – An n-BuLi initiated rearrangement of 114 leading to a small amount of 
the product, 102 and the by-product 116. 
 
It was thought that the yield of 102 could be further improved by moving to the 
more facile exchanging 2-iodoaryl phosphonate derivative to increase the 
chance of the subsequent intramolecular 1,4-rearrangement. The 2-iodoaryl 
phosphonate 118, was synthesised identically to 114 and progressed in a 
similar yield of around 75%. A slight excess of n-BuLi was then added to a 
solution of 118 in THF at -78oC over 15 minutes and the reaction was 
subsequently warmed up to room temperature and stirred overnight which lead 




Scheme 43 - Synthesis of the iodo-phosphonate 118 and subsequent n-BuLi 




To increase the yield of 102 further, the less nucleophilic, Turbo Grignard 
reagent was attempted again. Turbo Grignard (2.4 Eqv.) was added to 118 in 
THF at room temperature and the reaction was then left to stir for 24 hours 
leading to increased yields of 102 in up to 65%. A mechanism for this reaction 
is shown in Scheme 44. The initiation of the C-I bond at room temperature 
with Turbo-Grignard clearly shows improved reactivity of 118 compared to 114 
and validates our move to the iodo-containing compounds. Furthermore, the 
throughput of the material was increased as 102 could be purified from the 
crude material by crystallisation from an ethyl acetate: hexane mixture in high 
purity, eliminating the need for difficult separation by column chromatography. 
The remaining 35% yield was typically split between unreacted phosphonate 
or the displacement of benzyl alcohol from isopropyl group of Turbo Grignard. 
This increased the overall yield of the bis-diol to 50% over the two steps, up 
from ~25% over the 4 steps of the previous methods and now that a reliable 
method to the main pro-chiral substrate existed, the enzymatic de-












Scheme 44 – Turbo Grignard induced metallo-rearrangement of 118, to form the 
prochiral substrate, 102, for the enzymatic desymmetrization. 
 
2.4 - Expansion of the rearrangement reaction 
 
To further test the scope of the metallo-induced phosphonate rearrangement 
we attempted the reaction on two different alkyl containing phosphonates. In 
addition to this, we also attempted a possible 1,5-rearrangement of a triaryl, 
benzylic phosphonate, where the C-X bond was -meta to the phosphonate. 
We hypothesised that ethyl and cyclohexyl containing phosphonate 
derivatives would be good candidates to test the scope of the rearrangement 
and so the required phosphonates were synthesised. Both the ethyl, and 
cyclohexyl phosphonate derivatives were synthesised via the same route as 
the triaryl phosphonates 114 and 118. 2-iodobenzyl alcohol was deprotonated 
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with LDA and added to the corresponding alkyl phosphinic dichloride, or alkyl 
dichlorophosphine in the case of the cyclohexyl derivative. As the cyclohexyl 
dichlorophosphine could not be purchased as the oxide it was oxidized to the 
phosphonate prior to purification with hydrogen peroxide. The ethyl 
phosphonate derivative 119 proceeded in a yield of 56% whereas the 
cyclohexyl derivative 121 proceeded in 44% yield over the two steps, which 




Scheme 45 – Synthesis of the two alkyl diphenyl phosphonates, 119 and 121, 
through the addition of LDA to 117 and then through the addition of ethyl phosphinic 
dichloride or cyclohexyl dichlorophosphine. 
 
Turbo Grignard (2.4 Eqv.) was then added to the diphenyl alkyl phosphonates 
in THF at room temperature and monitored by TLC. The reaction with the ethyl 
derivative 98 led to several different products by TLC including cleavage of the 
phosphonate to yield benzyl alcohol (Scheme 46) as well as two different 
products which did not resemble the phosphine oxide product expected. The 
rearrangement of the cyclohexyl derivative 121 also led to cleavage of the 
phosphonate to yield benzyl alcohol and another product by TLC (Scheme 
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46). The second product, unfortunately, showed heavy degradation during 
purification by column chromatography and gave an extremely complicated 
31P NMR and TLC, which was not evident in the crude analysis. We 
hypothesised that the presence of an alpha acidic proton on the alkyl groups 
may cause issues due to the proximity of the carbanion formed after the 
metallo-halide exchange which could deprotonate the alkyl proton and 
subsequently halt the intramolecular rearrangement. 
 
 
Scheme 46 – Failed rearrangements of 119 and 121 with turbo Grignard both 
leading to 122. 
 
Therefore, to test this idea we attempted the rearrangement of a tbutyl 
phosphophonate derivative. The phosphonate 124 was synthesised by 
addition of LDA to 2-iodobenzyl alcohol and then subsequent addition of tbutyl 
dichlorophosphine, as the corresponding oxide was not available. This meant 
that, like the cyclohexyl derivative, an extra oxidation step was needed to form 
the phosphonate, which was done through the addition of excess hydrogen 






Scheme 47 – Synthesis of the dibenzyl t-butyl phosphonate 124 from 2-iodobenzyl 
alcohol. 
 
Turbo-Grignard (2.4 eqv.) was then added to 124 in THF at room temperature 
and left to stir for 24 hours after which the reaction was worked up to give a 
very viscous, polymeric substance which was not soluble in organic or 
aqueous solvents. We hypothesised that this polymeric structure could be the 
result of an intermolecular reaction where subsequent units of phosphonate 
react instead of the intramolecular rearrangement, however we could not 
characterise the product that was synthesised (Scheme 48). This change in 
reactivity could be due to the increased steric hinderance at the phosphorus 
atom associated with the tbutyl group which could prevent formation of the 
cyclic intermediate. Further work could be done to establish conditions which 
allow for 1,4-rearrangement of alkyl containing phosphonates. 
 
 
Scheme 48 – Proposed polymeric, phosphorus-containing structure 125 from the 




Moving to the 1,5-rearrangement, the bis-3-iodobenzyl phenyl phosphonate 
127, was synthesised identically to 118 but proceeded in higher yields (89% 
vs 75%) than that of the ortho-substituted phosphonates (Scheme 49). This 
increased yield is most likely due to the lower percentage of lithium-halogen 




Scheme 49 – Synthesis of the phosphonate 127 from 126 following the same 
method for previous phosphonates. 
 
The Turbo-Grignard reagent was then added to 127 and the reaction was 
stirred for 18 hours, after which no rearrangement to the diol product was 
observed. The phosphonate, however, had undergone activation by the Turbo 
Grignard and was subsequently protonated upon workup leading to 128 
(Scheme 50), which was seen through the appearance of two new protons in 
the aromatic region of the 1H NMR. This highlights that the -meta lithiated 
species is not capable of undergoing the 1,5-rearrangement under analogous 
conditions to 118, most likely due to the increased distance from the 
phosphorus atom. This reaction could be probed further through various 






Scheme 50 – Failed metallo-induced 1,5-rearrangement of the bis 3-iodobenzyl 
phenyl phosphonate which led to the protonation of the carbanion on workup giving 
128. 
3 – Enzymatic transformations   
 
Now that we had produced the pro-chiral phosphine oxide 95, we could 
attempt the enantioselective enzymatic transformations to give P-chiral 
phosphine oxides. Due to the structure of 102, containing a benzyl alcohol, we 
hypothesised that both lipases and alcohol oxidases could show actiity 
towards this group to give a chiral product (Scheme 51). On this basis, and 
the fact that lipases typically operate in organic solvents[114], we hypothesised 
that this would be an ideal starting point for the desymmetrization of 102, due 
to its high lipophilicity.  
  
 






3.1 – Lipase-catalysed desymmetrization 
 
Initial screening for the enzymatic desymmetrisation of 102 to give a chiral 
phosphine oxide was attempted utilizing three different lipases, commonly 
used in the catalytic esterification’s. The three lipases which were all 
commercially available, included porcine pancreatic lipase (PPL), Candida 
antarctica lipase A (CAL-A) and Candida antarctica lipase B (CAL-B), both of 
which were immobilized on the immobead 150 support from Sigma Aldrich. 
Although both CAL-A and CAL-B lipases have been used extensively in the 
literature for the esterification of a variety of different substrates[115-117], neither 
of these enzymes have been shown to catalyse the desymmetrisation of triaryl 
phosphine oxides. A similar desymmetrisation (Scheme 52) and kinetic 
resolution had been performed on the diaryl alkyl phosphine oxide 131, but it 
was reported that no activity was seen on the triaryl phosphine oxide 102, due 




Scheme 52 – Literature desymmetrization of a diaryl methyl phosphine oxide 131 
leading to the chiral mono-acetate, but also the spirophosphorane, 133. 
 
The initial screening reactions were attempted using two acetate donors which 
were also readily available; isopropenyl acetate (ISPA) and vinyl acetate (VA) 
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as these are commonly used in lipase catalysed reactions. Both these vinyl 
acetate donors are key due to the ability of the leaving group to tautomerize to 
acetone and acetaldehyde, respectively, and subsequently prevent the 
reversible reaction from occurring.  In order to maximise reactivity, the reaction 
was attempted with the acetate donor as both the reactant and the reaction 




Scheme 53 – Initial screening of the desymmetrization of 102, with pyridine, a 
lipase and an acetate donor. 
 
We began with 25 mM of 95, 5 mg of either immobilized or lyphophilized 
enzyme made up to 1 mL with either VA or ISPA (Scheme 53). A small amount 
of pyridine (2 µL) was also added to the reaction to suppress the cyclization of 
102 to 110 which can occur due to the small amounts of water present in the 
enzyme which could potentially hydrolyse the acetate donor releasing acetic 
acid which would promote the cyclisation. The reactions were shaken at 37oC 
for 96 hours after which an aliquot was taken and analysed by chiral HPLC 
against a racemic standard of the mono-acetate 129, and the bis-acetate 134 
of which both were synthesised by addition of AcCl and Et3N to 102 in DCM 
(Scheme 54). Strangely, the mono-acetate 129 and the bis-acetate 134, both 
had the same Rf by TLC which made purification of the separate compounds 
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difficult. However, they could be separated by chiral HPLC column [Footnote1] 
which was sufficient for the condition screening reactions on an analytical 
scale, without the need for purification. 
 
 




A control reaction was also performed in parallel which contained all the 
reagents, but the enzyme was omitted to measure whether any background 
esterification was occurring from the presence of pyridine and vinyl acetate. 
However, it was shown that no product was formed in the absence of the 
lipase. Results of the initial reactions (Table 7) with the three lipases were 
varied, as PPL showed almost no activity on 102, whereas CAL-B showed 
some activity but an extremely low e.e. of less than 10%. CAL-A showed 
extremely promising activity for the first attempt as it displayed a conversion 
of 53% to the mono-acetate 129 with an e.e. of 81% with isopropenyl acetate 
and a conversion of 73% to the mono-acetate 129 with an e.e. of 91% when 
 




vinyl acetate was used as the acetate donor, which was surprising for the initial 























































Reaction Conditions: Incubated at 37oC at 180 RPM for 96 hours. Total volume 1 mL, 
25 mM substrate, vinyl acetate/isopropenyl acetate as solvent, 5 mg of 
lyophilized/immobilized enzyme, 75 mM pyridine. HPLC Conditions: Daicel AD 




3.1.2 – Immobead 150 CAL-A organic solvent screen 
 
As CAL-A gave the best result for the initial testing we subjected the lipase to 
several different conditions to see if both conversion and e.e. could be 
improved. Firstly, we screened desymmetrization of 102 in 5 different organic 
solvents. The use of organic solvents in enzyme catalysed reactions has been 
shown in the literature to drastically change the activity and selectivity of 
enzymes.[118-120] The chosen organic solvents included ethyl acetate, DCM, 
toluene, diethyl ether and THF alongside the two different acetate donors, vinyl 
acetate and isopropenyl acetate which were added in 3 equivalents (75 mM) 
















Table 8 – Solvent screening for the immobead 150 CAL-A catalysed 
desymmetrization of 102. 
Solvent Acetate Donor Conversion to 129 e.e. (129) 






























Reaction Conditions: Incubated at 37oC at 180 RPM for 24 hours. Total volume 1 mL, 
organic solvent to volume, 25 mM substrate, 75 mM vinyl acetate/isopropenyl acetate, 
5 mg immobead 150 CAL-A, 75 mM pyridine. HPLC Conditions: Daicel AD column, 
1.2 mL/min, 83% Hexane/IPA at 210 nm. 
 
Activity was only seen in toluene and diethyl ether after 18 hours. In toluene a 
conversion to 129 of 26% with ISPA and 53% with VA was found. Whereas 
diethyl ether showed a more consistent conversion to 129 of 46% in ISPA and 
47% in VA after 24 hours. Both solvents resulted in relatively high e.e. but 
diethyl ether gave better enantioselectivity of up to 90% e.e. despite the 
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substrate being much less soluble in diethyl ether than toluene. Although the 
use of diethyl ether as the reaction solvent gave favourable results, they did 
not outperform the use of VA as both solvent and acetate donor. 
 
3.1.3 – Effect of temperature 
 
The effect of temperature was also probed to see if this had any effect on both 
conversion and subsequent e.e. of the reaction. Due to the stability of the 
Candida antarctica lipase family,[121,122] we could increase the temperature 
beyond 37oC to 50oC without denaturing the protein, which is beyond the 
working range of most enzymes. In addition to the high temperature, we also 
attempted reaction with a decreased temperature of 20oC to see if a slower 
reaction would give better selectivity. Both reactions were attempted in vinyl 
acetate as solvent and donor, with the same concentrations of enzyme and 
substrate as used in previous screening reactions.  
 
Table 9 – Temperature screening for the Immobead 150 CAL-A catalysed 










20oC VA 36% 2% 77% 
37oC VA 67% 22% 91% 
50oC VA 41% 5% 64% 
Reaction Conditions: Incubated at 20-50oC at 180 RPM for 24 hours. Total volume 1 
mL, 25 mM substrate, vinyl acetate/isopropenyl acetate as solvent, 5 mg enzyme, 75 




Both the lower and higher temperatures showed a significant decrease in e.e. 
with 50oC giving an e.e. of 64% and 20oC giving an e.e. of 77% after 24 hours 
which when compared to 37oC (Table 9).  
 
3.1.4 – Enzyme concentration studies 
 
We then probed the concentration of the enzyme in the reaction and so 
increased the amount of enzyme three-fold, from 5 mg to 15 mg, to see how 
this would affect e.e. and the conversion. The reaction was left for 24 hours at 
37oC using vinyl acetate, as both the donor and the solvent. This led to a 
conversion of 72% and an e.e. of 92.7% which was the highest e.e. seen to 
this point in the project and was a promising step forward to potentially 
producing enantiopure compounds. In order to understand the dynamics of the 
desymmetrization reaction and how the e.e. changed over the course of a 24-
hour reaction, an aliquot from the reaction was taken at regular intervals and 
measured by chiral HPLC to gauge both the e.e. and conversion. The time plot 
in Figure 12 shows that over the 24-hour period, the e.e. began at 87.7% and 
then slowly increased to the final e.e. of 92.7% after 24 hours with a 





Figure 12 – 24 Hour time plot of Immobead 150 CAL-A catalysed desymmetrization 
of 102. Reaction Conditions: Incubated at 37oC at 180 RPM for 24 hours. Total 
volume 1 mL, 25 mM substrate, vinyl acetate as solvent, 15 mg of immobead 150 
CAL-A, 75 mM pyridine. HPLC Conditions: Daicel AD column, 1.2 mL/min, 83% 
Hexane/IPA at 210 nm. 
 
3.2 – Immobilization of CAL-A  
 
In another bid to improve the e.e. we hypothesised that the use of a different 
enzyme immobilisation support could give higher selectivity. The use of 
different supports has previously been shown in the literature to improve both 
the conversion and e.e. of lipase catalysed reactions.[123,124] We used three 
different enzyme supports which were available to us including, Eupergit CM, 
Purolite ECR8215 epoxy and Purolite ECR8285 butyl epoxy, all of which are 


































































Enantiomeric Excess (%) 129 Conversion (%) to 129 Conversion (%) to 134
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the opening of an epoxide ring on the support by the -NH2 of lysine residues in 
the structure of the enzyme (Scheme 55).  
 
 
Scheme 55 – Covalent attachment of the enzyme to the support through opening of 
an epoxide ring from the lysine residues of the protein. 
 
Immobilization of crude CAL-A to the enzyme supports was achieved through 
the addition of the immobilization support to a solution of the enzyme in pH 7, 
0.1 M potassium phosphate buffer. A concentration reading of the solution was 
taken at 0 hours and then the mixture was then left to shake at room 
temperature for 24 hours. After the allotted time, a second concentration 
reading of the solution was taken and the difference between the two values 
should equate to the enzyme loading. The three different supports showed 

































Reaction Conditions: Incubated at 37oC at 180 RPM. Total volume 1 mL, 25 mM 
substrate, vinyl acetate to volume, 15 mg of supported enzyme. HPLC Conditions: 
Daicel AD column, 1.2 mL/min, 83% Hexane/IPA at 210 nm. a) After 24 h b) After 48 
h. 
 
The Purolite butyl epoxy resin showed the greatest degree of loading at 3.4 
mg/mL followed by the Purolite epoxy resin at 2.4 mg/mL and lastly, the 
Eupergit resin showed the lowest enzyme loading at 2 mg/mL. Of the three 
supports the Purolite BE performance was far superior to both Eupergit and 
the Purolite epoxy resin giving a conversion to 129 of 67% and e.e. of over 
94% after just 24 hours (Table 10 & Figure 13). The Purolite butyl epoxy 
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reaction was left to shake for another 24 hours hour to see if any of the minor 
enantiomers was consumed via a double filter effect but unfortunately, this 
only led to an increase in e.e. of <1% but led to the consumption of 18% of 
mono-acetate. This shows that there is no selectivity for the second 





Figure 13 - Purolite butyl epoxy immobilized CAL-A catalysed desymmetrization of 102 (17.9 min) to give 129 (13.9 min and 20.2 min) in 95% 




3.2.1 – Purolite BE immobilized CAL-A condition screen 
 
To fully explore the reactivity of CAL-A supported on Purolite BE, we screened 
the range of conditions used with the Sigma Aldrich Immobead 150 CAL-A. 
We first tested whether VA or ISPA was superior as the solvent/donor. Purolite 
BE immobilized CAL-A only showed activity when vinyl acetate was used, 
which was surprising as both acetate donors had shown some sort of activity 
thus far under most conditions. We then attempted an organic solvent screen 
to gauge whether the Purolite BE support would show drastically different 
reactivity in various solvents. The same 5 solvents were used as in the 
previous solvent screen (with Immobead 150 CAL-A) which included a mix of 
polar and non-polar solvents.  The reactions were attempted on a 25 mM scale 
along with 3 equivalents of vinyl acetate (75 mM) and were left to shake at 
37oC for 18 hours. As with the previous solvent screen, activity was only seen 
in 2 of the solvents (Table 11), with vinyl acetate as both the acetate donor 









Table 11 – Solvent screening for the Purolite BE immobilized CAL-A catalysed 
desymmetrization of 102. 
Solvent Acetate Donor Conversion to 129 e.e. 
(129) 
EA VA 9% 23% 
DCM VA 0% N/A 
Toluene VA 0% N/A 
Et2O VA 7% 15% 
THF VA 0% N/A 
VA VA 65% 94% 
Reaction Conditions: Incubated at 37oC at 180 RPM. Total volume 1 mL, organic 
solvent to volume, 25 mM substrate, 75 mM vinyl acetate/isopropenyl acetate, 15 mg 
Purolite BE CAL-A. HPLC Conditions: Daicel AD column, 1.2 mL/min, 83% 
Hexane/IPA at 210 nm. 
 
Although the 3.4 mg/mL degree of immobilization of CAL-A onto the Purolite 
BE resin in pH 7, 0.1 M potassium phosphate buffer gave very favourable 
results in the desymmetrization of 95, we attempted to load a greater amount 
of enzyme to see if this increased the rate of conversion and the e.e. of the 
reaction. Increased buffer concentration has been known to influence the 
amount of enzyme loaded onto the support due to the increase in ionic 
strength of the solution. The loading was attempted again increasing the 
concentration of the phosphate buffer from 0.1 M to 1 M. This led to a 
significantly improved loading of CAL-A at 21 mg/mL onto the Purolite BE 
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support. We then attempted another time course reaction over 24 hours to 
gauge how the increased loading of the enzyme would affect the reaction. 
 
 
Figure 14 – 24-hour time plot of the Purolite CAL-A immobilized lipase catalysed 
acetylation of 102, with the increased degree of enzyme loading at 21 mg/mL. 
Reaction Conditions: Incubated at 37oC at 180 RPM for 24 hours. Total volume 1 mL, 
25 mM substrate, vinyl acetate as solvent, 15 mg of Purolite BE CAL-A (21 mg/mL), 
75 mM pyridine. HPLC Conditions: Daicel AD column, 1.2 mL/min, 83% Hexane/IPA 
at 210 nm. 
 
As shown in Figure 14, the increased loading of CAL-A led to a higher rate of 
conversion with 60% conversion after only 0.5 hours compared to only 31.5% 
conversion of the lower loaded (3.4 mg/mL) enzyme support. However, the 
increased loading of CAL-A had a negative impact on the e.e. of the product, 





























































Conversion (%) to 129 Enantiomeric Excess (%) 129 Conversion (%) to 134
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loaded support led to an e.e. of 87% which rose to a final value of just under 
93%. 
 
Table 12 – 24-Hour time plots for the 21 mg/mL and the 3.4 mg/mL Purolite BE 
immobilized CAL-A catalysed acetylation of 102. 
Time (Hours) 21 mg/mL  3.4 mg/mL 
 Conversion 
to 129 
e.e. (129) Conversion 
to 129 
e.e. (129) 
0.5 60% 83.4% 35% 87.7% 
1 72% 84.4% 42% 87.3% 
2 80% 85.1% 53% 87.6% 
3 84% 85.7% 61% 87.9% 
4 86% 86.1% 69% 89.5% 
5 88% 86.6% 75% 90.2% 
6 89% 86.9% 81% 90.5% 
24 93% 87.5% 93% 92.7% 
Reaction Conditions: Incubated at 37oC at 180 RPM. Total volume 1 mL, 25 mM 
substrate, vinyl acetate to volume (1 mL), 15 mg Purolite BE CAL-A (21/3.4 mg/mL). 
HPLC Conditions: Daicel AD column, 1.2 mL/min, 83% Hexane/IPA at 210 nm. 
 
3.2.3 – Substrate concentration with Purolite BE CAL-A 
 
We also probed how substrate concentration affected the conversion and e.e.   
so, this was varied over the range of 10 mM to 100 mM. At the higher substrate 
concentration of 100 mM, solubility was an issue, however at all other 
concentrations the substrate was soluble in vinyl acetate. The reactions were 
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shaken at 37oC for 18 hours and analysed by chiral HPLC, the results of which 
are shown in Table 13. 
 
 
Table 13 – Effect of substrate concentration on the Purolite BE immobilized CAL-A 









10 mM 86% 11% 85% 
25 mM 79% 16% 88% 
50 mM 82% 11% 87% 
100 mM 75% 4% 81% 
Reaction Conditions: Incubated at 37oC at 180 RPM. Total volume 1 mL, 10-100 mM 
substrate, vinyl acetate to volume, 15 mg Purolite BE CAL-A. HPLC Conditions: 
Daicel AD column, 1.2 mL/min, 83% Hexane/IPA at 210 nm. 
 
Whilst 25 mM substrate concentration did not give the greatest conversion to 
108, it gave the best e.e. by a small margin. However, it seems that substrate 
concentration does not have a great effect on either the activity or the 
enantioselectivity of the enzyme. 
3.2.4 – Water concentration screen with Purolite BE CAL-A 
 
At this point in the project, a larger batch of CAL-A was purchased to allow for 
scaling up of the reaction. Unfortunately, this batch showed slightly less 
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enantioselectivity than that of the previous batch. When the reaction was 
attempted with the new batch using the same conditions previously tested, this 
led to a lower e.e. of 90%, instead of the previously obtained e.e. of 95%. 
 
We attempted to remedy the loss of selectivity through the controlled addition 
of water to the enzyme support as previously published work[123] within the 
group and elsewhere has also shown that the degree of water still present 
within the enzyme support can have a remarkable effect on the activity and 
selectivity.[125-128] The residual water is bound to the enzyme allowing it to 
maintain its essential surface water tension and active conformation which is 
key for the retention of activity. In order to ensure that no water was present in 
the Purolite BE immobilized CAL-A, it was dried under vacuum until it was a 
free-flowing solid. Varying concentrations of water from 25 mM to 125 mM was 
then added back into the reaction, plus one reaction where the support was 
saturated with water and one reaction where it was fully dried.  The reaction 
was attempted under previous conditions with 25 mM substrate and vinyl 
acetate as both the acyl donor and solvent. Due to the addition of water to the 
reaction, hydrolysis of vinyl acetate to release acetic acid could potentially be 
an issue and therefore to mitigate this risk, 25 mM sodium bicarbonate was 
added, as opposed to pyridine which was previously used, due to it being less 
damaging to the protein. The reactions were left to stir at 37oC for 24 hours 
after which an aliquot was taken from each and analysed by chiral HPLC 
(Table 14). Interestingly, on the 1 mL scale reactions only a small percentage 
(<5%) of the spirophosphorane was observed meaning that the sodium 





Table 14 – Effect of water concentration in the Purolite BE immobilized CAL-A 
catalysed desymmetrization of 102. 
Concentration of 
water 






25 mM VA 46% 6% 81% 
50 mM VA 66% 11% 84% 
75 mM VA 75% 11% 84% 
100 mM VA 71% 16% 87% 
125 mM VA 73% 14% 86% 
Saturated VA 17% 3% 54% 
Dried VA 52% 3% 76% 
Reaction Conditions: Incubated at 37oC at 180 RPM. Total volume 1 mL, 25 mM 
substrate, vinyl acetate to volume, 25 – 125 mM H2O, 15 mg Purolite BE CAL-A, 25 
mM NaHCO3. HPLC Conditions: Daicel AD column, 1.2 mL/min, 83% Hexane/IPA at 
210 nm. 
 
It was shown that between 50 mM and 125 mM of water the outcome of the 
reaction was largely similar. However, the use of the saturated support 
drastically reduced the conversion and e.e. of the reaction which is most likely 
due to the repulsion of the lipophilic substrate. Although the addition of 100 
mM of water seemed to improve the reaction outcome slightly, we found the 
large loss in enantioselectivity could be remedied through the addition of three 
times as much immobilized CAL-A than used previously. These conditions 
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when combined on a small scale, 1 mL reaction again gave high conversion 
and an e.e. of just under 96%.  Fortunately, the immobilized enzyme could be 
reused in multiple reactions before a loss in activity is observed meaning that 
the increased addition of immobilized enzyme was not detrimental to the 
throughput of the chiral material.  
 
3.2.5 – Purolite CAL-A scale up reaction 
 
We then attempted to scale up to a 10 mL reaction volume (Scheme 56), using 
all of the combined conditions which gave the best results which included 25 
mM substrate, 25 mM sodium carbonate, 100 mM water, 5 equivalents w/w of 
Purolite BE immobilized CAL-A compared to the substrate, with vinyl acetate 
as solvent. The 10 mL reaction was shaken at 37oC for 24 hours after which 
an aliquot was taken for chiral HPLC analysis which showed that all starting 
material had been consumed and that the mono-acetate and bis-acetate were 
present in a 2:1 ratio and that the e.e. of the mono-acetate was at 95%. The 
reaction was worked up, the mono-acetate and bis-acetate were columned as 
a single spot due to their identical R.F. and analysed by 1H NMR and 31P NMR 
both of which confirmed the presence of the mono-acetate and bis-acetate in 







Scheme 56 – 10 mL scale reaction for the Purolite immobilized CAL-A 
catalysed desymmetrization of 102. 
 
We then attempted to increase the scale of the reaction again, up to 50 mL, 
which led to a very different outcome compared to the smaller scale reactions. 
The 50 mL reaction gave the spirophosphorane 110 was present in 60% 
conversion after 24 hours with only 21% of 129 (Scheme 57). The addition of 
water on the larger scale may have caused a greater amount of hydrolysis of 
the vinyl acetate which in turn would release a larger amount of acetic acid 
which the 25 mM of sodium bicarbonate could not negate.  
 
 
Scheme 57 – 50 mL scale purolite immobilized CAL-A catalysed 
desymmetrization which led to a large amount of 110 due to the acidic 
promoted cyclization of 102. 
 
We then attempted the reaction on this scale again but increased the 
concentration of sodium bicarbonate to 125 mM so that it was in excess of the 
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100 mM water which may cause the hydrolysis. The reaction was then left to 
stir at 37oC for 24 hours and an aliquot was taken which was then analysed by 
chiral HPLC. Even with excess sodium bicarbonate (125 mM), the reaction 
had still largely formed the spirophosphorane 110 due to the release of acetic 
acid. In order to find conditions which would prevent the cyclisation of 102 on 
the 50 mL scale reactions, we screened several different organic and inorganic 
bases, alongside 25 mM of substrate 95 and 100 mM of water in vinyl acetate 
as the solvent. These bases included pyridine (which had been used prior but 
not on a large scale), triethylamine, sodium carbonate, sodium acetate and di-
basic potassium phosphate buffer. We also included a control reaction which 
contained no base and another reaction in which water was omitted from the 
reaction. The reactions were shaken at 37oC for 18 hours and an aliquot taken 























Pyridine 43% 0% 44% 80% 
Triethyl amine 60% 4% 16% 81% 
Sodium 
Carbonate 
66% 5% 2% 80% 
Sodium Acetate 41% 0% 32% 67% 
No base 35% 0% 66% 80% 
Reaction Conditions: Incubated at 37oC at 180 RPM. Total volume 50 mL, 25 mM 
substrate, vinyl acetate to volume, 100 mM H2O, 2.5 g enzyme support. HPLC 
Conditions: Daicel AD column, 1.2 mL/min, 83% Hexane/IPA at 210 nm. 
 
Most of the bases did not prevent the formation of the spirophosphorane 110 
on the larger-scale reactions however, sodium carbonate did seem to give the 
lowest levels of 110 whilst retaining reasonable activity. We hypothesised that 
a lower concentration of water would be needed to retain activity and lessen 
the formation of the spirophosphorane on these larger scale reactions. As 
shown by Table 14, 50 mM of water gave similar results to 75 mM, and 
therefore a 50 mM concentration of water would give better results on the 
larger scale reaction and so these conditions were used to produce any chiral 
material on a larger scale. Unfortunately, using these conditions on larger-
scale reactions, the e.e. was shown to be slightly lower than the smaller scale 
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reactions (10 mL) which could most likely be attributed to the poor mixing 
ability of a shaker compared to other mixing methods. This could be remedied 
using some other mixing techniques such as a spin reactor which allows for 
the increased mixing of solutions without the destruction of the enzyme 
support. 
 
3.3 – Lipase-catalysed hydrolytic desymmetrization reactions  
 
To access the opposite enantiomer to that of the esterification, we also 
attempted the reverse, hydrolysis reaction as the singular hydrolysis of the 
corresponding bis acetate should allow us to produce the opposite enantiomer 
of 129. We synthesised 134 using 2 equivalents of acetyl chloride in DCM with 
the base, triethylamine and set up several conditions which have been shown 
in the literature to be used for the lipase catalysed hydrolysis of esters.[114, 129-
131] These conditions usually require a solvent which can be saturated with 
water or the use of biphasic systems which circumvent any issues of solubility 
which may arise with the inclusion of water, which could prove problematic 
due to the lipophilicity of our phosphine oxide. Initially we employed a biphasic 
system with toluene as the organic layer in which the substrate would be 
soluble and then a water layer to allow for hydrolysis to occur. The reaction 
was stirred vigorously to allow a mixture of the two layers and was left for 24 
hours at 37oC using the lipase, Immobead 150 CAL-A, and was followed by 





Scheme 58 – Lipase catalysed hydrolysis of 134, with a biphasic toluene/water 
solvent system. 
 
The enzymatic hydrolysis (Scheme 58) showed some activity towards the bis-
acetate 134 albeit low, with only 14% conversion to 129 over 24 hours with an 
e.e. of 18%, the double hydrolysed product diol 102 was also present in 1%. 
Although the ability to access the opposite enantiomer by means of hydrolysis 
would be useful, our synthetic approach (explained later), meant that this was 
not the only means by which we could access the opposite enantiomer and so 
the hydrolytic desymmetrization was not pursued further. 
 
3.4 – Kinetic resolution of derivatives of 102 
 
In addition to the desymmetrization reactions, we hypothesised that the kinetic 
resolution of a related benzyl containing compound could be beneficial as this 
would give us both enantiomers in the form of the resulting acetate and the 
unreacted enantiomeric alcohol. Kinetic resolutions are often employed in 
synthesis, usually favoured over desymmetrization reactions due to the 
difficulty in preparing pro-chiral substrates. We knew that the benzyl ether 
group would be stable to any enzymatic conditions but would also provide a 
large amount of steric bulk which may aid in the enzymatic kinetic resolution. 
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Therefore, benzyl bromide was added to 95 in 1.2 equivalents along with 2 
equivalents of silver oxide in DCM (Scheme 59). The reaction was monitored 
by TLC to show the formation of the mono-benzylated product. Only small 
amounts would be needed for screening, so we stopped the reaction after 5 
hours and purified the mono-benzylated product 135 in 20% yield. 
 
 
Scheme 59 – Synthesis of racemic 135 which can be used for the lipase catalysed 
kinetic resolution. 
 
For the kinetic resolution reaction of 135, we used the Purolite BE immobilized 
CAL-A which gave us the most favourable reactivity for the previous 
desymmetrization reactions. The substrate 135 was used at 25 mM 
concentration along with 1.5 equivalents of vinyl acetate (37.5 mM) as the 
acetate donor. The reaction was then made up to 1 mL with 5 different organic 









Table 16 – CAL-A catalysed kinetic resolution of 135 in different organic solvents. 
Solvent Yield of 135 e.e. of 135 Yield of 136 e.e. of 136 
VA 76% 28% 23% 88% 
DCM 100% 0% 0% 0% 
Et2O 56% 32% 23% 43% 
THF 100% 0% 0% 0% 
EA 96% 2% 4% 88% 
Toluene 95% 5% 4% 86% 
Reaction Conditions: Incubated at 37oC at 180 RPM. Total volume 1 mL, 25 mM 
substrate, vinyl acetate 37.5 mM, 20 mg Purolite BE CAL-A, organic solvent to 
volume. HPLC Conditions: Daicel AD column, 1.2 mL/min, 83% Hexane/IPA at 210 
nm. 
 
Only significant activity was seen in either VA or Et2O but in both the cases 
the selectivity was not as high as the desymmetrization reactions. Only small 
amounts of product (<5%) was seen in both ethyl acetate and toluene after 24 
hours and no activity was observed in THF and DCM. Although it would be 
beneficial to have access to both enantiomers via this method, the lower e.e. 
observed and the poor activity means this enzymatic reaction was not 





3.5 – Alcohol oxidase catalysed desymmetrization and kinetic 
resolution reactions 
 
Together with the lipase-catalysed reactions, the pro-chiral phosphine oxide 
102 could potentially be a substrate for an alcohol oxidase which would give 
rise to an aldehyde derivative 123 (Scheme 59). One alcohol oxidase which 
has been used extensively in these types in transformation is a mutant of 
Galactose oxidase, GOaseM3-5. GOaseM3-5 is a copper-based enzyme which 
uses molecular oxygen to catalyse the oxidation of alcohols. This enzyme has 
been used to catalyse the oxidation of alcohols in aqueous conditions or in 
combination with either DMSO or CH3CN (up to 30%, as a co-solvent) to aid 
in solubilising lipophilic substrates.[132-134] Initial attempts at the oxidation of 
102 involved GOaseM3-5 in 0.1 M potassium phosphate buffer with the 30% 
DMSO co-solvent along with the enzyme catalase (Scheme 60), which 
catalyses the breakdown of any hydrogen peroxide formed as a by-product 
from the oxidation. Even with the 30% DMSO co-solvent, 102 still showed poor 
solubility in these conditions and so even after 24 hours of reaction, no 
aldehyde product was observed by 1H NMR. 
 
 




To circumvent the issue of insolubility of the substrate in the aqueous system, 
the enzymatic reaction was attempted using an organic-aqueous, bi-phasic 
system, a method often utilized in enzymatic catalysis to avoid solubility 
issues.[135,136] Diol 102 was then dissolved in toluene and added to the reaction 
along with sodium taurocholate to aid formation of an emulsion to give 
sufficient mixing between the organic and aqueous phase.[137] The reaction, 
shown in Scheme 61, was then shaken at 37oC for 24 hours after which the 
toluene was removed and the residue analysed by 1H NMR to see if an 




Scheme 61 – Failed GOase oxidation of 102 to give 130 in a biphasic toluene/buffer 
solvent system. 
 
With this in mind, we hypothesised that the addition of a solubilizing group on 
one of the -OH groups would allow us to increase the solubility whilst still 
retaining the ability to undergo an enantioselective transformation albeit to a 
kinetic resolution. The addition of a nicotinic acid group would give us the 
ability to synthesise a quaternary salt which would drastically improve the 
solubility of the phosphine oxide in the aqueous media needed for the reaction. 
To achieve this, the diol was reacted with 1 equivalent of isonicotinoyl chloride, 
which was chosen so that the nitrogen was -para to into the ring, and this 
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proceeded in 28% yield (Scheme 62). The modest yield was expected due to 
the formation of both the bis-ester and the monoester with only 1 equivalent of 
the acid chloride. 
 
 
Scheme 62 – Addition of the isonicotinamide ester to 95 to give the isonicotinamide 
derivative (±)-137. 
 
To form the quaternary salt, 137 was then reacted with 1 equivalent of methyl 
iodide in DCM, which caused the iodide salt to crash out of solution which 
could be filtered off from the reaction. 1H NMR showed slight degradation of 
the product and so it was subjected to the GOaseM3-5 reaction immediately to 
minimise loss of product. However, even after 24 hours, no aldehyde peak 
was seen by 1H NMR analysis (Scheme 63). 
 
 





3.6 – Conclusion 
 
In summary, the formation of P-chiral phosphine oxides was best achieved 
through the desymmetrization of 102, catalysed by Purolite BE immobilized 
CAL-A (5 eqv. w/w) at 37oC, with 25 mM substrate, 50 mM water, 125 mM 
sodium carbonate and vinyl acetate as solvent. Although this reaction could 
be scaled to a volume of 50 mL, this led to a slight decrease in e.e. of the 
mono-acetate product 129 due to the poor mixing of the larger reaction volume 
and the immobilized enzyme. However, smaller scale 10 mL reactions gave 
high selectivity (upto 96% e.e.) whilst retaining good conversion to 129 with 
minimal spirophosphorane 110 formation. In addition, the kinetic resolution of 
derivatives of 102 gave good selectivity for the acetate ester 134 (upto 88%) 
however, conversion to the acylated products was poor (<25%). Both the 
lipase-catalysed hydrolysis reactions and GOaseM3-5 reactions which required 
aqueous conditions proved to be difficult due to the solubility of the lipophilic 
substrates, which not even the use of biphasic systems or co-solvents could 
remedy. Future work could be done to improve both the desymmetrization and 










4 – Synthetic route to ‘ligand’ Structures 
 
Now that we had an established chemo-enzymatic route to the chiral 
phosphine oxide 129 with an e.e. upwards of 95% we began the synthetic 
route to target compounds which resembled a ligand like structure. We 
hypothesised that a suitable ligand structure would resemble the structure 
shown in Figure 15. 
 
Figure 15 – Potential ligand structure for the copper-catalysed asymmetric 
1,6-boration reactions 
 
Separation of 129 from the by-products of the enzymatic reactions was 
particularly difficult due to the oddly similar R.F. of the bis-acetate 134 as well 
any unreacted starting material. Therefore, to facilitate separation by TLC and 
column chromatography, the reaction mixture was silyl protected compound 
in-situ to give mono-acetate 140 (Scheme 64), which now could be separated 





Scheme 64 – Silylation of 129 to give 140 which facilitated separation of the 
products by column chromatography. 
 
Elaboration of phosphine oxide 140 would require deoxygenation of one of the 
benzylic alcohol groups to form a tolyl substituent followed by formation of a 
benzyl ether from the remaining benzyl alcohol. As the product of enzymatic 
desymmetrization was the mono-acetate, the deoxygenation of the free 
benzylic alcohol was attempted using several different methods. The 
deoxygenation of the benzylic alcohol has been completed on similar 
structures in the literature but required 3 steps overall and caused 
considerable loss of yield.[102] With this in mind, we attempted the 
deoxygenation in a single step which has also been demonstrated previously 
on a variety of structures containing benzylic alcohols. Three different 
reactions were attempted, all of which are shown in Scheme 65. These 
included the formation of an activated phosphoether bond which would be 
subsequently cleaved by NaBH4 and two different palladium catalysed 
reactions which used either triethyl silane or formic acid as the hydride source. 





Scheme 65 – Attempted one-pot reactions for the reductive cleavage of the 
hydroxyl group from 129 to yield an ortho-tolyl group. 
 
Due to the lack of deoxygenation in a single reaction, the 3 step route 
mentioned above and described by Kaczmarczyk et al.[102] was attempted in 
which the alcohol 129 was mesylated prior to the iodination and reductive 
halogenation. The reaction proceeded in almost complete conversion to give 
product 142, with only minor chlorinated product and this was used without 
purification as it showed large amounts of degradation when purified by 
column chromatography. Displacement of the mesylate with iodide was 
accomplished using sodium iodide in acetone in a Finkelstein-type reaction 







Scheme 66 – Formation of the benzylic iodide 143. 
 
The benzylic iodide was then reacted with tributyltin hydride with AIBN for the 
reductive cleavage (scheme 67).[140] The reaction was left to reflux for 24 
hours in anhydrous toluene after which TLC indicated that all starting material 
had been consumed. Crude analysis by 1H NMR showed several new peaks. 
However, none of these equated to the formation of a -CH3 group. The lack of 
success may be due to the AIBN being wet. 
 
 
Scheme 67 – The failed, radical reduction and reductive cleavage of the benzylic 
iodide derivative 143. 
 
Nickel-based reductants have also been used for the reductive cleavage of 
benzylic halides, and specifically to displace benzylic iodides.[106-108] Both 
aqueous Raney Ni and nickel borohydride, which was synthesised in-situ from 
nickel (II) chloride hexahydrate and sodium borohydride, have shown efficacy 
for this transformation.[141-143] Both reagents were therefore tested and gave 
very different reactivities towards the phosphine oxide 143. Unfortunately, 
Raney nickel showed no reactivity towards the C-I bond and only starting 
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material was recovered (Scheme 67). The use of nickel (II) chloride and 
sodium borohydride gave two products, the first of which was the product 141, 
which stemmed from the expected cleavage of the C-I bond and was present 
in 56% yield. The second product, 144, showed the cleavage of the benzylic 
iodide but also cleavage of the benzylic acetate ester leading to the bis-tolyl 
phenyl phosphine oxide (Scheme 68). This reactivity towards the benzylic 
ester was surprising, however. Previous literature has shown that these 
conditions have been applied to the cleavage of benzyl acetates previously 
and had good selectivity towards benzyl acetate esters.[143] 
 
Scheme 68 – Cleavage of the benzylic iodide and acetate ester through the 
addition of nickel chloride and sodium borohydride at room temperature. 
 
The percentage of the acetate ester cleavage could be suppressed further 
through a reduction in temperature. When the reaction was attempted at 0oC, 
improved selectivity was obtained with compound 141 obtained in 70% yield 






Scheme 69 - Cleavage of the benzylic iodide and acetate ester of 143 through the 
addition of nickel chloride and sodium borohydride at 0oC. 
 
Due to the reactivity towards the benzylic ester using nickel boride, we 
hypothesised that we could achieve the same reductive cleavage on the 
acetate ester without the requirement of the formation of the benzylic iodide. 
As described previously, the product of the enzymatic reaction needed the 
addition of the -TBDPS group to aid in separation by column chromatography, 
we hypothesised that this silyl protected product would be better suited to the 
deoxygenation and would not require the 2 steps needed to form the benzylic 
iodide. This would decrease the steps needed and the loss in yield to form the 
benzylic iodide, this route would also give us access to the opposite 
enantiomer the approach shown in Scheme 70. 
 
 
Scheme 70 – Potential synthetic approach for the formation of both the (S)- and 




The nickel boride reaction on 140 was attempted under identical conditions to 
before and followed by TLC which indicated that the reaction went smoothly 
to one product (Scheme 71). However, multiple aliquots of NaBH4 were 
needed throughout the reaction which could be due to the lower reactivity of 
the benzylic ester cleavage compared to the benzylic iodide. However, the 
product was still formed in 82% yield. The slight loss in yield seemed to be due 
to poor mass recovery during the working up. The reaction was filtered through 
a pad of celite and despite multiple organic washes, the yield did not seem to 
improve beyond that described. The product was characterised through 31P 
NMR, 1H NMR and 13C NMR showing a singular phosphorus shift at δ 33.28, 
a relatively simple 1H NMR with the 9 protons of the silyl –tButyl group, the –
CH3 of the newly formed methyl group at δ 2.4, which is in agreement with 
similar phosphine oxide tolyl shifts, and finally the diastereotopic –CH2 
adjacent to the silyl ether at δ 4.99 with the 23 aromatic protons . 
 
 
Scheme 71 – Cleavage of the acetate ester through the addition of nickel chloride 
and sodium borohydride which led to a slight loss in e.e. 
 
Unfortunately, the cleavage of the benzylic ester also led to a slight reduction 
of e.e. (approximately 10%) which is most likely due to the possible stereo-
mutation of the phosphine oxide which could occur through the reduction of 
the phosphine oxide and subsequent oxidation of the phosphorus centre. 
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Therefore, to limit any potential reduction and loss of e.e. the reaction was 
attempted at two lower temperatures of 0oC (Scheme 72) and -20oC. Both 
conditions showed no loss of e.e. when compound 146 was analysed by chiral 
HPLC. This 0oC was the preferred reaction temperature. 
 
 
Scheme 72 – Cleavage of the acetate ester through the addition of nickel chloride 
and sodium borohydride at 0oC which showed no observable loss in e.e. 
 
The silyl group was then removed by tetrabutylammonium fluoride (TBAF) in 
THF to give the alcohol 147 in high yield (Scheme 73), which could potentially 
be used as a ligand once reduced to the corresponding phosphine. We 
hypothesised that a benzyl ether would provide increased steric bulk at the 
ortho- position but may also prevent the possible binding and reduce the 
reactivity of the ligand structure. 
 
 
Scheme 73 – Removal of the TBDPS- ether using 1.5 equivalents of 




The alcohol 147 was also one of the few chiral molecules during the synthesis 
of the chiral ligand which was crystalline. We thought this product would a 
suitable candidate for recrystallisation to increase the e.e. an to potentially 
obtain crystal structure so that the absolute configuration of the phosphorus 
centre could be assigned. Several different solvent combinations were tested 
to recrystallize 147, with a mixture of diethyl ether and hexane initially giving 
crystals of low quality. These first attempts did slightly increase the e.e. (+2-
3% e.e.) of the phosphine oxide but as we had yet to reduce the phosphine 
oxide to the phosphine it seemed wasteful to lose any potential yield to 
purification prior to the reduction which would most likely cause a further loss 
in the e.e. of the chiral material. The protection of the hydroxyl was achieved 
through the formation of the benzyl ether. The hydroxyl was deprotonated with 
sodium hydride at 0oC and then a slight excess of benzyl bromide was added 
along with a catalytic amount of tetrabutylammonium iodide (TBAI) which 
forms the more active benzyl iodide, in-situ.[144]  
 
 
Scheme 74 – Benzylation of 147 using sodium hydride, TBAI and benzyl bromide in 
THF. 
 
The reaction proceeded smoothly to the benzylated product in 97% yield but 
did lead to the loss of 6% of the e.e. of the phosphine oxide, which was 
unexpected (Scheme 74). The benzyl ether product was characterised 
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through NMR in which the 1H NMR showed the -CH3 at δ 2.49, two benzyl -




Figure 16 – 1H NMR of benzyl ether 148. 
 
A literature search revealed that the addition of sodium hydride alongside a 
source of iodine can lead to the de-arylation of phosphine oxides which could 
explain the potential loss of e.e. using this method of benzylation. The loss of 
e.e. was decreased to only 3% when TBAI was omitted from the reaction 
(Scheme 75), highlighting the possible dearylation mechanism described by 
Tejo et al. as a potential pathway for the e.e. decreasing under these 
conditions.[145] However, the omission of TBAI also had a drastic effect on the 
rate of the reaction although this could be rescued through an increase in the 





Scheme 75 – Benzylation of 147 using sodium hydride and benzyl bromide without 
TBAI, in THF. 
 
The reaction was then attempted with the base, NaHMDS, which was added 
at -78oC to a solution of the phosphine oxide and was left to stir for 1 hour, 
after which benzyl bromide and TBAI was added and subsequently left 
overnight which led to the product in 67% yield, with only a minute drop (< 1%) 
in the e.e. of the product (Scheme 76) which was by far a more important 
factor in the synthesis of the final compounds.  
 
 
Scheme 76 – Benzylation of 147 using NaHMDS, TBAI and benzyl bromide in THF. 
 
Although the large loss of e.e. had been remedied using NaHMDS as the base, 
the lower yield of 67% was unfortunate and could be improved upon. As 
different bases had only been tried so far, a different approach was taken in 
which the benzylating agent was activated further through the addition of 
silver(I) oxide which increases the electrophilicity of the benzyl halide through 
co-ordination to the halogen.[146] Silver(I) oxide was added in slight excess (1.5 
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eqv.) to 147 in DCM and the reaction left to stir for 18 hours after which the 
reaction had not gone to completion, but had gone cleanly to the benzylated 
derivative, which was encouraging. The reaction was attempted again with a 
larger amount of silver oxide (1.5 equivalents increased to 4 equivalents), 
which pushed the reaction to completion after 18 hours with minimal loss in 
e.e. (Scheme 77). 
 
 
Scheme 77 – Benzylation of 147 with silver oxide and benzyl bromide to give the 















5 – Stereoselective reduction of phosphine oxides 
 
Now that we had arrived at a structure which could potentially be used as a 
ligand for asymmetric catalysis, we then embarked upon the final step of the 
synthesis, the stereoselective reduction of the chiral phosphine oxide to yield 
the chiral phosphine 152. Over the course of the project, multiple methods of 
reduction had been attempted on various intermediates often to test whether 
the reduction could be accomplished without eroding e.e. Whilst multiple 
methods exist for the stereospecific reduction these are often only applicable 
for certain structures as the stability to both oxidation and reduction varies 
greatly with the substituents attached to the phosphorus atom.[147,148] 
Furthermore, very few of these stereoselective methods proceed without any 
loss in chirality and usually lead to a decrease in e.e. which would be 
detrimental during the last step to form the phosphine. The most common 
method of reduction includes the use of silanes such as trichlorosilane which, 
depending on the presence of base, can cause either inversion of retention of 
the phosphorus atom chirality (Scheme 78).[149,150] However, in both cases the 
use of trichlorosilane has been reported to decrease the e.e. in the range of 5-
25% which we deemed too much of a loss to be a viable method for our 
synthetic route. In order to maintain chirality, the conditions needed to be 
relatively mild and not exceed temperatures which can allow inversion to occur 





Scheme 78 – Trichlorosilane reduction of 149 which can proceed with inversion or 
retention of the chirality depending on addition of triethyl amine. 
 
The first method of reduction attempted involved the use of the reducing agent 
lithium aluminium hydride at low temperatures of -60oC which would limit the 
chance of inversion of the resulting phosphine and has been shown to retain 
chirality.[151] This method requires the formation of a methoxyphosphonium salt 
followed by displacement of the methoxy group with hydride. This method was 
demonstrated on several compounds retaining the e.e. of the phosphorus 
atom; however, it does cause inversion of the centre due to the attack of the 
hydride from the back of the molecule (Scheme 79).[151] 
 
 
Scheme 79 – Reductive cleavage of the methoxy phosphonium salt by lithium 
aluminium hydride leading to inversion of the phosphorus atom. 
 
In order to ensure that the methoxyphosphonium salt had been formed, we 
attempted the reaction stepwise and so methyl triflate was added to the 
phosphine oxide 148 in deuterated chloroform so that the formation of the 
product could be measured by NMR. The reaction was left for 24 hours and 
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analysed by 31P NMR in which two major peaks were present. The first peak 
had a shift of δ 68.9 which most likely due to the desired methoxyphosphonium 
salt product as similar compounds have been reported in the literature[152] with 
a 31P NMR shift of δ 74.5. A second broad peak with a shift of δ 44.7 was also 
present in the reaction which belonged to an unknown product in a similar 
abundance. However, due to the products being phosphonium salts, 
purification by column chromatography of the methoxy phosphonium 
intermediate would be difficult and so lithium aluminium hydride was added to 
the reaction at -60oC and left for 5 hours (Scheme 80). The reaction was then 
stopped and the crude material analysed by NMR which showed heavy 
degradation of the two products, most likely due to P-C bond cleavage, which 
has been shown to occur on similar triaryl phosphine oxides when lithium 
aluminium hydride is added in THF.[153] 
 
 
Scheme 80 – Failed reaction for the formation of the methoxyphosphonium salt and 
then subsequent displacement by lithium aluminium hydride. 
 
 
Due to the harsh nature of lithium aluminium hydride and the degradation 
shown, we attempted the reaction again using the less reactive, sodium 
borohydride, which has also been shown to reduce phosphine oxides with 
virtually no erosion of e.e. to give the corresponding phosphine-borane.[154] 
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The phosphine oxide 148 was reacted separately with two different 
methylating agents, trimethoxyoxonium tetrafluoroborate and methyl triflate, in 
DCM at reflux to ensure that the methoxyphosphonium salt was formed and 
then the reaction cooled to room temperature and NaBH4, dissolved in glyme, 
was added to the reaction and subsequently refluxed. After 24 hours at reflux, 
the reaction was worked up and both reactions were analysed by 31P NMR 
and unfortunately no phosphine product was observed from either attempt at 
the reaction (Scheme 81). 
 
 
Scheme 81 – Failed reduction of the phosphine oxide 141 from the formation of the 





Following on from the attempted use of sodium borohydride to reduce 151 to 
give the phosphine-borane, it was noted that borane complexes, such as 
borane-THF and borane-SMe2, have also been shown to reduce phosphine 
oxides which have a proximal hydroxyl group to yield the phosphine borane, 





Scheme 82 – Literature reaction and mechanism of the BH3 mediated reduction of 
phosphine oxides with a proximal hydroxyl group. 
 
Stankevic et al. developed this reaction on phosphine oxides which contained 
a hydroxyl group up to 2 carbons distant from the phosphorus centre [154,157] 
and although 147 contains its hydroxyl group 3 carbons away we hypothesized 
this reaction could show the same reactivity due to the ability of the hydroxyl 
to add into the phosphine oxide during the formation of the spirophosphorane 
product 110 (Scheme 35). The phosphine borane product of the reaction 
would also be stable to both oxidation and inversion and therefore would be 
ideal to store straight after the reaction and would only require a small addition 
of an amine such as DABCO to release the phosphine prior to use.[158] Three 
equivalents of borane-THF was added to 147 in THF, at the lower literature 
temperature of 0oC to test whether this would reduce the phosphine oxide 
(Scheme 83). Unfortunately, no activity was seen at this lower temperature 
and so the temperature was increased to 60oC.[157] However, even after 24 
hours at 60oC no characteristic phosphine-borane peak could be seen in the 






Scheme 83 – Failed formation of the phosphine-borane 156 with the use of borane 
THF in THF at either room temperature or 60oC. 
 
Another method which included both a relatively mild hydride source and lower 
temperatures was that described by Han et al. Polymethyl hydrogen siloxane 
(PMHS) was used as a hydride source in excess alongside a super 
stoichiometric amount of titanium isopropoxide.[159] This method has been 
used to reduce the bulky phosphine oxide 157 with only a minor decline in e.e. 
(0.1%), as shown in Scheme 84.  
 
 
Scheme 84 – Reduction of 157 with PMHS and titanium isopropoxide in THF 
leading to a loss of only 0.1% e.r. 
 
An excess of PMHS was added to the 147, in THF followed by 4 equivalents 
of Ti(OiPr)4 and the reaction was stirred at 65oC for 18 hours after which no 
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reaction was observed and only the phosphine oxide was recovered (Scheme 
85). The reaction was then repeated at a higher temperature (85oC) and again 
no reduction was observed and again, only starting material was recovered 
from the reaction. We hypothesised that the lack of reduction could be due to 
the free hydroxyl binding to the titanium species, preventing co-ordination to 
the phosphine oxide; we hypothesised the benzyl ether 148 would therefore 
be better suited to this reduction. 
 
 
Scheme 85 – Failed reduction of the phosphine oxide 147 with titanium 
isopropoxide and polymethyl hydrogen siloxane. 
 
The reaction was then attempted again on the benzyl ether protected 148 
under identical conditions which led to a reduction of the phosphine oxide to 
the phosphine 152 in 98% yield (Scheme 86), which was pleasing after the 
previous failed attempts and also suggests that the free -OH was likely to be 
interfering with the reaction and possibly co-ordinating to the titanium species. 
The pure phosphine showed a vastly different 31P NMR shift at δ -23.15 
compared to the phosphine oxide at δ 34.4 and fortunately showed only slight 
oxidation (<0.1%) due to atmospheric oxygen. This observed change in 
oxidative stability was a much-needed property as it would allow the use of the 
ligand under a variety of conditions and would not require an oxygen-free 
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Scheme 86 – Successful reduction of the benzyl ether protected phosphine oxide 
with titanium isopropoxide and polymethyl hydrogen siloxane to give in racemised 
phosphine. 
 
With a view to measure any potential e.e. degradation which may have 
occurred in the reduction, the phosphine was analysed by chiral HPLC, but no 
separation of enantiomers could be obtained by the chiral column (Daicel 
chiralpak-AD hexane:isopropanol, 83:17) due to the highly lipophilic nature of 
the phosphine. Therefore, the phosphine was oxidised back to the phosphine 
oxide using excess hydrogen peroxide in a DCM/water mixture and the 
phosphine oxide was analysed by chiral HPLC against the same sample of the 
phosphine oxide which had not been exposed to reductive conditions.  
Unfortunately, after the reduction and re-oxidation, the sample had racemised 
almost completely as shown by the chromatogram in Figure 17, which was 
unexpected due to the method being successfully applied to other chiral 






Figure 17 – Chiral HPLC analysis of 152 (14.2 and 16.5 min) after reduction using titanium isopropoxide at 65oC and reoxidation to 




The unexpected racemisation observed may have been due to three possible 
reasons. The simplest explanation is due to the temperature (65oC) causing 
inversion of the phosphorus atom in the phosphine which is entirely possible 
for our triaryl phosphine 152. This temperature dependent inversion could also 
be occurring on one of the intermediates in the mechanism of the reduction, 
such as the phosphonium species highlight in red in Scheme 87.[161]  
 
 
Scheme 87 – Possible mechanism for the reduction of phosphine oxides with 
Ti(OiPr)4 and a silane hydride source via the formation of the reactive titanium 
hydride species. 
 
Another explanation could be due to a second reported mechanism where 
titanium isopropoxide is used as there is also a radical pathway which is 
plausible. This secondary radical pathway has been shown to be prominent 
when titanium isopropoxide is used in catalytic amounts and progresses 
through the mechanism shown Scheme 88, in which pseudorotation of the 





Scheme 88 – Possible radical mechanism for the reduction of phosphine oxides 
with Ti(OiPr)4  and TMDS which can lead to racemisation of the intermediate 160. 
 
The second method of racemisation could be due to the elevated temperature 
causing pyramidal inversion of the phosphorus atom in the resulting phosphine 
product. However, it is unknown at what temperature the energy barrier is 
reached. Although the suppression of a possible radical pathway is difficult, 
the reaction was attempted using lower temperatures of 40oC (Scheme 89), 
20oC and 0oC and a different source of silane to see if the reduction was still 
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possible and if any erosion of e.e. was still observed at these varying 
temperatures. The change of silane was due to the extensive, high-
temperature workup needed to degrade and remove the PMHS from the 
reaction. TMDS has also been applied to the reduction of phosphine oxides 
alongside titanium isopropoxide. At 0oC no reduction was observed after 24 
hours so the temperature was increased to 20oC.  This led to a very small 
amount of phosphine after a further 24 hours.  The reaction at 40oC led to 
reduction of the phosphine oxide in 66% yield after 24 hours. This was oxidised 
for chiral analysis which showed that the e.e. had decreased by 26% but was 
still enantioenriched, which was a promising step forward. Furthermore, the 
reduction has proceeded with overall retention of the chiral centre which 
highlights that the reduction is most likely proceeding through the mechanism 
described in Scheme 87. 
 
 
Scheme 89 – Reduction of the phosphine oxide with titanium isopropoxide and 
excess TMDS at 40oC leading to conversion to the phosphine with a 26% decrease 
in e.e. 
 
The reaction was attempted again at 25oC, but the equivalents of both the 
silane and titanium isopropoxide were increased 2.5-fold to 25 equivalents and 
10 equivalents respectively (Scheme 90) and were added neat without any 
THF solvent. The increase in these reagents would hopefully increase the 
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formation of titanium hydride and an improved yield of the phosphine. The 
reaction was stirred for 18 hours under nitrogen, worked up and the crude 
material was analysed by 31P NMR which showed that the phosphine oxide 
had been reduced in 92.5% yield. This was encouraging as only a small 
percentage of phosphine was present at 25oC when lower equivalents of 
reagents were used. The phosphine was purified, oxidized using hydrogen 
peroxide and the resulting phosphine oxide analyzed by chiral HPLC which 
showed only an 8% loss in e.e. which again was a forward step towards 
minimizing the loss of e.e. through reduction.  
 
 
Scheme 90 – Reduction of the phosphine oxide at 25oC with increased equivalents 
of both titanium isopropoxide and TMDS leading to the phosphine with an 8% 
decrease in e.e. 
 
Due to the decreasing loss in e.e. with relation to temperature, we attempted 
the same reduction at 15oC with several different silanes. We anticipated at 
this lower temperature the reaction would not be as facile and therefore 
attempting the reaction with several different silanes would give us a greater 
chance of seeing the reduction of the phosphine oxide. PMHS, TMDS and 
triethyl silane were all added in 25 equivalents to the reaction alongside 10 
equivalents of Ti(OiPr)4  and left to stir at 15oC for 24 hours. After this time, no 
reaction was seen with triethyl silane, TMDS showed partial reduction and 
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PMHS gave complete reduction of the phosphine oxide. The product from the 
PMHS containing reaction was purified, oxidized, and chiral HPLC analysis of 
the resulting phosphine oxide showed only a 4% loss in e.e. at this 
temperature which again was a promising step forward. Finally, we attempted 
the reaction at 5oC with the same equivalents of PMHS and Ti(OiPr)4, as 
described above, added neat to the phosphine oxide and the reaction was 
shaken for 48 hours instead of 24 hours as we anticipated at this temperature 
the reaction would be much slower. Purification, oxidation and analysis by 
chiral HPLC showed the phosphine oxide had been reduced in 72% 
conversion and that there was only a ~2% loss in e.e. which we anticipated 
was probably best we could achieve. However, this small loss in e.e. was very 
impressive in the area of stereoselective phosphine oxide reduction. The 














Table 16 – Reduction of 148 with titanium isopropoxide and silanes at different 
temperatures and its effect on e.e. and conversion. 






Δ e.e. Conversion 
65oC PMHS 24  Excess 4 Racemised 97% 
40oC TMDS 24 10 4 -26% 66% 
25oC TMDS 24 10 4 NR NR 
25oC TMDS 24 25 10 -8% 92% 
15oC TMDS 24 25 10 -5% 63% 
15oC Et3SiH 24 25 10 NR NR 
15oC PMHS 24 Excess 10 -4% 95% 
5oC PMHS 48 Excess 10 -2% 72% 
HPLC Conditions: Daicel AD column, 1.2 mL/min, 91% Hexane/IPA at 210 nm. 
 
In order to clarify whether the phosphine was stable at the elevated 
temperature, we then refluxed the phosphine (85% e.e.) in THF at 65oC for 24 
hours as this was the same temperature used for the reduction, shown in 
Scheme 86, which gave us full racemisation. The sample was then oxidised 
to the phosphine oxide for analysis by chiral HPLC which showed that the 
phosphine had fully racemised at 65oC and was not stable to inversion at this 
temperature. Although this instability was disappointing, the intended 
asymmetric 1,6-boration reaction takes place at room temperature (Scheme 
25) and so we attempted a stability test of the phosphine at room temperature 
in solution (25oC ambient temperature). The phosphine (84% e.e.) was split 
into 3 aliquots and oxidised at different time points back to the phosphine oxide 
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for analysis by chiral HPLC. The first sample was analysed shortly after 
reduction which showed that the phosphine was at 84% e.e. after reduction, 
after 24 hours another aliquot was oxidised and analysed which showed that 
the e.e. had fallen to 78% showing a decrease of 6%. The next aliquot was 
oxidised after 72 hours and analysed which showed a decrease in e.e. of 19% 
from the starting e.e. of 84% down to 65% (Figure 18). Due to the inversion 
of the phosphines at room temperature, this tells us that temperature-
dependent inversion barrier is around the 20oC-25oC range. 
 
 
Figure 18 – Loss of e.e. of 152 at room temperature in DCM over 72 hours. 
 
Although this shows that the phosphine is not stable to inversion at room 
temperature in solution, the addition of the metal catalyst could prevent this 
inversion as the phosphine lone pair would bind to the metal centre. However, 
the loss of any e.e. of the phosphine during a reaction would be difficult to 















6 – DFT Modelling of the inversion barrier of tertiary 
phosphines 
 
Due to the configurational instability of 152, we hypothesised that the use of 
molecular modelling would expedite the process of finding more stable triaryl 
phosphines through DFT calculations of the inversion barrier of several 
different related phosphines. This would allow us to test numerous phosphines 
for inversion stability without having to synthesise them.  As reported by Holz 
et al., the Gibbs free energy of both the trigonal pyramidal geometry and the 
trigonal planar transition state can be calculated using DFT, where the 
difference equates to the inversion energy barrier.[24] 
 
 
Figure 19 – DFT modelling of A) the trigonal pyramidal ground state and B) the 
trigonal planar transition state of 161. 
 
 
Previous stability studies reported in the literature have shown that lowering 
the steric demands of the three substituents attached to the phosphorus atoms 
gives large increases to the inversion barrier energy.[23,24] Furthermore, 
changes in the electronic effects of the substituents can also lead to increases 
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in the inversion barrier, as electron-donating groups in the -ortho or -para 
position of the phenyl rings destabilise the planar transition state.[42,45,57] 
Therefore, a range of different tertiary phosphine structures (Table 17), which 
contained phenyl rings with varying substituents were submitted for DFT 
calculations. We also included a bridged structure which could potentially 
inhibit the inversion mechanism of the phosphine. Two different diphenyl alkyl 
phosphines were also calculated to gauge how the inversion energy changed 
when moving to diaryl alkyl phosphines. Although it would be impossible to 
calculate the absolute temperature at which the inversion would occur from 
these calculations, we could formulate a trend within our calculated structures 
to gauge which phosphines would give increased stability. We could also use 
the work by Holz et al. to also give an estimate at a potential half-life through 
















Table 17 – Phosphine structures submitted for DFT calculation. 
 PR1R2R3 
Compound R1 R2 R3 
161 Ph o-tolyl 
 
152 Ph o-tolyl 
 
162 Ph o-tolyl 
 
163 Ph o-tolyl 
 
164 Ph o-tolyl 
 
165 Ph o-tolyl 
 




168 Me o-tolyl 
 






172a Ph Me p-tolyl 
173a Ph Me o-anisyl 
a – Validation structures for which the literature experimental inversion barrier was available. 
 
For the trigonal pyramidal configuration, a conformer search was undertaken 
using molecular mechanics which identified several energy minimum 
structures.  Higher-level calculations were then conducted on the lowest 
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energy conformer, giving us a more accurate representation of the ground 
state of the trigonal pyramidal configuration. The lowest energy conformer was 
then optimised to find the geometry equilibrium using a higher level, ѠB97X-
D density functional method with the 6-31G* dataset with Van-der Waals 
dispersions (which should account for the large aromatic rings in the 
phosphine structures). From the optimised geometry equilibrium calculation, 
we gained the phosphines ground state energy, which was confirmed through 
the lack of imaginary frequencies in the phosphines calculated IR.  
 
We estimated the transition state to be the trigonal planar structure where the 
sum of the internal phosphine C-P-C bonds equalled 360o. The equilibrium 
geometry of this structure was then optimized to find the lowest energy 
conformation of the transition state. From the optimised trigonal planar 
geometry, the transition state geometry was then calculated using the same 
DFT, ѠB97X-D computation method with the 6-31G* dataset, from which we 
gained a single imaginary frequency which corresponded to the inversion 
pathway (umbrella inversion) of the central phosphorus atom. The difference 
between the Gibbs free energy of both configurations (trigonal pyramidal and 
trigonal planar) was then estimated the be the inversion energy barrier. In 
order to validate our calculations, we also included two structures which were 
similar to our proposed structures and for which the experimental inversion 
barrier was available for comparison. Furthermore, we also included the 
measurement of the sum of the internal angles (C-P-C angles) surrounding 
the phosphorus in the trigonal pyramidal structure which would also give an 
insight into the stability of the molecule to inversion as shown in previous 
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work.[24] A higher the sum of the internal C-P-C angles would indicate 
increased planarity of the molecule which would lie closer to the planar 
transition state and therefore would require less energy for inversion to occur. 
 




 Calculated ΔG  
25oC 




170 318.4 91.21 kJ/mol 90.92 kJ/mol Cyclic 
161 306.5 118.09 kJ/mol 117.64 kJ/mol Benzylic 
169 309.5 122.74 kJ/mol 122.53 kJ/mol tButyl Alkyl 
162 305.6 124.08 kJ/mol 124.34 kJ/mol Benzylic 
163 304.2 125.97 kJ/mol 125.49 kJ/mol Phenolic 
152 304.7 129.62 kJ/mol 128.72 kJ/mol Benzylic 
166 303.6 133.61 kJ/mol 134.45 kJ/mol Amine 
164 303.9 134.79 kJ/mol 135.0 kJ/mol Phenolic 
167 301.9 139.59 kJ/mol 140.49 kJ/mol Phenolic 
171 299.1 146.26 kJ/mol 146.63 kJ/mol Cyclic  
172 301.6 147.22 kJ/mol 148.74 kJ/mol Methyl Alkyl 
173 301.8 151.63 kJ/mol 152.49 kJ/mol Methyl Alkyl 
165 305.4 155.35 kJ/mol 155.95 kJ/mol Phenolic 
168 303.5 167.94 kJ/mol 168.31 kJ/mol Methyl Alkyl 
 
 
As mentioned previously, we included two structures to act as validations for 
our computational method and in both cases, our calculated inversion barrier 
value was overestimated, by 11% and 13%, respectively. Our calculated 
inversion barriers for compounds 172 and 173, as shown in Table 18, are 
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147.2 kJ/mol and 151.6 kJ/mol, compared to their experimental inversion 
barriers of 126.8 kJ/mol and 128.9 kJ/mol (Figure 20). 
 
 
Figure 20 – Calculated ΔG for two phosphines for which the literature experimental 
value was available for comparison. 
 
Higher-level theory calculations would undoubtedly close the gap between the 
calculated and experimental values, as shown by Holz et al. who employed 
the B3PW91 level of theory with a more accurate data set and the calculated 
values were within 3% of the experimental values.[24] However, these methods 
would have been too expensive to run on the systems we had available. This 
meant that we could not fully relate our calculated values to literature values, 
but we could gain a useful trend within our own compounds. Starting with the 
acyclic tertiary phosphines, there was a clear trend within our results with the 
benzylic structures, showing inversion barriers lower than the phenolic 
derivatives, apart from our synthesised compound 152, which showed an 
unexpectedly high inversion barrier compared to the other benzylic 
compounds. As we have found from our experimental results, even with the 
increased calculated inversion barrier for 152, compared to the other benzylic 
compounds, the phosphine 152 still exhibits inversion at room temperature. 
This suggests that the use of other similar benzylic structures as P-chiral 
phosphine ligands could be limited. However, the inversion barrier does 
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increase as we move to the phenolic structures in our series. Although 
compound 164 has a calculated inversion barrier lower than that of 152, it 
would be difficult to see this being reflected in an actual experimental value as 
the series shows that the increasing number of electron-donating groups 
increases the inversion barrier. This is shown by the structure 167, which 
contains two phenolic groups and displays a higher inversion barrier indicative 
that delocalisation of the phenolic oxygens into the aromatic ring destabilize 
the trigonal planar transition state for inversion (Figure 21).  
 
 
Figure 21 – Calculated ΔGibbs for benzylic phosphine 152 and phenolic phosphine 
167. 
 
Interestingly, even the compound 165, which contains an electron-withdrawing 
group in the -ortho position, in the form of a phenolic acetate ester, showed a 
very high inversion barrier of 150.96 kJ/mol. In order to gauge our triaryl 
phosphines stability compared to related P-chiral phosphines such as (R)-
PAMP, we also included two diaryl alkyl phosphines compounds, one 
containing a methyl group and the second containing a tbutyl group (Figure 
20). We anticipated that the methyl would give a greater inversion barrier as 
the literature suggests and this was reflected in our calculation which gave an 
inversion barrier of 168.3 kJ/mol and a low C-P-C angle sum of only 303.5o. 
However, although the inversion stability of the diaryl alkyl phosphines is very 
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favourable, this is often offset by their oxidative stability where the lower steric 
demands often cause the phosphine to oxidize rapidly on exposure to air. 
When moving to the tbutyl containing phosphine, the inversion barrier actually 
falls below that of the majority of triaryl containing phosphines, at 122.74 
kJ/mol (Figure 22), which can be attributed to large steric bulk which is 
reflected in the molecule’s C-P-C angles sum of 309.5o which was the second-
highest C-P-C angle sum in our series. 
 
 
Figure 22 – Calculated ΔG for the two-alkyl containing phosphine 168 and 169. 
 
Cyclic structures, which link two of the substituents of the phosphines, have 
also been shown to drastically increase the inversion barrier of phosphines 
due to inability of the phosphine to undergo the inversion process. We included 
two different cyclic structures, 170 and 171, linked through groups in the -ortho 
position which included, a dimethylene ether linkage and a phenolic linkage. 
The calculated inversion barrier of the larger linked structure, 170, showed an 
extremely poor inversion barrier of only 91.2 kJ/mol, which was the lowest in 
our series by a large margin, this is most likely attributed to the steric demands 
of the molecule as the sum of the internal angles was extremely large at 
318.4o. The phenolic linked molecule 171 showed a much higher inversion 
barrier of 146.2 kJ/mol, which was more in line with what we expected (Figure 
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23). However, synthesis of this type of chiral phosphine would be difficult due 
to the lack of available starting materials. 
 
 
Figure 23 - Calculated ΔG for the cyclic phosphines 170 and 171. 
 
In conclusion, the calculations show that the move towards phenolic structures 
would provide phosphines of greater inversion stability. Although it is difficult 
to estimate the absolute temperature at which inversion would occur, phenolic 
structures could provide ligand stability at room temperature which would 













7 – Synthesis of phenolic derivatives  
 
 7.1 – Synthesis of phenolic derivatives from benzylic 
compound 129 
 
Due to the unexpected instability of the phosphine 152 (Scheme 91), we 
sought alterations to the structure. Given that we had established a synthetic 
route and efficient enzymatic desymmetrization of 102, we attempted to modify 
intermediates derived from the biotransformation product 102. 
 
 
Scheme 91 – Chemo-enzymatic route to the configurationally unstable phosphine 
152 from diol 102. 
 
 As shown by several literature inversion studies and our own DFT 
calculations[22-25], the inclusion of phenolic substituents which can prevent 
delocalisation of the phosphorus atoms lone pair, can increase the inversion 
energy barrier quite substantially. With this in mind, we attempted the 
synthesis of a phenolic derivative from the benzyl alcohol 147 (Scheme 92). 
We hypothesised that Baeyer-Villiger oxidation of either the corresponding 
aldehyde or ketone would allow access to the phenolic derivative through the 





Scheme 92 – Potential synthesis of configurationally stable phenolic phosphine 175 
from the benzylic compound 147. 
 
To achieve this, the phosphine oxide 147 hydroxyl group was oxidised to the 
aldehyde using pyridinium chlorochromate (PCC), in DCM at room 
temperature which went in high yield (Scheme 93) and was easily 
characterizable due to the aldehyde peak at δ 10.8 in the 1H NMR.[164] 
 
 
Scheme 93 – Oxidation of 147 with PCC to yield the aldehyde derivative 176 and 
attempted Baeyer-Villiger leading to the acid derivative 177. 
 
At this point, we could also use the aldehyde product as a potential reactant 
for the Baeyer-Villiger oxidation as well as the precursor for the synthesis of 
the ketone derivative. We, therefore, attempted the Baeyer-Villiger oxidation 
on 177 through the addition of a slight excess hydrogen peroxide, in DCM and 
the reaction was stirred vigorously.[165] After consumption of the starting 
material the reaction was worked up and analysed by 1H NMR which showed 
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that the aldehyde peak was no longer present but unfortunately, the aldehyde 
had been oxidised to the corresponding carboxylic acid.  
 
The aldehyde derivative 176 was then dissolved in THF and cooled to 0oC, 
after which methyl magnesium bromide was added slowly to reaction and left 
to warm up to room temperature. The reaction was then quenched with sat. 
ammonium chloride to yield the secondary alcohol shown in Scheme 94. 
Analysis of the alcohol showed the appearance of the two diastereomers in 
both the 1H and 31P NMR in a ratio of 63:37.  
 
 
Scheme 94 – Synthesis of ketone derivative 179 and attempted Baeyer-Villiger 
oxidation with m-CPBA. 
 
The secondary alcohol was then oxidised to the ketone with PCC which 
proceeded in high yield (Scheme 94) which was characterised through the 
appearance of a peak in the 13C NMR at δ 202.0 corresponding to the 
deshielded ketone carbonyl. The Baeyer-Villiger oxidation was then attempted 
on the corresponding ketone, which should give a better chance of forming the 
acetate ester due to the migration of the phenyl ring being more favourable. A 
slight excess of meta-chloroperoxybenzoic acid (m-CPBA) was added to 179 
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in DCM at room temperature and the reaction monitored by TLC (Scheme 94). 
After 2 hours, TLC indicated that only starting material was present and so the 
temperature was increased to 50oC and the reaction stirred for 24 hours. The 
reaction was worked up which showed that there was almost complete 
consumption of the starting material through 31P NMR analysis. However, in 
addition to the possible product, there was a large amount of degradation 
where the degradation products showed phosphine-like shifts. As a result, the 
synthesis of phenolic derivatives from the benzylic derivatives was not 
attempted further. 
 
7.2 – Direct synthesis of phenolic derivatives 
 
DFT Modelling had suggested that phenolic containing compounds would give 
the best chance of producing inversion stable ligands. The conjugation of the 
oxygen into the aromatic ring could limit the conjugation of the phosphorus 
lone pair into the aromatic ring, which would destabilize the planar pyramidal 
transition state and raise the inversion barrier energy. As the synthesis of 
phenolic groups from the benzylic compounds was extremely long and 
ultimately led to degradation, we hypothesised that synthesis of phenolic 
compounds as direct substrates for the enzymatic reactions would expedite 
this process. We had previously synthesised a phenolic derivative through the 
protection of 2-bromophenol (181) with DHP and catalytic p-TSA in DCM and 
then lithium-halogen exchange with n-BuLi to form the nucleophilic lithiated 
species followed by addition of dichlorophosphine and oxidation to the 
143 
 
phosphine oxide 183. The THP group was then removed in acidic methanol to 
give the phosphine oxide 112 in 15% yield over the 4 steps (Scheme 95). 
 
 
Scheme 95 – Synthesis of the phosphine oxide 112 from 181. 
 
However, as the idea for the two-step synthesis of 102 had been adapted from 
the literature method for the synthesis of 112, we already had an alternative 
two-step route in place to access the phenolic derivative 112 in good quantities 
for the screening of the enzymatic conditions. To compare our halogen-
exchange rearrangement with the literature method, two different 







Scheme 96 – Synthesis of the two phenolic phosphonates, 185 and 111 from 2-
iodophenol and phenol, respectively. 
 
The synthesis of the phosphonate from 2-iodophenol went in lower yield than 
that of the phenol derivative (56% against 70%), which is most likely due to 
the increased amount of lithium halogen exchange due to the -ortho directing 
effect of the oxygen. However, both phosphonates were synthesised in 
moderately high yields and were straightforward to purify by column 
chromatography. Rearrangement reactions were then attempted on the two 
different phosphonates which should give the same phosphine oxide product 
112. Turbo Grignard (2.4 eqv.) was added to the phosphonate 185 in THF at 
room temperature, which was analogous to the reaction conditions used for 
the benzyl alcohol derivatives described previously. Following the literature 
method for the rearrangement of 111, LDA (2.2 eqv.) was added in THF at -
78oC which was then slowly allowed to warm to room temperature and left to 
stir for 18 hours (Scheme 97). Both reactions were worked up identically and 







Scheme 97 – A) Turbo Grignard mediated rearrangement of the 2-iodophenolic 
phosphonate 185 leading to 112. B) LDA mediated rearrangement of the phenolic 
phosphonate 111 to 112. 
 
The rearrangement of 185 with Turbo Grignard went in 57% yield compared 
to the LDA mediated rearrangement which went in a slightly lower yield of 50% 
suggesting that the lithium halogen exchange is more favourable than the 
corresponding deprotonation of 111. Further optimisation of the halogen 
exchange reaction could be done to increase the yields. 
 
In addition, we also attempted the rearrangement of the ethyl phenolic 
derivative 187 as an expansion of the 1,3-rearrangement reaction. We hoped 
that the increased -ortho directing effect of the phenolic derivative, compared 
to a benzylic derivative which was also attempted (Scheme 45), may allow the 
rearrangement to occur more readily. Furthermore, the resulting ethyl 
containing phosphine could be advantageous due to the extra inversion 
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stability owed to alkyl derivatives. The phosphonate was synthesised as 
shown below in 53% yield and then the phosphonate was added to a solution 
of Turbo Grignard (2.6 Eqv.) in THF and left to stir for 24 hours. TLC analysis 
of the reaction showed 2 major spots which when purified were shown to be 
the expected rearrangement product 188 in 27% yield and a large amount of 
phenol which must have been displaced from the phosphonate (Scheme 98).  
 
 
Scheme 98 – Synthesis of the ethyl containing phosphonate 187 and its 
subsequent Turbo Grignard initiated rearrangement to give 188. 
 
8 – Enzymatic desymmetrization and kinetic resolutions of 
phenolic containing phosphine oxide derivatives  
 
8.1 – Desymmetrization reactions 
 
Now that we had synthesised the pro-chiral phosphine oxide 112, we 
attempted to apply the enzymatic conditions which had been used to 
desymmetrize 102 previously, as these conditions were shown to give good 





Scheme 99 – Approaches to the enzymatic transformation of phenolic phosphine 
oxide 112 or racemic (±)-192. 
 
The substrate 112 was screened against CAL-A immobilized on Purolite tbutyl 
epoxy resin, CAL-B and CAL-A immobead 150 from Sigma Aldrich using both 
acetate donors, VA and ISPA. The reactions contained 25 mM substrate and 
were shaken at 37oC for 18 hours after which an aliquot was taken and 
analysed by chiral HPLC using the corresponding racemic mono-acetate 189 
standard. The enantiomers of 189 would not separate under the same HPLC 
conditions as the benzyl derivative 129 and so different chiral columns (AD-H 
and OJ) and HPLC methods were tested to try and separate the enantiomers. 
However, no baseline separation was possible but an estimation of the e.e. 
could be obtained from the analysis. We could then apply a modification to the 
structure which would allow us to separate and determine the exact e.e. of the 
modified structure. 
 
The reactions using VA as the solvent showed no activity under any 
conditions, which is most likely due to the poor solubility of 112 in VA. 
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However, varying degree of conversion were observed when using ISPA and 
each of the three different enzymes (Table 19). CAL-A showed 34% 
conversion to the monoacetate product 189. Increased product formation was 
seen with CAL-B and the purolite BE immobilized CAL-A showed almost 
complete conversion of the substrate to the mono-acetate and a large amount 
of the bis-acetate 193. However, all reactions gave a low e.e. for 189 which 
was disappointing, given the success with the benzyl alcohol derivative 102 
under these conditions. The e.e. could have increased slightly as the 
conversion to 189 increased but due to the poor selectivity over 18 hours, the 
reactions were not measured further. The poor enantioselectivity may be 
attributed to the lower steric bulk of the phenol derivative.  
 
 










CAL-B ISPA 52% 6% 32% 
CAL-A ISPA 34% 5% 25% 
Purolite BE 
CAL-A 
ISPA 45% 53% 27% 
Reaction Conditions: Incubated at 37oC at 180 RPM. Total volume 1 mL, 25 mM 
substrate, vinyl acetate to volume, 30 mg immobilized enzyme. HPLC Conditions: 




With this in mind, we hypothesised that the lipase-catalysed hydrolysis of the 
bulkier, bis-acetate 193, may show improved selectivity due to greater steric 
demands in the enzyme active site. The bis-acetate was synthesised using 
AcCl and Et3N in DCM to give the product in high yield (89%) (Scheme 100).  
 
 
Scheme 100 – Synthesis of the phenolic bis-acetate 193 from the addition of Acetyl 
chloride and triethyl amine in DCM. 
 
As shown previously in the lipase-catalysed hydrolysis reactions of 135, the 
solubility of the triaryl phosphine oxide substrate in aqueous conditions was 
poor due to its lipophilicity. However, use of different co-solvents has been 
reported to increase the solubility of substrates in aqueous conditions whilst 
maintaining enzymatic hydrolytic activity. Four solvents which have shown 
success in lipase enantioselective hydrolysis reactions are acetone, THF, 
DMSO and tert-butanol[166-168]. Our substrate showed good solubility in DMSO 
and THF and poor solubility in both acetone and tert-butanol and so conditions 
for hydrolytic desymmetrisation of 193 were initially tested using mixtures of 
DMSO and buffer and THF and buffer. A range of different lipases was used 
including Immobead 150 CAL-A and CAL-B, Purolite immobilized CAL-A, 
Humicola sp., Novazyme 435 and PPL, alongside a control reaction which 
contained no enzyme to gauge background hydrolysis. The reactions were 
attempted on a 1 mL scale with 25 mM substrate with a 50:50 mix of the co-
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solvent (THF or DMSO) to buffer, which would hopefully ensure solubility of 
the substrate (Scheme 101). The reactions were shaken for 18 hours and an 
aliquot was taken after 2 hours and at the end of the 18-hour reaction for 
analysis by chiral HPLC. The control which contained no enzyme showed a 
large amount of background hydrolysis (up to 70%) giving both the mono-
acetate 189 and 112. This was seen across the whole series of reactions with 
no e.e. observed with any of the different lipases and conditions. This was 
most likely due to the instability of the phenolic acetate ester under aqueous 
conditions. Therefore, moving forward, we knew that the lipase-catalysed 
hydrolysis in aqueous conditions would not be useful for phenolic derivatives. 
 
 
Scheme 101 – The lipase catalysed hydrolytic desymmetrization of 193 which led to 
the formation of 189 and 112 in 0% e.e. due to background hydrolysis of the acetate 
ester. 
 
Moving on from the aqueous hydrolysis, we hoped that the transesterification 
of the bis-acetate 193 with a suitable alcohol would be more promising as this 
would not require aqueous conditions and therefore would limit any 
background hydrolysis. Previous work within the group has shown that the use 
of a butanol rinsed enzyme preparation (BREP) of the lipase, Humicola sp., 
for the transesterification of enol acetate esters gave chiral molecules in high 
selectivity [168]. The BREPs were prepared through the addition of a solution of 
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the lipase enzyme, CAL-A or Humicola sp., to silica followed by a series of 
washes of the lipase-silica mixture with both n-butanol, and the reaction 
solvent of choice. For our reactions, we chose THF and toluene to act as the 
reaction solvent as our bis-acetate showed good solubility in both solvents and 
lipases also show high stability in these solvents. DMSO was no longer used 
for this reaction due to the difficulty in removing any residual DMSO prior to 
analysis by chiral HPLC as DMSO is detrimental to the column supports. The 
silica adsorbed CAL-A (150 mg) was added to the bis-acetate substrate (25 
mM) in either THF or toluene (1 mL) as the reaction solvent and n-butanol was 
then added, in 3 equivalents with respect to the substrate, to start the 
transesterification (Scheme 102). The reactions were run alongside a control 
reaction in which the added silica was prepared through the series of solvent 
washes but in lieu of the addition of a lipase. 
 
 
Scheme 102 – Transesterification of 193 with BREP-CAL-A and BREP-Humicola 
sp. 
 
The reactions were left to shake at 25oC and then an aliquot of the reaction 
was analysed by chiral HPLC to measure conversion and selectivity. The use 
of both enzymes with THF and toluene showed some transesterification 
activity as the monoacetate was present in all reactions ranging from 5% to 
36% compared to the control reaction which showed no activity. The Humicola 
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sp. enzyme in THF showed the greatest amount of mono-acetate but 
unfortunately none of the reactions displayed any e.e.  
 
8.2 - Kinetic resolution reactions 
 
Due to the lack of any enzyme activity seen in the desymmetrization reactions, 
we attempted the kinetic resolution of several different compounds in hope 
that this would lead to enantioselectivity. We therefore synthesised the mono-
benzylated phenolic derivative (±)-194 (Scheme 103) and subjected the 
racemic mixture of (±)-194 to the same conditions as those used in previously 
attempted kinetic resolutions but whilst conversion was modest (upto 30%), 
unfortunately a very low e.e. was observed. 
 
 
Scheme 103 – Lipase catalysed kinetic resolution of (±)-194. 
 
We hypothesised that moving to a bulkier ester, instead of the acetate ester, 
for the transesterification might give better results for a kinetic resolution and 
would be easier to analyse by chiral HPLC. Thus, we synthesised the 
phosphine oxide (±)-196, which contained the hexanoate ester and the benzyl 
ether (Scheme 104). This could increase the enantioselectivity in the 





Scheme 104 – Synthesis of the mono-benzylated compound (±)-194 and the 
hexanoic ester derivative (±)-196. 
 
The hexanoate ester product (±)-196 was formed through the addition of 
thionyl chloride to hexanoic acid to form the hexanoyl chloride after which any 
excess thionyl chloride was removed, and then triethylamine and the 
phosphine oxide (±)-194 in DCM was added, to give the desired product (±)-
196. The CAL-A and Humicola sp. BREP reactions were then attempted on 
this bulkier substrate with the inclusion of diethyl ether as a solvent as well as 
the previously utilised toluene and THF (Scheme 105). 
 
 
Scheme 105 – BREP-CAL-A/Humicola sp. transesterification of racemic (±)-196. 
 
The reactions were attempted on the same scale as the previous BREP 
reactions and left to shake at 37oC for 24 hours after which an aliquot was 
analysed by chiral HPLC, which showed no activity in any of the reactions. We 
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then increased the concentration of BREP from 100 mg to 300 mg per 1 mL 
and the concentration of n-butanol from 75 mM to 150 mM and again left the 
reaction for another 24 hours at 37oC. After these increases in amounts of 
enzyme and n-butanol, the only substantial activity was only seen with diethyl 
ether with CAL-A, albeit extremely poor (<10%). In addition to these BREP 
reactions, the transesterification reaction was also attempted in parallel with 
the immobilized CAL-A and CAL-B with the three different solvents (Scheme 
106) but as with the BREP reactions, no activity was seen in any case. This 
lack of activity could be due to the substrate molecule now being too large to 
fit into the active site of the enzyme.  
 
 
Scheme 106 –CAL-A/B catalysed transesterification of racemic (±)-189. 
 
9 - Conclusion 
 
We have successfully developed a chemo-enzymatic route to benzylic triaryl 
chiral phosphine oxides and phosphines which utilizes the enantioselectivity 
of enzymes in a lipase-catalysed desymmetrization. The use of Purolite BE 
immobilized CAL-A alongside vinyl acetate in optimized conditions gave the 
phosphine oxide 129 in yields of up to 70% with a e.e. of up to 96% (Scheme 
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56). This enzymatic methodology could potentially be applied to several 
different benzylic triaryl phosphine oxide structures, with only minor 
adjustments to the synthetic route to the prochiral precursor. We then arrived 
at the ‘ligand like’ structure 148 through the cleavage of the acetate ester using 
nickel borohydride and the addition of a benzyl ether group on the remaining 
alcohol for stability and steric bulk. A modified method for the reduction of the 
phosphine oxide 148 was used utilizing titanium isopropoxide and either 
TMDS or PMHS which yielded the chiral phosphine 152 with only small losses 
in e.e. (<4%) (Table 16). Although the phosphine 152 displayed poor stability 
to inversion, even at room temperature, further modifications to the structure 
with the inclusion of electron donating groups on the aromatic substituents 
(197-199) would destabilise the transition state for inversion, increasing 
stability (Scheme 107).  
Scheme 107 – Potential phosphine oxide and phosphine structures for increased 
inversion stability. 
Future work should be focused around creating analogues of the benzylic 
phosphines and phosphine oxides which would display increased stability to 
inversion whilst retaining a ‘ligand like’ structure which would be applicable to 
copper-catalysed asymmetric 1,6-boration reactions. Furthermore, if the 
enzymatic kinetic resolution or desymmetrization of the phenolic analogues 
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could be achieved this would provide a quicker route to more stable 
phosphines. However, further work is needed to establish conditions which 
give both high conversion and enantioselectivity for the phenolic phosphine 
oxides. In addition, once a stable phosphine structure has been established 
the use of phosphine-boranes (200 & 202) could expedite the synthetic route, 
without the need for the difficult phosphine oxide reduction which leads to a 
slight loss in e.e. (Scheme 108). 
 
Scheme 108 – Use of phosphine-boranes to bypass the loss of e.e. which occurs 















10 - Experimental  
10.1 - General experimental 
 
Analytical methods: Analytical thin layer chromatography (TLC) was 
performed on Whatman F254 precoated silica gel plates (250 μm thickness). 
Visualization was accomplished with a UV light and/or a KMnO4 solution. Flash 
column chromatography (FCC) was performed using Whatman Silica Gel60Å 
(230-400 mesh). Normal and reverse phase HPLC was performed on an 
Agilent system (Santa Clara, CA, USA) equipped with a G1379A degasser, 
G1312A binary pump, a G1329 well plate autosampler unit, a G1315B diode 
array detector and a G1316A temperature-controlled column compartment. 
The University of Liverpool Analytical Services Department provided mass 
spectrometry performed on a HR-ESI-MS TOF spectrometer (MicroMass). 
Solvents were of analytical or HPLC grade and were purchased or dried over 
molecular sieves where necessary. Potassium phosphate buffers were 
prepared using dibasic and monobasic potassium phosphate and pH adjusted 
to achieve the desired pH. Crude CAL-A solutions were purchased from 
STREM. Immobead CAL-A/B, PPL and Humicola sp. were purchased from 
Sigma Aldrich. 1H NMR and 13C NMR were recorded on Bruker AV 500 MHz 
& Bruker DPX 400 MHz NMR spectrometers in the indicated deuterated 
solvents. For 1H NMR CDCl3 was set to 7.26 ppm (CDCl3 singlet) and for 13C 
NMR to 77.66 ppm (CDCl3, centre of triplet). All values for 1H NMR and 13C 
NMR chemical shifts for deuterated solvents were obtained from Cambridge 
Isotope Labs. Data are reported in the following order: chemical shift in ppm 
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(δ), integration, (multiplicity, which are indicated by br (broadened), s (singlet), 
d (doublet), t (triplet), q (quartet), m (multiplet)) and coupling constants (J, Hz). 
 
10.2 - Chapter 2 synthesis of phosphines and phosphine oxides 
experimental 
 




2-Bromobenzyl alcohol (96) (0.93 g, 5 mmol) was dissolved in DCM (50 mL) 
and DHP (0.5 mL, 5.5 mmol, 1.2 eqv.) was added followed by p-TSA (95 mg, 
0.5 mmol). The reaction was left to stir at room temperature and monitored by 
TLC. When the reaction was deemed complete, the reaction was washed with 
sodium bicarbonate (10 mL), water (10 mL) and brine (10 mL) and the organic 
layer dried over MgSO4, filtered and the solvent removed in vacuo. The crude 
product was purified by column chromatography (eluent: hexane:ethyl acetate; 
33:1) to give the title compound (1.02g, 76%) as a clear liquid. 1H NMR (CDCl3, 
400MHz) δ 1.48-1.92 (6H, m), 3.54 (1H, m) 3.90 (1H, m) 4.55 (1H, d, J= 13.5 
Hz), 4.75 (1H, t, J = 3.4 Hz), 4.81 (1H, d, J  = 13.3 Hz,-CH2), 7.09 (1H, td, J = 
7.8, 1.6 Hz ), 7.27 (1H, td, J = 7.3 Hz, 3.6 Hz), 7.50 (2H, d, J = 7.9 Hz); 13C 
NMR (CDCl3, 100 MHz) δ 19.3, 25.5, 30.5, 62.0, 68.5, 98.3, 122.7, 127.3, 
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128.7, 129, 132.4, 137.9. HRMS: (ESI+) Calculated for C12H15BrO2Na: 







To a solution of 90 (0.59 g, 2.1 mmol) in THF (20mL), 1.6 M n-BuLi (1.49 mL, 
1.1 eqv.) was added dropwise at -78oC and the reaction left to stir for an hour. 
P,P-dichlorophenyl phosphine (0.14 mL, 1.08 mmol) was then added dropwise 
over 5 minutes and the reaction was allowed to warm to room temperature 
and was left for 24 hours. Water (10 mL) was then cautiously added to reaction 
and allowed to stir for ten minutes. The organic and aqueous layer were then 
separated and washed with water and ethyl acetate, respectively. The organic 
layer was then dried over MgSO4, filtered and the solvent removed in vacuo 
and the crude residue purified by column chromatography (eluent: 
hexane:ethyl acetate; 9:1)  to leave the title compound (210 mg, 40%) as a 
viscous clear oil. 1H NMR (CDCl3, 400 MHz) δ 1.18-1.69 (12H, m), 3.45 (2H, 
m), 3.81 (2H, m), 4.58 (2H, m) 4.71 (2H, m) 4.92 (2H, m), 6.85 (2H, dd, J = 
7.2, 3.8 Hz), 7.15 – 7.24 (4H, m), 7.29 (3H, m), 7.33 (2H, m), 7.53 (2H, m). 
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HRMS: (ESI+) Calculated for C30H36O4P: 491.2346 Found [M+H]+: 491.2328  
(3.59 ppm). 
 




To a solution of 2-bromobenzaldehyde (103) (1.26 mL, 10.8 mmol) in EtOH 
(15 mL), triethyl orthoformate (5.4 mL, 32.4 mmol) was added followed by a 
catalytic amount of conc. HCl. The reaction was left to stir at 50oC and was 
monitored by TLC. When complete, the volume of the reaction was reduced, 
and DCM (30 mL) was added followed by sodium bicarbonate (10 mL). The 
organic layer and aqueous layers were separated, and the organic layer 
washed with water (15 mL), brine (15 mL) and then dried over MgSO4 and the 
solvent removed in-vacuo. The product was purified by column 
chromatography to leave the title compound (2.36 g, 84%) as a clear liquid. 1H 
NMR (CDCl3, 400 MHz) δ 1.25 (6H, t, J = 7.1 Hz), 3.59 (2H, dq, J = 9.3, 7.0 
Hz), 3.69 (2H, dq, J = 9.3, 7.0 Hz), 5.68 (1H, s), 7.15 (1H, dd, J = 7.9, 1.7 Hz), 
7.32 (1H, dd, J = 11.1, 3.9 Hz), 7.53 (1H, dd, J = 8.0, 0.7 Hz), 7.68 (1H, dd, J 
= 8.0, 0.7 Hz). 13C NMR (CDCl3, 100 MHz) δ 15.23, 62.37, 101.29, 122.99, 
127.23, 128.31, 129.88, 137.97. HRMS: (ESI+) Calculated for C11H15O2BrNa : 









To a solution of 104 (1.82 g, 7.0 mmol) in anhydrous THF (50 mL) at -78oC, 
was added 1.6 M n-BuLi (4.8 mL, 7.75 mmol) dropwise and the reaction left to 
stir for an hour. Dichlorophenyl phosphine (0.48 mL, 3.5 mmol) was then 
added dropwise over 5 minutes, the reaction was allowed to warm to room 
temperature and was left for 24 hours. Water (25 mL) was then cautiously 
added to reaction and allowed to stir for ten minutes. The organic and aqueous 
layer were then separated and washed with water and ethyl acetate, 
respectively. The organic layer was then dried over MgSO4, filtered and the 
solvent removed in vacuo and the crude residue was purified by column 
chromatography (eluent: hexane:ethyl acetate; 19:1) to give the title 
compound (449 mg, 27%) as a yellow solid. 1H NMR (CDCl3, 400 MHz) δ 0.95 
(3H, t, J = 9.1 Hz), 0.99 (3H, t, J = 9.1 Hz), 3.39 (2H, m), 3.50 (2H, m), 6.11 
(1H, s), 6.13 (1H, s), 6.95 (1H, dd, J = 4.4, 1.0 Hz), 6.96 (1H, dd, J = 4.4, 1.0 
Hz), 7.25 (4H, m), 7.32 (3H, m), 7.30 (2H, td, J = 7.5, 1.1 Hz), 7.76 (1H, dd, J 
= 4.2, 1.3 Hz), 7.77 (1H, dd, J = 4.2, 1.3 Hz). 31P NMR (CDCl3, 162 MHz) δ -
28. HRMS: (ESI+) Calculated for C28H35O5PNa: 505.2114 Found [M+Na]+: 










To a solution of 102 (100 mg, 0.3 mmol) in THF (5 mL) was added 1 M HCl 
(0.3 mL, 0.3 mmol) and the reaction left to stir for 12 hours at 60oC. Once 
complete, the reaction was neutralized with sodium bicarbonate and the 
aqueous layer extracted with ethyl acetate (3 x 5 mL). The organic layer was 
then dried over magnesium sulphate, filtered and the solvent removed in-
vacuo. The residue was then purified by column chromatography (eluent: 
hexane:ethyl acetate; 95:5) to give the title compound (84 mg, 87%)  as a 
white solid. 1H NMR (CDCl3, 400 MHz) δ 4.93 (2H,  dd, J = 14.2, 2.2 Hz), 5.11 
(2H, dd, J = 14.2, 5.7 Hz), 7.32 (5H, m), 7.45 (2H, m), 7.52 (2H, m), 7.62 (2H, 
m), 8.39 (2H, m). 13C NMR (CDCl3, 100 MHz) δ 65.7, 122.4 (d, J = 16.3 Hz), 
127.7 (d, J = 13.3 Hz), 127.9 (d, 15.3 Hz), 129.1 (d, J = 3.3 Hz), 129.6-131.3 
(d, J  = 168.6 Hz), 130.4 (d, J = 11.5 Hz), 131.8 (d, J = 3.3 Hz), 140.1 (d, J = 
165.1 Hz), 148.4 (d, J = 27.0 Hz). 31P NMR (CDCl3, 162 MHz) δ -36.4. HRMS: 











To a solution of 97 (1.5 g, 5.56 mmol) in anhydrous THF (80 mL) at -78oC, was 
added 1.6 M n-BuLi (3.82 mL, 6.11 mmol) dropwise and the reaction left to stir 
for an hour. P,P-dichlorophenylphosphine (0.37 mL, 2.78 mmol) was then 
added dropwise over 5 minutes, the reaction was allowed to warm to room 
temperature and was left for 24 hours. Water (30 mL) was then cautiously 
added to reaction and allowed to stir for ten minutes. The organic and aqueous 
layer were then separated and washed with water and ethyl acetate, 
respectively. The organic layer was then dried over MgSO4, filtered and the 
solvent removed in vacuo and the crude residue was dissolved in 2:1 solution 
of DCM (30 mL) and H2O (15 mL) and H2O2 (0.63 mL, 5.56 mmol) was added 
and the reaction was left to stir for 2 hours. The organic and aqueous layer 
were then separated and washed with H2O and DCM, respectively. The 
organic layer was then dried over MgSO4, filtered and the solvent removed to 
leave a crude residue which was dissolved in MeOH (10 mL) and p-TSA (53 
mg, 0.27 mmol) and left to stir for 5 hours after which the reaction was washed 
with sat. sodium bicarbonate solution (10 mL). The organic layer and aqueous 
layer were separated and the organic layer dried over MgSO4, filtered and the 
solvent removed after which the crude residue was purified by column 
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chromatography (eluent: ethyl acetate:hexane; 3:2) to give the title compound 
(210 mg, 23%)  as a white solid. 1H NMR (CDCl3, 400 MHz) δ 4.58 (2H, d, J = 
12.9 Hz), 4.67 (2H, d, J = 12.9 Hz), 5.22 (2H, br, -OH), 6.92 (2H, dd, J = 14.4, 
7.6 Hz), 7.27 (2H, m), 7.56 (9H, m). 13C NMR (CDCl3, 400 MHz) δ 64.5 (d, J = 
5.0 Hz), 127.4 (d, J = 13.2 Hz), 128.7 (d, J = 33.0 Hz), 129.83, 130.4, 130.8, 
131.5, 131.8 (d, J = 10.1 Hz), 132.1 (d, J = 10.1 Hz), 132.7 (d, J = 2.8 Hz), 
133.2 (d, J = 2.7 Hz), 133.5 (d, J = 133.Hz), 146.5 (d, J = 7.7 Hz). 31P NMR 
(CDCl3, 162 MHz) δ 40.49. HRMS: (ESI+) Calculated for C20H19O3PNa: 
361.0964 Found [M+Na]+: 361.0971 (-1.86 ppm). HPLC separation (DAICEL 
AD, hexane/isopropanol 83:17, 1.2 mL/min, UV = 254, 210 nm; tR = 19.4 min. 
 
Method B  
 
Hydrolysis of spirophosphorane 110 to give bis(2-
(hydroxymethyl)phenyl)(phenyl)phosphine oxide)  (102) 
 
Spirophosphorane 110 (0.65 g, 1.29 mmol) was dissolved in a 2:1 solution of 
ethanol (10 mL) and water (5 mL). Conc. HCl (0.5 mL) was then added 
dropwise and the reaction was stirred at 50oC and monitored by TLC. After 24 
hours, no starting material or spirophosphorane remained and the reaction 
volume was reduced and then neutralized by the addition of sat. sodium 
bicarbonate solution. The product was then extracted with DCM (20 mL x 3), 
and the organic layer dried over MgSO4, filtered and the solvent removed in 
vacuo. The product was then purified by column chromatography (eluent: ethyl 
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acetate:hexane; 3:2) to give the title compound (406 mg, 93%) as a white solid. 
Data identical to method A. 
 
10.3 - Chapter 2.3 phosphonate synthesis and rearrangement 
experimental 
 




Method A  
 
To a solution of 106 (0.93 g, 8.92 mmol) in THF (60 mL) was added, DMAP 
(31 mg, 0.44 mmol), triethyl amine (1.2 mL, 21.6 mmol) followed by 
dichlorophenyl phosphine (0.34 mL, 4.46 mmol) and the reaction was left to 
stir at room temperature for 4 hours After this time, H2O (30 mL) was added 
and the aqueous and organic layers were separated and washed with ethyl 
acetate and water, respectively. The organic layer was then dried over MgSO4, 
filtered and the solvent removed. The residue was then dissolved in a 2:1 
solution of DCM and H2O and 30% H2O2 (0.56 mL, 8.92 mmol) was added and 
the reaction stirred for 2 hours. The organic and aqueous layer were then 
separated and washed with H2O and DCM, respectively. The organic layer 
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was then dried over MgSO4, filtered and the solvent removed to leave a crude 
residue which was purified by column chromatography (eluent: hexane:ethyl 
acetate; 75:25) to give the title compound (0.71 g, 32%)  as a clear oil. 1H NMR 
(CDCl3, 400 MHz) δ 5.10 (2H, dd, J = 12.7, 7.2 Hz), 5.18 (2H, dd, J = 12.7 Hz, 
7.2 Hz), 7.12 (2H, t, J = 7.6 Hz), 7.26 (2H, t, J = 7.5 Hz), 7.40 – 7.58 (7H, m), 
7.86 (1H, d, J = 8.0 Hz), 7.89 (1H, d, J = 7.2 Hz). 13C NMR (CDCl3, 400 MHz) 
δ 67.0 (d, J = 4.9 Hz), 122.6, 127.5, 128.5 (d, J = 15.3 Hz), 129.3, 129.7, 131.8 
(d, J = 10.1 Hz), 132.6, 132.8 (d, J = 3.1 Hz), 135.4 (d, J = 7.5 Hz). 31P NMR 
(CDCl3, 162 MHz) δ 19.79. HRMS: (ESI+) Calculated for C20H17Br2O3PNa: 
519.9174 Found [M+Na]+: 516.9179 (-0.02 ppm), 517.9213 (-0.01 ppm), 





To a solution of diisopropyl amine (1.69 mL, 12 mmol) in THF (40 mL) at -78oC 
was added 1.6 M n-BuLi (6.87 mL, 11 mmol) and the reaction stirred for 10 
minutes. After this, 2-bromobenzyl alcohol (1.87 g, 10 mmol) was added and 
stirred for a further 30 minutes after which, phenyl phosphinic dichloride (0.786 
mL, 5 mmol) was added and the reaction allowed to warm to room temperature 
and was left for 16 hours. Water (20 mL) was then added to the reaction and 
the organic and aqueous layers were separated and washed with water and 
ethyl acetate, respectively. The organic layer was then dried over MgSO4, 
filtered, the solvent removed in vacuo and the crude material purified by 
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column chromatography (eluent: hexane:ethyl acetate; 75:25 to give the title 
compound (1.85 g, 75%)  as a clear oil. Data identical to method A. 
 




To a solution of diisopropyl amine (1.97 mL, 14 mmol) in THF (80 mL) at -78oC 
was added 1.6 M n-BuLi (7.5 mL, 12 mmol) and the reaction stirred for 10 
minutes. After this, 2-iodobenzyl alcohol (2.34 g, 10 mmol) was added and 
stirred for a further 30 minutes after which, phenyl phosphinic dichloride (0.74 
mL, 5 mmol) was added and the reaction allowed to warm to room temperature 
and was left for 16 hours. Water (40 mL) was then added to the reaction and 
the organic and aqueous layers were separated and washed with water and 
ethyl acetate, respectively. The organic layer was then dried over MgSO4, 
filtered, the solvent removed in vacuo and the crude material purified by 
column chromatography (eluent: hexane:ethyl acetate; 75:25) to give the title 
compound (2.2 g, 75%)  as a clear oil. 1H NMR (CDCl3, 400 MHz) δ 5.09 (2H, 
dd. J = 12.7, 7.4 Hz), 5.13 (2H, dd, J = 12.7, 7.4 Hz), 6.97 (2H, t, J = 7.6 Hz), 
7.30 (2H, t, J = 7.5 Hz), 7.42 (2H, d, J = 7.7 Hz), 7.45 (2H, m), 7.55 (1H, t, J = 
7.4 Hz), 7.78 (2H, d, J = 7.9 Hz), 7.8 (2H, dd, J = 13.6, 7.8 Hz). 13C NMR 
(CDCl3, 400 MHz) δ 71.39 (d, J = 5.0 Hz), 128.4, 128.5, 128.6, 129.0, 129.9, 
131.9 (d, J = 10.2 Hz), 132.8 (d, J = 3.1 Hz), 138.4 (d, J = 7.5 Hz), 139.3. 31P 
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NMR (CDCl3, 162 MHz) δ 19.52. HRMS: (ESI+) Calculated for C20H17I2O3PNa: 
612.8897 Found [M+Na]+: 612.8904 (1.16 ppm).   
 




To a solution of diisopropyl amine (1.97 mL, 14 mmol) in THF (80 mL) at -78oC 
was added 1.6 M n-BuLi (7.5 mL, 12 mmol) and the reaction stirred for 10 
minutes. After this, 3-iodobenzyl alcohol (1 g, 4.2 mmol) was added and stirred 
for a further 30 minutes after which, phenyl phosphinic dichloride (0.74 mL, 5 
mmol) was added and the reaction allowed to warm to room temperature and 
was left for 16 hours. Water (15 mL) was then added to the reaction and the 
organic and aqueous layers were separated and washed with water and ethyl 
acetate, respectively. The organic layer was then dried over MgSO4, filtered, 
the solvent removed in vacuo and the crude material purified by column 
chromatography (eluent: hexane:ethyl acetate; 75:25) to give the title 
compound (2.6 g, 89%)  as a clear oil. 1H NMR (CDCl3, 400 MHz) δ 4.97 (2H, 
dd, J = 12.1, 8.0 Hz), 5.05 (2H, dd, J = 12.1, 8.0 Hz), 7.05 (2H, t, J = 7.8 Hz), 
7.27 (2H, d, J = 7.8 Hz), 7.46 (2H, m), 7.56 (1H, t, J = 7.4 Hz), 7.68 – 7.59 (4H, 
m), 7.78 (1H, d, J = 7.7 Hz), 7.81 (1H, d, J = 7.8 Hz). 13C NMR (CDCl3, 100 
MHz) δ 13C NMR (101 MHz, CDCl3) δ 66.57 (d, J = 5.3 Hz), 94.3, 126.4, 127.0, 
128.2, 128.6 (d, J = 15.3 Hz), 130.3, 131.8 (d, J = 10.2 Hz), 132.9 (d, J = 3.1 
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Hz), 136.6, 137.4, 138.2 (d, J = 6.6 Hz). 31P (CDCl3, 162 MHz) δ 20.07.  HRMS: 
(ESI+) Calculated for C20H17I2O3PNa: 612.8896 Found [M+Na]+: 612.8912 
(2.46 ppm).  
 




To a solution of diisopropyl amine (1.97 mL, 14 mmol) in THF (60 mL) at -78oC 
was added 1.6 M n-BuLi (7.5 mL, 12 mmol) and the resulting mixture was 
stirred for 10 minutes.  2-Iodobenzyl alcohol (2.46 g, 10 mmol) was added and 
the reaction was warmed to room temperature and stir for 30 minutes. Ethyl 
phosphinic dichloride (0.51 mL, 5 mmol) was then added dropwise and the 
reaction was left to stir for 24 hours after which sat. ammonium chloride (40 
mL) was added and aqueous layer was extracted with ethyl acetate (3 x 25 
mL). The organic layer was then dried over MgSO4, filtered and the solvent 
removed in-vacuo and the crude material purified by column chromatography 
(eluent: hexane:ethyl acetate; 3:2) to give the title compound (1.5 g, 56%)  as 
a clear oil. 1H NMR (CDCl3, 400 MHz) δ 1.21 (3H, dt, J = 20.5, 7.7 Hz), 1.88 
(2H, dq, J = 18.3, 7.7 Hz), 5.02 (2H, dd, J = 11.3, 5.9 Hz), 5.04 (2H, dd, J  = 
11.3, 5.9 Hz), 7.00 (2H, td, J = 7.8, 1.7 Hz), 7.34 (2H, td, J = 7.6, 1.0 Hz), 7.43 
(2H, dd, J = 7.7, 1.4 Hz), 7.81 (2H, dd, J = 7.9, 0.9 Hz). 13C NMR (CDCl3, 100 
MHz) 6.6 (d, J = 6.9 Hz), 18.4, 19.8, 70.9 (d, J = 6.0 Hz), 97.48, 128.4, 128.9, 
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129.8, 138.7 (d, J = 6.7 Hz), 139.3. 31P NMR (CDCl3, 162 MHz) δ 34.73. 
HRMS: (ESI+) Calculated for C16H17O3PI2Na: 565.8902 Found [M+Na]+: 
565.8911 (1.14 ppm).  
 
 




To a solution of diisopropyl amine (1.41 mL, 10 mmol), in THF (60 mL) at -
78oC was added 1.6 M n-BuLi (5.4 mL, 8 mmol) and the resulting mixture 
stirred for 10 minutes. 2-Iodobenzyl alcohol (1.76 g, 7.2 mmol) was added and 
the reaction was warmed to room temperature and stir for 30 minutes. 
Dichlorocyclohexyl phosphine (0.66 g, 3.6 mmol) was then added dropwise 
and the reaction was left to stir for 24 hours after which sat. ammonium 
chloride (40 mL) was added and aqueous layer was extracted with ethyl 
acetate (3 x 25 mL). The organic layer was then dried over MgSO4, filtered 
and then dissolved in a 2:1 solution of DCM to water, then 30 % hydrogen 
peroxide (1 mL, 2 eqv.) was added and left to stir for 2 hours. Water (10 mL) 
was then added to the reaction and the organic layer separated and the 
aqueous layer was washed with DCM (10 mL). The organic layers were then 
combined, dried over MgSO4, filtered and solvent removed in-vacuo and the 
crude material purified by column chromatography (eluent: hexane:ethyl 
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acetate; 85:15) to give the title compound (0.9 g, 42%) as a white solid. 1H 
NMR (CDCl3, 400 MHz) δ 1.15-2.09 (11H, m), 5.02 (2H, dd, J = 11.5, 7.5 Hz), 
5.06 (2H, dd, J = 11.5, 7.5 Hz), 6.97 (2H, td, J = 7.7, 1.5 Hz), 7.32 (2H, td, J = 
7.7, 1.1 Hz), 7.42 (2H, dd, J = 7.6, 1.2 Hz), 7.78 (2H, dd, J = 7.9, 0.9 Hz). 13C 
NMR (CDCl3, 100 MHz) 25.77 (d, J = 1.4 Hz), 25.8 (d, J = 4.6 Hz), 26.0 (d, J 
= 16.5 Hz), 35.9 (d, J = 141.43 Hz), 70.8 (d, J = 6.4 Hz), 97.5, 128.4, 128.9, 
129.7, 138.9 (d, J = 6.6 Hz), 139.3. 31P NMR (CDCl3, 162 MHz) δ 33.86. 
HRMS: (ESI+) Calculated for C20H23O3PI2Na: 618.9366 Found [M+Na]+: 
618.9369 (-0.35 ppm). 
 




To a solution of diisopropyl amine (2 mL, 114 mmol), in THF (60 mL) at -78oC 
was added 1.6 M n-BuLi (7.5 mL, 12 mmol) and the resulting mixture stirred 
for 10 minutes. 2-Iodobenzyl alcohol (2.34 g, 10 mmol) was added and the 
reaction was warmed to room temperature and stir for 30 minutes. Dichloro t-
butyl phosphine (0.8 g, 5 mmol) was then added dropwise and the reaction 
was left to stir for 24 hours. After which sat. ammonium chloride (40 mL) was 
added and aqueous layer was extracted with ethyl acetate (3 x 25 mL). The 
organic layer was then dried over MgSO4, filtered, and then dissolved in a 2:1 
solution of DCM to water, then hydrogen peroxide (1 mL, 2 eqv.) was added 
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and left to stir for 2 hours. Water (10 mL) was then added to the reaction and 
the organic layer separated and the aqueous layer was washed with DCM (10 
mL). The organic layers were then combined, dried over MgSO4, filtered and 
solvent removed in-vacuo and the crude material purified by column 
chromatography (eluent: hexane:ethyl acetate; 80:20) to give the title 
compound (1.15 g, 41%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ 1.26 
(9H, d, J = 17.1 Hz), 4.98 (2H, dd, J = 12.1, 7.6 Hz), 5.04 (2H, dd, J = 12.1, 
7.6 Hz), 6.97 (2H, td, J = 7.7, 1.7 Hz), 7.32 (2H, td, J = 7.6, 1.0 Hz), 7.42 (2H, 
dd, J = 7.7, 1.5 Hz), 7.78 (2H, dd, J = 7.9, 1.0 Hz). 13C NMR (CDCl3, 100 MHz) 
δ 24.8 (d, J = 2.3 Hz), 31.8 (d, J = 141.5 Hz), 71.1 (d, J = 6.9 Hz), 97.5 (d, J = 
13.2 Hz), 128.4, 128.8, 129.7, 139.0 (d, J = 6.2 Hz), 139.3. 31P NMR (CDCl3, 
162 MHz) δ 38.16. HRMS: (ESI+) Calculated for C18H21I2O3PNa: 592.921 
Found [M+Na]+: 592.9208 (0.25 ppm).  
 







To a solution of bis(2-iodobenzyl) phenylphosphonate 118 (0.675 g, 1.14 
mmol) in THF (20 mL) at -78oC was added 1.6 M n-BuLi (1.57 mL, 2.51 mmol) 
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and the reaction left to warm up to room temperature over 24 hours. After this, 
water (10 mL) was added and the organic and aqueous layer separated and 
washed with water and ethyl acetate, respectively. The organic layer was then 
dried over MgSO4, filtered and the solvent removed in vacuo to leave a crude 
oil which was purified by column chromatography (eluent: chloroform:acetone; 
9:1) to give the title compound (0.14 g, 37%) as a white solid. 1H NMR (CDCl3, 
400 MHz) δ 4.58 (2H, d, J = 12.9 Hz), 4.67 (2H, d, J = 12.9 Hz),  5.22 (2H, br, 
-OH), 6.92 (2H, dd, J = 14.4, 7.6 Hz), 7.27 (2H, m), 7.56 (9H, m). 13C NMR 
(CDCl3, 400 MHz) δ 64.5 (d, J = 5.0 Hz), 127.4 (d, J = 13.2 Hz), 128.7 (d, J = 
33.0 Hz), 129.83, 130.4, 130.8, 131.5, 131.8 (d, J = 10.1 Hz), 132.1 (d, J = 
10.1 Hz), 132.7 (d, J = 2.8 Hz), 133.2 (d, J = 2.7 Hz), 133.5 (d, J = 133.Hz), 
146.5 (d, J = 7.7 Hz). 31P NMR (CDCl3, 162 MHz) δ 40.49. HRMS: (ESI+) 
Calculated for C20H19O3PNa: 361.0964 Found [M+Na]+: 361.0971 (-1.86 ppm). 
HPLC separation (DAICEL AD, hexane/isopropanol 83:17, 1.2 mL/min, UV = 




To a solution of bis(2-iodobenzyl) phenylphosphonate (1.79 g, 3 mmol) in THF 
(30 mL) was added 1.3 M (CH3)2CHMgCl · LiCl (5.63 mL, 7.2 mmol) and the 
reaction left to stir at room temperature for 24 hours. After this, the reaction 
was washed with sat. ammonium chloride solution (15 mL). The organic and 
aqueous layers were then separated and washed with water and ethyl acetate, 
respectively. The organic layer was then dried over MgSO4, filtered and the 
solvent removed in vacuo to leave a crude oil which was purified by 
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recrystallization from 3:2 ethyl acetate to hexane to give the title compound 
(0.66 g, 65%) as a white solid. Data identical to method A.  
 
10.4 - Chapter 3 enzymatic desymmetrization and kinetic resolution 
reactions experimental 
 
Enzyme Condition screening HPLC  
 
HPLC analysis was undertaken on an Agilent Infinity 1260 HPLC, using a 
DAICEL Chiralpak-AD column (Daicel, 5 μm particle size, 250 mm x 4.6 mm).  
The mobile phase comprised of (A) IPA: (B) Hexane with an isocratic system 
of 17% (A) to 83% (B) with a flow rate of 1.2 mL/min, an injection volume of 5 
μL and a column temperature of 30oC. Signals were recorded at 200 nm, 210 
nm, 220 nm, 254 nm.  
 
Lipase Enzyme Assay 
 
The diol 102 (8.4 mg, 25 mM), lipase enzyme (5 mg), base (25 mM), acyl donor 
(75 mM, 3 eqv.) and an appropriate solvent (1 mL) were left to shake for a 
specified amount of time at a specified temperature. An aliquot was then taken, 
the solvent removed, and the crude material resuspended in the HPLC mobile 
phase to be analysed by chiral HPLC. If needed, the reaction was purified by 
column chromatography (eluent: ethyl acetate:hexane; 60:40)  to give the 
product as an oil. 
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Scaled up Lipase Catalysed desymmetrisation of diol 102 to give 129 and 




The diol 102 (85 mg, 25 mM), Purolite immobilized CAL-A (5 eqv. w/w), sodium 
carbonate (132 mg, 125 mM) and water (9 µL, 50 mM) were all added to vinyl 
acetate (10 mL) and shaken at 37oC for 24 hours and monitored by chiral 
HPLC (<95% e.e.) after which the reaction was neutralized with sat. sodium 
bicarbonate solution (5 mL). The vinyl acetate was then removed in-vacuo and 
the aqueous layer extracted with ethyl acetate (5 mL x 3), dried over MgSO4, 
filtered and the solvent removed to leave the crude material. The crude residue 
was then dissolved in DCM (5 mL) and TBDPS-Cl (0.2 mL, 0.75 mmol) and 
imidazole (100 mg, 1.5 mmol) was added and refluxed for 15 hours after which 
the reaction was washed with 1 M HCl (5 mL), 1 M NaOH (5 mL) and sat. brine 
(5 mL) and the organic layer dried over MgSO4, filtered and the solvent 
removed in-vacuo. The product was then purified by column chromatography 
(eluent: hexane:ethyl acetate; 70:30) to give the title compound 140 (103 mg, 
66%) as a clear oil. 1H NMR (CDCl3, 400 MHz) δ 1.01 (9H, s), 1.68 (3H, s), 
176 
 
5.01 (2H, m), 5.39 (2H, q, J = 13.2 Hz), 7.04 (3H, m), 7.24 (5H, m), 7.35 (4H, 
m), 7.49 (9H, m), 7.59 (1H, t, J = 7.6 Hz), 8.05 (1H, dd, J = 7.4, 3.8 Hz). 13C 
NMR (CDCl3, 100 MHz) δ 19.3, 20.4, 26.9, 63.8 (m), 64.4 (d, J = 3.9 Hz), 126.2 
(d, J = 12.7 Hz), 127.1 (d, J = 10.0 Hz), 127.5, 127.6 (d, J = 2.1 Hz), 128.5 (d, 
J = 12.2 Hz), 128.8 (d, J = 101.4 Hz), 129.5 (d, J = 2.4 Hz), 130.0, 130.6 (d, J 
= 89.3 Hz), 131.9 (m), 132.0 (m), 132.3 (d, J = 2.5 Hz), 132.5 (d, J = 12.0 Hz), 
132.9 (d, J = 12.4 Hz), 133.3 (d, J = 4.0 Hz), 135.4 (d, J = 1.0 Hz), 141.0 (d, J 
= 6.9 Hz), 146.2 (d, J = 7.6 Hz), 170.2. 31P NMR (CDCl3, 162 MHz) δ 33.3. 
HRMS: (ESI+) Calculated for C38H39O4PSiNa: 641.2247 Found [M+Na]+: 





Peak Area Percentage by Area e.e. 
13.9 (129) 2729.9 1.5%  
17.9 (102) 1062 <1% N/A 
20.2 (129) 113858.5 65% 95% 
26.9 (134) 57231.2 33% N/A 
 




To a solution of diol 102 (10 mg, 25 mM) in DMSO (300 µL) was added 0.1 M 
KPi buffer (0.52 mL), catalase (80 µL, 3 mg/mL pH 7.6), sat. copper sulphate 
solution (80 µL) and GOase (20 µL, 3 mg/mL). The reaction was then shaken 
at 25oC for 24 hours, extracted with ethyl acetate, dried over MgSO4, filtered 
and the solvent removed in-vacuo. The crude residue was then analysed by 
1H NMR which showed no oxidation had occurred. 
 
Lipase screen for the catalysed hydrolytic desymmetrization of diacetate 134 
 
To a solution of diacetate 134 (9 mg, 25 mM) in toluene (1 mL) was added 
Lipase (25 mg), KPi Buffer (1 mL) and the reaction was stirred vigorously for 
24 hours at 37oC. An aliquot was then taken, and the toluene removed in-
vacuo, the residue was resuspended in the mobile phase of the HPLC and 
analysed by chiral HPLC. 
 
Kinetic Resolution screen of (±)-alcohol 135 by lipase catalysed acylation 
 
To a solution of the (±)-alcohol 135 (8.4 mg, 25 mM) in organic solvent (1 mL) 
was added lipase (20 mg) and an acetate donor (4.6 µL, 50 mM) and the 
reaction was shaken for 24 hours at 37oC after which can an aliquot was taken 
and analysed by chiral HPLC. 
 






Crude CAL-A (5 mL, 6000 U/g, STREM) was dissolved in 0.1 M KPi buffer pH 
7 (5 mL). The concentration before immobilisation was recorded (7 – 21 
mg/mL). Eupergit CM (10 g) was added and left in a shaking incubator on 150 
rpm at 25°C for 24 hours. The amount of enzyme absorbed onto the resin (2.0 
mg/mL) was determined by UV spectroscopy (428nm). Blocking buffer (3M 
Glycine in 0.1M KPi pH 7) was added and left to shake for 30 minutes. The 
immobilised enzyme was filtered off and washed with KPi buffer pH 7 and then 




Crude CAL-A (5 mL, 6000 U/g, STREM) was dissolved in 0.1 M KPi buffer pH 
7 (5 mL). The concentration before immobilisation was recorded (7 – 25 
mg/mL). Purolite resin (10 g) was added and left in a shaking incubator on 150 
rpm at 25°C for 24 hours. The amount of enzyme absorbed onto the resin (2.4 
– 21 mg/mL) was determined by UV spectroscopy (428nm). The immobilised 
enzyme was filtered off and washed with KPi buffer pH 7 and dried. 
 






Phosphine oxide 102 (80 mg, 0.32 mmol) was dissolved in dry DCM (5 mL). 
Triethyl amine (86 µL, 0.61 mmol) followed by acetyl chloride (40.3 µL, 0.56 
mmol) were added and the reaction left to stir for 2 hours. The organic layer 
was then washed with 1 M HCl (2.5 mL), H2O (2.5 mL), brine (2.5 mL) and 
dried over MgSO4, filtered and the solvent removed. The crude residue was 
then purified by column chromatography (eluent: hexane:ethyl acetate; 70:30) 
to give the title compound (90 mg, 89%) as a white solid. 1H NMR (CDCl3, 400 
MHz) δ 1.70 (3H, s), 4.58 (2H, dd, AB, J = 12.7 Hz), 5.49 (2H, dd, AB, J = 13.1 
Hz), 5.69 (1H, br, -OH), 7.00 (2H, m), 7.29 (2H, m), 7.46-7.64 (9H, m). 13C 
NMR (CDCl3, 100 MHz) δ 20.3, 64.5 (d, J = 4.0 Hz), 64.7 (d, J = 5.0 Hz), 127.3 
(d, J = 13.1 Hz), 127.6 (d, J = 12.9 Hz), 128.7 (d, J = 12.4 Hz), 129.7 (d, J = 
101.1 Hz), 130.5 (d, J = 10.0 Hz), 131.1 (d, J = 18.0 Hz), 131.7 (d, J = 10.1 
Hz), 132.1 (d, J = 10.0 Hz), 132.4 (d, J =2.8 Hz), 132.6 (d, J = 2.6 Hz), 132.8 
(d, J = 2.7 Hz), 133.4 (d, J = 1.4 Hz), 141.3 (d, J = 6.9 Hz), 146.4 (d, J = 7.8 
Hz), 170.3. 31P NMR (CDCl3, 162 MHz) δ 37.96. HRMS: (ESI+) Calculated for 
C22H21O4PNa: 403.107 Found [M+Na]+: 403.1075 (-1.29 ppm). HPLC 
separation (DAICEL AD, hexane/isopropanol 83:17, 1.2 mL/min, UV = 210 nm; 










Phosphine oxide 102 (58 mg, 0.17 mmol) was dissolved in dry DCM (5 mL). 
Triethyl amine (60 µL, 0.41 mmol) followed by acetyl chloride (27 µL, 0.37 
mmol) was added and the reaction left to stir for 2 hours. The organic layer 
was then washed with 1 M HCl (2.5 mL), H2O (2.5 mL), brine (2.5 mL) and 
dried over MgSO4, filtered and the solvent removed. The crude residue was 
then purified by column chromatography (eluent: hexane:ethyl acetate; 3:2) to 
give the title compound (41 mg, 55%) as a clear oil. 1H NMR (CDCl3, 400 MHz) 
δ 1.85 (6H, s), 5.40, (2H, m) 5.51 (2H, m), 7.04 (2H, m), 7.29 (2H, m), 7.49 
(2H, m) 7.53-7.64 (7H, m). 13C NMR (CDCl3, 100 MHz) δ 20.4, 64.4 (d, J = 4.1 
Hz), 127.4 (d, J = 12.7 Hz), 128.6 (d, J = 12.3 Hz), 130.1 (d, J = 9.9 Hz), 130.3, 
131.3, 132.0 (d, J = 2.9 Hz), 132.2 (d, J = 7.5 Hz), 132.2, 133.4 (d, J = 12.2 
Hz), 141.1 (d, J = 7.0 Hz), 170.3. 31P NMR (CDCl3, 162 MHz) δ 34.41. HPLC 
separation (DAICEL AD-H, hexane/isopropanol 83:17, 1.2 mL/min, UV = 254, 





Synthesis of (2-((benzyloxy)methyl)phenyl)(2-(hydroxymethyl)phenyl)(phenyl) 




To a solution of 102 (0.66 g, 2 mmol) in DCM (15 mL) was added silver (I) 
oxide (1.8 g, 8 mmol) and benzyl bromide (0.285 mL, 2.4 mmol) and the 
reaction was monitored by TLC for the appearance of the benzylated product. 
After 5 hours, reaction was filtered and the solution washed with water (3 x 5 
mL) and the organic layer dried over MgSO4, filtered and the solvent removed 
in-vacuo to leave the crude residue. The product was purified by column 
chromatography (eluent: hexane:ethyl acetate; 50:50) to give the title 
compound (159 mg, 20%) as a clear oil. 1H NMR (CDCl3, 400 MHz) δ 4.36 
(2H, s), 4.59 (2H, m), 4.91 (2H, s), 5.78 (1H, t, J = 7.38 Hz), 6.96 (2H, m), 7.24 
(7H, m), 7.49 (4H, m), 7.57 (4H, m), 7.81 (1H, dd, J = 7.6, 3.9 Hz). 13C NMR 
(CDCl3, 100 MHz) δ 64.7 (d, J = 4.9 Hz), 70.0 (d, J = 4.7 Hz), 72.8, 126.8 (d, 
J = 13.0 Hz), 127.3 (d, J = 13.0 Hz), 127.5, 127.9 (d, J = 57.5 Hz), 128.7 (d, J 
= 12.3 Hz), 128.8 (d, J = 102.5 Hz), 129.0 (d, J = 10.1 Hz), 131.0 (d, J = 6.9 
Hz), 131.7 (d, J = 10.0 Hz), 131.9, 132.1 (d, J = 10.0 Hz), 132.3 (d, J = 2.8 
Hz), 132.7 (d, J = 2.6 Hz), 132.9 (d, J = 12.9 Hz), 133.3 (d, J = 13.0 Hz), 138.0, 
144.2 (d, J = 7.3 Hz), 146.4 (d, J = 7.7 Hz). 31P NMR (CDCl3, 161 MHz) δ 38.0 
(s). HRMS: (ESI+) Calculated for C27H25O3PNa: 451.1434 Found [M+Na]+: 
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451.1439 (-1.21 ppm). HPLC separation (DAICEL AD, hexane/isopropanol 
83:17, 1.2 mL/min, UV = 254, 210 nm; tR (A) = 14.0 min, tR (B) = 17.4 min, 
e.e. = 0%. 
 





To a solution of 102 (0.25 g, 0.75 mmol) in DCM (8 mL) was added 
isonicotinoyl chloride hydrochloride (0.13 g, 0.75 mmol), followed by triethyl 
amine (0.21 mL, 1.51 mmol) and the reaction left to stir at room temperature 
for 24 hours. After this time, the reaction was stopped, washed with water ( 3 
x 5 mL) and the organic layer was dried over MgSO4, filtered and the solvent 
removed in vacuo to leave a residue which was purified by column 
chromatography (eluent: hexane:ethyl acetate; 4:1) to give the title compound 
(95.3 mg, 28%) as a clear oil. 1H NMR (CDCl3, 400 MHz) δ 4.69 (2H, d, J = 
6.7 Hz), 5.70 (1H, t, J = 7.3 Hz), 5.86 (2H, m), 6.90 (1H, dd, J = 14.3, 7.6 Hz), 
7.04 (1H, dd, J = 14.3, 7.6 Hz), 7.34 (1H, t, J = 7.1 Hz), 7.47 (6H, m), 7.58 (4H, 
m), 7.69 (1H, m), 8.59 (2H, d, J = 5.3 Hz). 13C NMR (CDCl3, 100 MHz) δ 64.6 
(d, J = 5.0 Hz), 65.6 (d, J = 3.8 Hz), 122.8, 127.3 (d, J = 13.1 Hz), 128.1 (d, J 
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= 12.9 Hz), 128.8 (d, J = 12.4 Hz), 129.5, 131.0, 130.5, 131.5 (d, J = 10.0 Hz), 
131.7 (d, J = 10.1 Hz), 132.0 (d, J = 10.0 Hz), 132.5 (d, J = 2.8 Hz), 132.7 (d, 
J = 2.6 Hz), 132.9 (d, J = 2.6 Hz), 133.3 (d, J = 13.0 Hz), 133.7 (d, J = 12.6 
Hz), 136.8, 140.5 (d, J = 6.8 Hz), 146.3 (d, J = 7.8 Hz), 150.2, 164.6. 31P NMR 
(CDCl3, 162.8 MHz) δ 38.11. HRMS: (ESI+) Calculated for C26H23NO4P: 
444.1359 Found [M+H]+: 444.1365 (-1.22 ppm). 
 
10.5 - Chapter 4 synthesis of ligand structures experimental 
HPLC analysis 
 
HPLC analysis was undertaken on an Agilent Infinity 1260 HPLC, using a 
DAICEL Chiralpak-AD column (Daicel, 5 μm particle size, 250 mm x 4.6 mm).  
The mobile phase comprised of (A) IPA: (B) Hexane with an isocratic system 
of 9% (A) to 91% (B) with a flow rate of 1.2 mL/min, an injection volume of 5 
μL and a column temperature of 30oC. Signals were recorded at 200 nm, 210 
nm, 220 nm, 254 nm. 
 






To a solution of 140 (0.23 g, 0.37 mmol) in THF (10 mL) was added 1 M TBAF 
(0.56 mL, 0.56 mmol) dropwise. The reaction was then allowed to stir at room 
temperature for 24 hours, after which the reaction was washed with sat. 
ammonium chloride solution (10 mL) and the aqueous layer extracted with 
ethyl acetate (10 mL). The organic layer was then dried over MgSO4, filtered 
and the solvent removed. The residue was then purified by column 
chromatography (eluent: hexane:ethyl acetate; 3:2) to give the title compound 
(133 mg, 94%) as a clear oil. 1H NMR (CDCl3, 400 MHz) δ 1.70 (3H, s), 4.58 
(2H, d, AB, J = 12.7 Hz), 5.49 (2H, d, AB, J = 13.1 Hz), 5.69 (1H, br, -OH), 
7.00 (2H, m), 7.29 (2H, m), 7.46-7.64 (9H, m). 13C NMR (CDCl3, 100 MHz) δ 
20.3, 64.5 (d, J = 4.0 Hz), 64.7 (d, J = 5.0 Hz), 127.3 (d, J = 13.1 Hz), 127.6 
(d, J = 12.9 Hz), 128.7 (d, J = 12.4 Hz), 129.7 (d, J = 101.1 Hz), 130.5 (d, J = 
10.0 Hz), 131.1 (d, J = 18.0 Hz), 131.7 (d, J = 10.1 Hz), 132.1 (d, J = 10.0 Hz), 
132.4 (d, J =2.8 Hz), 132.6 (d, J = 2.6 Hz), 132.8 (d, J = 2.7 Hz), 133.4 (d, J = 
1.4 Hz), 141.3 (d, J = 6.9 Hz), 146.4 (d, J = 7.8 Hz), 170.3. 31P NMR (CDCl3, 
162 MHz) δ 37.96. HRMS: (ESI+) Calculated for C22H21O4PNa: 403.107 Found 
[M+Na]+: 403.1075   (-1.29 ppm). HPLC separation (DAICEL AD, 
hexane/isopropanol 83:17, 1.2 mL/min, UV = 254, 210 nm; tR (A) = 14.8 min, 













To monoacetate 129 (133 mg, 0.35 mmol) in DCM (5 mL) was added 
triethylamine (60 µL, 0.45 mmol) followed by mesyl chloride (30 µL, 0.39 
mmol) and the reaction stirred for 5 hours at room temperature. The reaction 
was then washed with sat. sodium bicarbonate (5 mL), 1 M HCl (5 mL) and 
brine (5 mL). The organic layer was then dried over MgSO4, filtered and the 
solvent removed and the mesylated compound used without purification. To 
mesylated material 142 (152 mg. 0.33) was added sodium iodide (149 mg, 1 
mmol) and acetone (5 mL). The reaction was then left 12 hours and the solvent 
removed in-vacuo, the residue was then dissolved in ethyl acetate (10 mL) 
and washed with sat. Na2S2O3 solution. The organic layer was then dried over 
MgSO4, filtered and the solvent removed. The residue was then purified by 
column chromatography (eluent: hexane:ethyl acetate; 1:1) to give the title 
compound (110 mg, 68%)  as a cream solid. 1H NMR (CDCl3, 400 MHz) δ 1.76 
(3H, s), 5.04 (2H, dd, J = 14.0, 9.9 Hz), 5.51 (2H, m), 6.94 (1H, dd, J = 14.0, 
7.7 Hz), 7.10 (1H, dd, J = 14.2, 7.5 Hz), 7.19 (1H, m), 7.30 (1H, m), 7.51 (3H, 
m), 7.60 (6H, m). 13C NMR (CDCl3, 100 MHz) δ 3.56 (d, J = 4.4 Hz), 20.5, 64.4 
(d, J = 4.1 Hz), 127.0 (d, J = 12.6 Hz), 127.6 (d, J = 12.7 Hz), 128.6 (d, J = 
12.3 Hz), 129.8 (d, J = 16.0 Hz), 130.2 (d, J = 15.9 Hz), 130.8 (d, J = 15.9 Hz), 
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131.3, 132.2 (d, J = 2.8 Hz), 132.3, 132.4, 132.4, 132.5 (d, J = 2.5 Hz), 133.3 
(d, J = 12.5 Hz), 133.5 (d, J = 6.3 Hz), 133.6 (d, J = 3.6 Hz), 141.1 (d, J = 7.0 
Hz), 144.5 (d, J = 6.9 Hz), 170.3. 31P NMR (CDCl3, 162 MHz) δ 34.7. HRMS: 
(ESI+) Calculated for C22H20O3PINa: 513.0087 Found [M+Na]+: 513.0092 (-
0.89 ppm).  
 
Synthesis of (2-(((tert-butyldiphenylsilyl)oxy)methyl)phenyl)(phenyl)(o-




To a solution of 140 (254 mg, 0.43 mmol) in MeOH (10 mL), was added 
NiCl2.6H2O (50 mg, 0.43 mmol) followed by NaBH4 (51 mg, 1.39 mmol) after 
which the solution turned black and became effervescent. The reaction was 
then stirred at 0oC and followed by TLC with NaBH4 (5 mg) being added at 
regular intervals. Once complete, the reaction was quenched with excess 
MeOH (10 mL) and filtered through a pad of celite, which was washed with 
both ethyl acetate and DCM. The filtrate was then concentrated and washed 
with water and the aqueous layer re-extracted with ethyl acetate. The organic 
layers were then combined, dried over MgSO4, filtered and the solvent 
removed in-vacuo. The residue was then purified by column chromatography 
(eluent: hexane:ethyl acetate; 50:50) to give the title compound (202 mg, 83%) 
as a clear oil. 1H NMR (CDCl3, 400 MHz) δ 1.03 (9H, s), 2.40 (3H, s), 4.94 (1H, 
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d, J = 15.3 Hz), 5.04 (1H, d, J = 15.3 Hz), 6.96 (2H, m), 7.16 (1H, m), 7.2-7.28 
(6H, m), 7.35 (5H, m), 7.49 (7H, m), 7.59 (1H, t, J = 7.6 Hz), 8.04 (1H, dd, J = 
7.6, 4.0 Hz). 13C NMR (CDCl3, 100 MHz) δ 19.3, 21.7 (d, J = 4.4 Hz), 26.94, 
63.8 (d, J = 4.6 Hz), 125.3 (d, J = 12.9 Hz), 126.3 (d, J = 12.5 Hz), 127.6 (d, J 
= 2.7 Hz), 128.4 (d, J = 12.0 Hz), 128.6 (d, J = 100.2 Hz), 129.5 (d, J = 1.2 
Hz), 130.5 (d, J = 102.2 Hz), 131.7 (d, J = 2.7 Hz), 131.8 (m, overlapping 
peaks), 132.1 (d, J = 9.8 Hz), 132.3 (d, J = 11.7 Hz), 132.7 (d, J = 13.0 Hz), 
133.4 (d, J = 4.3 Hz), 135.4, 143.3 (d, J = 7.9 Hz), 146.2 (d, J = 7.5 Hz). 31P 
NMR (CDCl3, 400 MHz) δ 33.2 (s). HRMS: (ESI+) Calculated for 
C36H37O2PSiNa: 583.2193 Found [M+Na]+: 583.2197 (-0.74 ppm). 
 




To a solution of 139 (202 mg, 0.36 mmol) in THF (5 mL) was added 1 M TBAF 
(0.54 ml, 0.54 mmol) and the reaction stirred at room temperature for 2 Hours. 
The reaction was then stopped by the addition of sat. ammonium chloride (5 
mL) and the aqueous layer was then extracted with ethyl acetate (5 mL x 3), 
the organic layers were combined, dried over MgSO4, filtered and then the 
solvent removed in-vacuo. The crude material was then purified by column 
chromatography (eluent: hexane:ethyl acetate; 50:50) to give the title 
compound (110 mg, 95%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ 2.50 
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(3H, s), 4.61 (2H, d, J = 7.2 Hz), 5.91 (1H, t, 7.2 Hz, -OH), 6.92 (1H, dd, J = 
14.7, 7.9 Hz) 6.99 (1H, dd, J = 14.5, 8 Hz), 7.13 (1H, t, J = 6.8 Hz), 7.26 (1H, 
m), 7.33 (1H, m), 7.49 (5H, m), 7.60 (3H, m). 13C NMR (CDCl3, 100 MHz) δ 
21.8 (d, J = 4.6 Hz), 64.8 (d, J = 4.7 Hz), 125.4 (d, J = 13.2 Hz), 127.3 (d, J = 
13.0 Hz), 128.7 (d, J = 12.2 Hz), 129.9 (d, J = 104.2 Hz), 130.9 (d, J = 5.6 Hz), 
131.7 (d, J = 9.9 Hz), 132.0 (d, J = 10.3 Hz), 132.1 (m), 132.2 (m), 132.4 (d, J 
= 2.5 Hz), 132.7 (d, J = 2.6 Hz), 133.1 (d, J = 13.2 Hz), 143.5 (d, J = 7.8 Hz), 
146.6 (d, J = 7.6 Hz). 31P NMR (CDCl3, 162 MHz) δ 38.02 (s). HRMS: (ESI+) 
Calculated for C20H19O2PNa: 345.1015 Found [M+Na]+: 345.102 (-1.58 ppm). 
HPLC separation (DAICEL AD, hexane/isopropanol 91:9, 1.2 mL/min, UV = 

















To a solution of 140 (110 mg, 0.33 mmol) in THF (5 mL) at 0oC was added 
NaH (17.28 mg, 0.36 mmol) after which the reaction allowed to warm up to 
room temperature. TBAI (11 mg, 0.03 mmol) and benzyl bromide (42.7 µL, 
0.36 mmol) were added and the reaction monitored by TLC. After all starting 
material had been consumed, the reaction was quenched with water (5 mL). 
The organic layer was separated, washed with sat. ammonium chloride 
solution, sat. brine and dried over magnesium sulphate. The product was 
purified by column chromatography (eluent: hexane:ethyl acetate; 50:50) to 
give the title compound (103 mg, 97%) as a clear oil. 1H NMR (CDCl3, 400 
MHz) δ 2.49 (s, 3H), 4.40 (s, 2H), 4.94 (1H, d, J = 13.7 Hz), 5.01 (1H, d, J = 
13.7 Hz), 7.05 (3H, m), 7.24 (7H, m), 7.42 (3H, m), 7.43 (2H, t, J = 7.5 Hz), 
7.60 (2H, m), 7.83 (1H, dd, J = 7.7, 3.8 Hz). 13C NMR (CDCl3, 100 MHz) δ 21.8 
(d, J = 4.4 Hz), 70.1 (d, J = 4.3 Hz), 72.7, 125.3 (d, J = 12.9 Hz), 126.7 (d, J = 
12.7 Hz), 127.4, 127.6, 128.2, 128.5 (d, J = 12.1 Hz), 128.7 (d, J = 10.1 Hz), 
129.7 (d, J = 100.6 Hz), 130.9 (d, J = 102.7 Hz), 131.8 (m), 132.1 (m), 132.6 
(d, J = 12.5 Hz), 133.0 (d, J = 13.0 Hz), 133.1, 138.3, 143.3 (d, J = 7.8 Hz), 
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144.1 (d, J = 7.2 Hz). 31P NMR (CDCl3, 162 MHz) δ 34.7. HRMS: (ESI+) 
Calculated for C27H25O2PNa: 435.1484 Found [M+Na]+: 435.1488 (-0.91 ppm). 
HPLC separation (DAICEL AD, hexane/isopropanol 91:9, 1 mL/min, UV = 210 
nm; tR (A) = 21.4 min, tR (B) = 25.2 min), e.e = 83%.  
Method B  
 
To a solution of 147 (322 mg, 1 mmol) in DCM (10 mL) was added Silver (I) 
Oxide (926 mg, 4 mmol) and the reaction stirred at 40oC and followed by TLC. 
Once all starting material had been consumed, the reaction was cooled to 
room temperature and washed with water (10 mL). The organic layer was dried 
over MgSO4, filtered and the solvent removed in-vacuo to leave the crude 
residue which was purified by column chromatography (eluent: hexane:ethyl 
acetate; 50:50) to give the title compound (383 mg, 93%) as a clear oil. Data 
identical to method A. HPLC separation (DAICEL AD, hexane/isopropanol 








10.6 – Chapter 5 phosphine oxide reduction experimental  
HPLC analysis 
 
HPLC analysis was undertaken on an Agilent Infinity 1260 HPLC, using a 
DAICEL Chiralpak-AD column (Daicel, 5 μm particle size, 250 mm x 4.6 mm).  
The mobile phase comprised of (A) IPA: (B) Hexane with an isocratic system 
of 9% (A) to 91% (B) with a flow rate of 1.2 mL/min, an injection volume of 5 
μL and a column temperature of 30oC. Signals were recorded at 200 nm, 210 
nm, 220 nm, 254 nm.  
 




To a solution of phosphine oxide 148 (20 mg, 48 µmol) in THF (2 mL) under 
argon was added PMHS (1 mL) followed by titanium isopropoxide (60 µL, 194 
µmol, 10 equiv). The mixture was heated at 65oC for 18 hours to complete the 
reaction. The mixture was cooled to ambient temperature. Then the solvent 
was removed under reduced pressure and residue was cooled to 0oC and 1M 
NaOH (15 mL) was added slowly. The mixture was extracted with ethyl 
acetate, dried over MgSO4, filtered and the solvent removed in-vacuo and the 
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residue purified by column chromatography (eluent: hexane:ethyl acetate; 
97:3) to give the title compound (17.7 mg, 94%) as a white solid. 1H NMR 
(CDCl3, 400 MHz) δ 2.24 (3H, s), 4.69 (2H, m), 6.64 (1H, m), 6.76 (1H, m), 
6.97 (1H, t, J = 7.3 Hz), 7.05-7.30 (15H, m), 7.49 (1H, dd, J = 7.0, 4.3 Hz). 13C 
NMR (CDCl3, 100 MHz) δ 20.1 (d, J = 21.2 Hz), 69.4 (d, J = 24.4 Hz), 71.3, 
125.0, 126.3, 126.7, 126.9 (d, J = 57.1 Hz), 127.0 (d, J = 5.5 Hz), 127.5 (d, J 
= 7.2 Hz), 127.6, 127.8 (d, J = 24.7 Hz), 129.0 (d, J = 4.7 Hz), 132.2 (d, J = 
61.2 Hz), 133.1 (d, J = 20.1 Hz), 134.4 (d, J = 10.9 Hz), 134.6 (d, J = 9.4 Hz), 
141.12 (d, J = 25.9 Hz), 141.7 (d, J = 23,8 Hz). 31P NMR (CDCl3, 162 MHz) δ 
-23.75. HRMS: (ESI+) Calculated for C27H26OP: 397.1716 Found [M+H]+: 
397.1716 (-0.11 ppm). 
 
Oxidation of phosphine bis(2-(hydroxymethyl)phenyl)(phenyl)phosphine 




Phosphine 152 (17.7 mg, 45 µmol) was dissolved in a 2:1 solution of DCM to 
water (1 mL), then 30 % hydrogen peroxide (0.1 mL) was added and left to stir 
for 2 hours. Water (1 mL) was then added to the reaction and the organic layer 
separated and the aqueous layer was washed with DCM (2 mL). The organic 
layers were then combined, dried over MgSO4, filtered and solvent removed 
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in-vacuo and the crude material purified by column chromatography (eluent: 
hexane:ethyl acetate; 50:50)  to give the title compound (19 mg, 99%) as a 
clear oil. 1H NMR (CDCl3, 400 MHz) δ 2.49 (s, 3H), 4.40 (s, 2H), 4.94 (1H, d, 
J = 13.7 Hz), 5.02 (1H, d, J = 13.7 Hz), 7.05 (3H, m), 7.24 (7H, m), 7.42 (3H, 
m), 7.43 (2H, t, J = 7.5 Hz), 7.60 (2H, m), 7.83 (1H, dd, J = 7.7, 3.8 Hz). 13C 
NMR (CDCl3, 100 MHz) δ 21.8 (d, J = 4.4 Hz), 70.1 (d, J = 4.3 Hz), 72.7, 125.3 
(d, J = 12.9 Hz), 126.7 (d, J = 12.7 Hz), 127.4, 127.6, 128.2, 128.5 (d, J = 12.1 
Hz), 128.7 (d, J = 10.1 Hz), 129.7 (d, J = 100.6 Hz), 130.9 (d, J = 102.7 Hz), 
131.8 (m), 132.1 (m), 132.6 (d, J = 12.5 Hz), 133.0 (d, J = 13.0 Hz), 133.1, 
138.3, 143.3 (d, J = 7.8 Hz), 144.1 (d, J = 7.2 Hz). 31P NMR (CDCl3, 162 MHz) 
δ 34.7. HRMS: (ESI+) Calculated for C27H25O2PNa: 435.1484 Found [M+Na]+: 
435.1488 (-0.91 ppm). HPLC separation (DAICEL AD, hexane/isopropanol 









10.7 – Chapter 6 inversion barrier calculation experimental (DFT) 
DFT Inversion Studies of Phosphines 152, 161-173 
 
Structure optimizations have been carried out at the ѠB97X-D density 
functional level of theory with the 6-31G* dataset using the SPARTAN 18 
program. The optimized geometries were characterized as energy minimums 
at the potential energy surface from frequency calculations at the same level 
of theory; i.e., the energy minimum structure has only real frequencies or 
authentic transition state have only one imaginary vibration mode, which 
connects the reactant and product. The Gibbs free energies that were 
calculated in au were then scaled to the designated temperature and 
converted to kJ/mol and the difference between the two conformations 
energies taken as the inversion barrier. 
 
10.8 - Chapter 7 synthesis of phenolic structures from 147 experimental 




To a solution of 147 (100 mg, 0.31 mmol) in DCM (5 mL) was added pyridinium 
chlorochromate (85 mg, 0.37 mmol) and the reaction stirred at room 
temperature for 5 hours after which an excess of diethyl ether was added, and 
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the reaction filtered. The solvent was then removed in-vacuo and the residue 
purified by column chromatography (eluent: hexane:ethyl acetate; 50:50)  to 
give the title compound (70 mg, 71%) as a white solid. 1H NMR (CDCl3, 400 
MHz) δ 2.52 (3H, s), 7.00 (2H, dd, J = 14.4, 7.5 Hz), 7.17 (2H, m), 7.34 (1H, 
dd, J = 7.5, 4.3 Hz), 7.42-7.72 (8H, m), 8.19 (1H, dd, J = 4.0, 0.8 Hz), 10.84 
(1H, s). 13C NMR (CDCl3, 100 MHz) δ 21.8, 125.5 (d, J = 13.2 Hz), 128.8 (d, J 
= 12.3 Hz), 129.0 (d, J = 8.8 Hz), 130.5 (d, J = 104.1 Hz), 131.66, 132.1-132.22 
(m, overlapping signals), 132.2 (d, J = 2.8 Hz), 132.3 (d, J = 2.8 Hz), 132.5 (d, 
J = 2.7 Hz), 132.7 (d, J = 3.7 Hz), 132.9 (d, J = 11.0 Hz), 133.0, 133.2, 135.4 
(d, J = 95.3 Hz), 139.9 (d, J = 6.4 Hz), 143.3 (d, J = 8.0 Hz), 191.6 (d, J = 5.2 
Hz). 31P NMR (CDCl3, 161 MHz) δ 34.17. HRMS: (ESI+) Calculated for C20H-
17O2PNa : 343.0858 Found [M+Na]+: 343.0863 (-1.39 ppm). 
 




To a solution of 176 (35 mg, 0.1 mmol) in THF (2 mL) at 0oC, was added 3 M 
MeMgBr (46.5 µL, 0.14 mmol) and the reaction warmed up to room 
temperature and left to stir for 5 hours after which the reaction was quenched 
through the addition of sat. ammonium chloride solution (2 mL). The organic 
layer and aqueous layer were then separated, and the aqueous layer extracted 
with ethyl acetate (3 x 1 mL) and the organic layers combined, dried over 
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MgSO4, filtered and the solvent removed in-vacuo. The crude residue was 
then purified by column chromatography (eluent: hexane:ethyl acetate; 50:50) 
to give the title compound (25 mg, 74%) as a white solid. 1H NMR (CDCl3, 400 
MHz) δ 1.53 (3H, d, J = 6.6 Hz), 2.47 (3H, s), 5.24 (1H, m), 6.85-7.05 (2H, m), 
7.10-7.25 (2H, m), 7.33 (1H, dd, J = 11.1, 6.7 Hz), 7.42-7.72 (8H, m). 13C NMR 
(CDCl3, 100 MHz) δ 20.8, 21.6 (d, J = 4.6 Hz), 66.9 (d, J = 5.2 Hz), 125.3 (d, 
J = 13.2 Hz), 126.9 (d, J = 13.2 Hz), 127.2 (d, J = 10.0 Hz), 128.7 (d, J = 12.2 
Hz), 130.0, 132.1-132.3 (m, overlapping peaks), 132.4 (d, J = 2.6 Hz), 132.6 
(d, J = 2.6 Hz), 132.9 (d, J = 13.4 Hz), 133.5 (d, J = 13.2 Hz), 143.3 (d, J = 8.0 
Hz), 150.4 (d, J = 7.3 Hz). 31P NMR (CDCl3, 161 MHz) δ 38.7. HRMS: (ESI+) 
Calculated for C21H21O2PNa : 359.1171 Found [M+Na]+: 359.1178 (-1.85 
ppm). 
 




To a solution of 178 (2-(1-hydroxyethyl)phenyl)(phenyl)(o-tolyl)phosphine 
oxide (25 mg, 0.075 mmol) in DCM (5 mL) was added pyridinium 
chlorochromate (20 mg, 0.089 mmol) and the reaction stirred at room 
temperature for 5 hours after which an excess of diethyl ether was added, and 
the reaction filtered. The solvent was then removed in-vacuo and the residue 
purified by column chromatography (eluent: hexane:ethyl acetate; 70:30) to 
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give the title compound (21 mg, 84%) as a colourless residue. 1H NMR (CDCl3, 
400 MHz) δ 2.41 (3H, s), 2.44 (3H, s), 7.05-7.17 (2H, m), 7.26 (1H, m), 7.41 
(1H, t, J = 7.4 Hz), 7.47 (4H, m), 7.54 (1H, m), 7.55-7.67 (4H, m). 13C NMR 
(CDCl3, 100 MHz) δ 21.5 (d, J = 4.7 Hz), 22.6, 125.0 (d, J = 13.4 Hz), 127.6 
(d, J = 9.3 Hz), 128.4 (d, J = 12.3 Hz), 129.89 (d, J = 11.9 Hz), 130.6 (d, J = 
17.8 Hz), 131.6-131.8 (m, overlapping peaks), 131.9 (d, J = 2.7 Hz), 132.1 (d, 
J = 9.8 Hz), 132.9 (d, J = 105.9 Hz), 133.7 (d, J = 13.2 Hz), 134.0 (d, J = 10.7 
Hz), 142.6 (d, J = 8.3 Hz), 145.2 (d, J = 7.1 Hz), 202.3. 31P NMR (CDCl3, 161 
MHz) δ 34.30. HRMS: (ESI+) Calculated for C21H19O2PNa: 357.1015 Found 
[M+Na]+: 357.1023 (-2.2 ppm).  
 
10.8.1 – Chapter 8.2 direct synthesis of phenolic phosphine oxides 
experimental 
 




2-Bromophenol (181) (1.23 mL, 11.6 mmol) was dissolved in DCM (50 mL) 
and DHP (1.26 mL, 13.9 mmol) was added followed by PPTS (0.27 g, 1.1 
mmol). The reaction was left to stir at room temperature for 24 hours. After the 
allotted time, the reaction was washed with sodium bicarbonate (25 ml), water 
(25 mL) and brine (25 mL) and the organic layer dried with MgSO4, filtered and 
the solvent removed in-vacuo. The crude product was purified by column 
198 
 
chromatography (eluent: hexane:ethyl acetate; 33:1)  to give the title 
compound (2.24 g, 75%) as a clear oil. 1H NMR (CDCl3, 400MHz) δ 1.51 – 
2.17 (6H, m), 3.56 (1H, m), 3.87 (1H, td, J = 11.0, 2.8 Hz), 5.47 (1H, s), 6.81 
(1H, t, J = 7.6 Hz), 7.12 (1H, d, J = 8.2 Hz), 7.19 (1H, t, J = 7.8 Hz), 7.50 (1H, 
d, J = 8.2 Hz). 13C NMR (CDCl3, 100 MHz) δ 18.3, 25.3, 30.2, 61.7, 96.6, 
113.15, 122.77, 128.3, 133.2, 153.4. HRMS: (ESI+) Calculated for 
C11H13BrNaO2: 280.0148 Found [M+Na]+: 280.0138 (3.28 ppm). 
  




To a solution of 182 (01.94 g, 7.57 mmol) in anhydrous THF (50 mL), 1.6 M n-
BuLi (5.2 mL, 8.33 mmol) was added dropwise at -78oC and the reaction left 
to stir for an hour. P,P-dichlorophenylphosphine (0.51 mL, 3.78 mmol) was 
then added dropwise over 5 minutes, the reaction was allowed to warm to 
room temperature and was left to stir for 24 hours. Water (25 mL) was then 
cautiously added to reaction and allowed to stir for ten minutes. The organic 
and aqueous layer were then separated and washed with water and ethyl 
acetate, respectively. The organic layer was then dried over MgSO4, filtered 
and the solvent removed in vacuo and the crude residue was dissolved in 2:1 
solution of DCM (10 mL) and H2O (5 mL) and H2O2 (0.85 mL, 7.5 mmol) was 
added and the reaction was left to stir for 2 hours. The organic and aqueous 
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layer were then separated and washed with H2O and DCM, respectively. The 
organic layer was then dried over MgSO4, filtered and the solvent removed to 
leave a crude residue which was used in the next step without purification. 
 
 The residue was dissolved in methanol (30 mL) and pTSA (150 mg, 0.75 
mmol) was added and the reaction was left to stir at room temperature for 24 
hours. After this time, the volume of the reaction was reduced and DCM (25 
mL) was added. The organic layer was then washed with sat. sodium 
bicarbonate (15 mL), water (15 mL), brine (15 mL) and dried over MgSO4, 
filtered and the solvent removed in vacuo. The resulting solid was purified by 
column chromatography (eluent: hexane:ethyl acetate; 70:30)  to give the title 
compound (483 mg, 20%) as a white solid. 1H NMR (400 MHz, CDCl3) δ 6.90 
(4H, m), 7.39 – 7.72 (9H, m), 10.83 (2H, s). 13C (CDCl3, 100 MHz) δ 115.1, 
116.2, 117.1 (d, J = 7.2 Hz). 119.4 (d, J = 12.1 Hz), 128.8 (d, J = 9.9 Hz), 131.3 
(d, J = 10.7 Hz), 132.2 (d, J = 2.7 Hz), 133.4 (d, J = 9.0 Hz), 134.7 (d, J = 1.8 
Hz), 161.2 (d, J = 3.4 Hz) 31P NMR (CDCl3, 162 MHz) δ 34.0. HRMS: (ESI+) 















Method A  
 
To a solution of phenol (186) (0.84 g, 8.92 mmol) in THF (60 mL) was added, 
DMAP (54 mg, 0.44 mmol), triethyl amine (3 mL, 21.6 mmol) followed by 
dichlorophenyl phosphine (0.6 mL, 4.46 mmol) and the reaction was  left to stir 
at room temperature for 4 hours. After this time, sat. ammonium chloride 
solution (30 mL) was added and the aqueous and organic layers were 
separated and washed with ethyl acetate and water, respectively. The organic 
layer was then dried over MgSO4, filtered and the solvent removed. The 
residue was then dissolved in a 2:1 solution of DCM and H2O and 30% H2O2 
(1 mL, 8.92 mmol) was added and the reaction stirred for 2 hours. The organic 
and aqueous layer were then separated and washed with H2O and DCM, 
respectively. The organic layer was then dried over MgSO4, filtered and the 
solvent removed to leave a crude residue which was purified by column 
chromatography (eluent: hexane:ethyl acetate; 90:10) to give the title 
compound (0.95 g, 69%) as a white solid. 1H NMR (CDCl3, 400 MHz) δ 7.12 
(2H, t, J = 7.0 Hz), 7.26 (8H, m), 7.46 (2H, dd, J = 12.1, 7.3 Hz), 7.55 (1H, t, J 
= 7.4 Hz), 7.98 (1H, d, J = 8.1 Hz), 8.02 (1H, d, J = 8.1 Hz). 13C NMR (CDCl3, 
100 MHz) δ 120.6 (d, J = 4.5 Hz), 125.2 (d, J = 0.6 Hz), 128.7 (d, J = 15.8 Hz), 
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129.7, 132.2 (d, J = 10.4 Hz), 133.2 (d, J = 3.1 Hz), 150.4 (d, J = 7.6 Hz). 31P 
NMR (CDCl3, 162 MHz) δ 11.81. HRMS: (ESI+) Calculated for C18H15O3PNa : 




To a solution of diisopropyl amine (2 mL, 14 mmol), in THF (60 mL) was added 
1.6 M n-BuLi (7.5 mL, 12 mmol) at -78oC and stirred for 10 minutes after which 
phenol (0.94 g, 10 mmol) and the reaction was allowed to warm to room 
temperature and stir for 30 minutes.  Phenyl phosphinic dichloride (0.75 mL, 5 
mmol) was then added dropwise and the reaction was left to stir for 24 hours 
after which sat. ammonium chloride (40 mL) was added and aqueous layer 
was extracted with ethyl acetate (3 x 25 mL). The organic layer was then dried 
over MgSO4, filtered and then dissolved in a 2:1 solution of DCM to water, then 
hydrogen peroxide (1 mL, 2 eqv.) was added and left to stir for 2 hours. Water 
(10 mL) was then added to the reaction and the organic layer separated and 
the aqueous layer was with DCM (10 mL). The organic layers were then 
combined, dried over MgSO4, filtered and solvent removed in-vacuo and the 
crude material purified by column chromatography (eluent: hexane:ethyl 
acetate; 85:15) to give the title compound (1.07 g, 70%) as a white solid. Data 











To a solution of diisopropyl amine (1.98 mL, 14 mmol) in THF (40 mL) at -78oC 
was added 1.6 M n-BuLi (7.5 mL, 12 mmol) and the reaction stirred for 10 
minutes. After this, 2-iodophenol (2.2 g, 10 mmol) was added and stirred for a 
further 30 minutes after which, phenyl phosphinic dichloride (0.786 mL, 5 
mmol) was added and the reaction allowed to warm to room temperature and 
was left for 16 hours. Sat. ammonium chloride solution (20 mL) was then 
added to the reaction and the organic and aqueous layers were separated and 
washed with water and ethyl acetate, respectively. The organic layer was then 
dried over MgSO4, filtered, the solvent removed in vacuo and the crude 
material purified by column chromatography (eluent: hexane:ethyl acetate; 
90:10)  to give the title compound (1.58 g, 56%) as a clear oil. 1H NMR (CDCl3, 
400 MHz) δ 6.85 (2H, t, J = 7.6 Hz), 7.24 (2H, td, J = 7.8, 1.4 Hz), 7.46 (2H, 
dt, J = 8.2, 1.3 Hz), 7.51 (2H, m), 7.61 (1H, td, J = 7.3, 1.3), 7.75 (2H, d, J = 
7.9 Hz), 8.19 (2H, m). 13C NMR (CDCl3, 400 MHz) δ 88.9 (d, J = 7.8 Hz), 
120.89 (d, J = 2.7 Hz), 126.2 (d, J = 195.1 Hz), 126.6 (d, J = 0.6 Hz), 128.6 (d, 
J = 16.2 Hz), 129.6 (d, J = 1.0 Hz), 132.8 (d, J = 11.0 Hz), 133.7 (d, J = 3.2 
Hz), 139.3, 150.6 (d, J = 7.2 Hz). 31P NMR (CDCl3, 161 MHz) δ 12.49. HRMS: 










To a solution of 185 (1.5 g, 2.67 mmol) in THF (25 mL), was added 1.3 M 
Turbo Grignard (4.9 mL, 6.4 mmol) and the reaction was stirred at room 
temperature of 24 hours. After this, the reaction was washed with sat. 
ammonium chloride solution (15 mL). The aqueous layer was then acidified 
with 1 M HCl and then washed with ethyl acetate (3 x 10 mL). The organic 
fractions were then combined, dried over MgSO4, filtered and the solvent 
removed in vacuo to leave a crude oil which was purified by column 
chromatography (eluent: hexane:ethyl acetate; 70:30)  to give the title 
compound (440 mg, 57%) as a white solid. 1H NMR (400 MHz, CDCl3) δ 6.90 
(4H, m), 7.39 – 7.72 (9H, m), 10.83 (2H, s). 13C (CDCl3, 100 MHz) δ 115.1, 
116.2, 117.1 (d, J = 7.2 Hz). 119.4 (d, J = 12.1 Hz), 128.8 (d, J = 9.9 Hz), 131.3 
(d, J = 10.7 Hz), 132.2 (d, J = 2.7 Hz), 133.4 (d, J = 9.0 Hz), 134.7 (d, J = 1.8 
Hz), 161.2 (d, J = 3.4 Hz) 31P NMR (CDCl3, 162 MHz) δ 34.0. HRMS: (ESI+) 
Calculated for C18H15O3PNa: Found [M+Na]+: 333.0653 (-0.68 ppm). HPLC 
separation (DAICEL AD, hexane/isopropanol 80:20, 1.2 mL/min, UV = 210, 






To a solution of diisopropyl amine (1.98 mL, 14 mmol) in THF (40 mL) at -78oC 
was added 1.6 M n-BuLi (7.5 mL, 12 mmol) and the reaction stirred for 10 
minutes. After this, 90 (1.07 g, 3.45 mmol) was added and the reaction allowed 
to warm to room temperature and was left for 16 hours. Sat. ammonium 
chloride solution (20 mL) was then added to the reaction and the organic and 
aqueous layers were separated and washed with water and ethyl acetate, 
respectively. The organic layer was then dried over MgSO4, filtered, the 
solvent removed in vacuo and the crude material purified by column 
chromatography (eluent: hexane:ethyl acetate; 75:25)  to give the title 
compound (0.38 g, 35%) as a clear oil. Data identical to method A. 
 




To a solution of diisopropyl amine (2 mL, 14 mmol), in THF (60 mL) was added 
1.6 M n-BuLi (7.5 mL, 12 mmol) at -78oC and stirred for 10 minutes after which 
2-iodophenol (2.20 g, 10 mmol) and the reaction was allowed to warm to room 
temperature and stir for 30 minutes. Ethyl phosphinic dichloride (0.53 mL, 5 
mmol) was then added dropwise and the reaction was left to stir for 24 hours 
after which sat. ammonium chloride (40 mL) was added and aqueous layer 
was extracted with ethyl acetate (3 x 25 mL). The organic layer was then dried 
over MgSO4, filtered and the solvent removed in-vacuo and the crude material 
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purified by column chromatography (eluent: hexane:ethyl acetate; 85:15) to 
give the title compound (1.32 g, 52%) as a white solid. 1H NMR (CDCl3, 400 
MHz) δ 1.47 (3H, dt, J = 22.0, 7.7 Hz), 2.28 (2H, dq, J = 18.5, 7.7 Hz), 6.88 
(2H, t, J = 7.6 Hz), 7.26 (2H, td, J = 7.6, 1.6 Hz), 7.37 (2H, dt, J = 8.2, 1.3 Hz), 
7.79 (2H, d, J = 7.9 Hz). 13C NMR (CDCl3, 100 MHz) δ 24.8 (d, J = 2.3 Hz), 
31.8 (d, J = 141.5 Hz), 71.1 (d, J = 6.9 Hz), 97.5 (d, J = 13.2 Hz), 128.4, 128.8, 
129.7, 139.0 (d, J = 6.2 Hz), 139.3. 31P NMR (CDCl3, 162 MHz) δ 38.16. 
HRMS: (ESI+) Calculated for C14H13I2O3PNa: 536.8584 Found [M+Na]+: 
536.8582 (0.39 ppm).  
 




To a solution of 187 (1.2 g, 2.37 mmol) in THF (20 mL) was added 1.3 M Turbo 
Grignard (4.4 mL, 5.7 mmol) at room temperature and left to stir for 18 hours. 
The reaction was then quenched with the addition of sat. ammonium chloride 
solution (15 mL) and the aqueous layer extracted with ethyl acetate (3 x 10 
mL) and the organic layers combined, dried over MgSO4, filtered and the 
solvent removed. The crude residue was then purified by column 
chromatography (eluent: hexane:ethyl acetate; 60:40)  to give the title 
compound (166 mg, 27%) as a clear oil. 1H NMR (DMSO, 400 MHz) δ 1.04 
(3H, dt, J = 18.7, 7.6 Hz), 2.5 (2H, m), 6.90 (4H, m), 7.38 (2H, m), 7.61 (2H, 
ddd, J = 13.0, 7.7, 1.6 Hz), 11.04 (2H, s). 13C NMR (DMSO, 100 MHz) δ 5.59 
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(d, J = 5.4 Hz), 22.69 (d, J = 72.9 Hz), 116.0 (d, J = 97.3 Hz), 116.9 (d, J = 7.1 
Hz), 119.4 (d, J = 11.4 Hz), 132.5 (d, J = 8.2 Hz), 134.2, 160.8 (d, J = 3.8 Hz). 
31P NMR (DMSO, 161 MHz) δ 44.99. HRMS: (ESI+) Calculated for C14H16O3P: 
Found [M+H]+: 263.0834 (-0.9 ppm). 
 
10.9 - Chapter 8 phenolic phosphine oxide desymmetrization and 
kinetic resolution experimental  
HPLC analysis was undertaken on an Agilent Infinity 1260 HPLC, using a 
DAICEL Chiralpak-AD column (Daicel, 5 μm particle size, 250 mm x 4.6 mm).  
The mobile phase comprised of (A) IPA: (B) Hexane with an isocratic system 
of 20% (A) to 80% (B) with a flow rate of 1.2 mL/min, an injection volume of 5 
μL and a column temperature of 30oC. Signals were recorded at 200 nm, 210 
nm, 220 nm, 254 nm.  
 




Phosphine oxide 112 (80 mg, 0.32 mmol) was dissolved in dry DCM (5 mL) 
and triethyl amine (86 µL, 0.61 mmol) followed by acetyl chloride (40.3 µL, 
0.56 mmol) was added  and the reaction left to stir for 2 hours. After this the 
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organic layer was then washed with 1 M HCl (2.5 mL), H2O (2.5 mL), brine 
(2.5 mL) and dried over MgSO4, filtered and the solvent removed. The crude 
residue was then purified by column chromatography (eluent: hexane:ethyl 
acetate; 70:30)  to give the title compound (90 mg, 89%) as a white solid. 1H 
NMR (CDCl3, 400 MHz) δ 1.85 (6H, s), 7.28 (4H, m), 7.48 (4H, m), 7.57 (3H, 
m), 7.77 (2H, m). 13C NMR (CDCl3, 100 MHz) δ 20.5, 123.9 (d, J = 6.3 Hz), 
124.3, 125.3, 125.7 (d, J = 11.9 Hz), 128.5 (d, J = 12.3 Hz), 131.6 (d, J = 10.3 
Hz), 132.0 (d, J = 2.8 Hz), 133.4 (d, J = 2.0 Hz), 133.5 (d, J = 8.5 Hz), 152.5 
(d, J = 1.6 Hz), 168.5. 31P NMR (CDCl3, 162 MHz) δ 33.57. HRMS: (ESI+) 
Calculated for C22H19O5PNa: 417.0862 Found [M+Na]+: 417.0866 (-0.97 ppm). 
HPLC separation (DAICEL AD, hexane/isopropanol 80:20, 1.2 mL/min, UV = 
210, 254 nm; tR = 24.8 min 
 





Phosphine oxide 112 (61 mg, 0.19 mmol) was dissolved in dry DCM (5 mL) 
and triethyl amine (30 µL, 0.21 mmol) followed by acetyl chloride (14.1 µL, 
0.19 mmol) was added  and the reaction left to stir for 2 hours. After this the 
organic layer was then washed with 1 M HCl (2.5 mL), H2O (2.5 mL), brine 
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(2.5 mL) and dried over MgSO4, filtered and the solvent removed. The crude 
residue was then purified by column chromatography (eluent: hexane:ethyl 
acetate; 3:1) to give the title compound (60 mg, 86%) as a white solid. 1H NMR 
(CDCl3, 400 MHz) δ 1.83 (3H, s), 6.84 (1H, td, J = 7.1, 1.8 Hz), 6.99 (1H, m), 
7.05 (1H, m), 7.28 (2H, m), 7.41 (2H, m), 7.51 (2H, m), 7.61 (2H, m), 7.75 (2H, 
m), 11.20 (1H, s). 13C NMR (CDCl3, 100 MHz) δ 20.3, 110.6 (d, J = 106.9 Hz), 
118.6 (d, J = 7.8 Hz), 119.1 (d, J =12.7 Hz), 124.2 (d, J = 103.4 Hz), 124.3 (d, 
J = 6.2 Hz), 125.8 (d, J = 12.0 Hz), 128.8 (d, J = 12.7 Hz), 131.3 (d, J = 10.5 
Hz), 131.4 (d, J = 108.5 Hz), 131.5 (d, J = 10.2 Hz), 134.0 (d, J = 9.2 Hz), 
134.2  (d, J = 2.0 Hz), 134.4 (d, J = 2.2 Hz), 152.8 (d, J = 1.8 Hz), 163.8 (d, J 
= 3.1 Hz), 168.3. 31P NMR (CDCl3, 161 MHz) δ 36.9. Calculated for 
C20H17O4PNa: 375.0757 Found [M+Na]+: 375.0762 (-1.4 ppm). HPLC 
separation (DAICEL AD, hexane/isopropanol 80:20, 1.2 mL/min, UV = 210, 
254 nm; tR (A) = 18.4 min, tR (B) = 19.0, e.e. = 0%. 
 
Butanol Rinsed Enzyme Preparation (BREP) 
 
To an aqueous enzyme solution (2.5 mL Crude CAL-A, 6000 U/g) in pH 7 KPi 
buffer (2.5 mL) was added silica (0.5 g) and the resulting solution was left to 
shake at room temperature for 2 hours. The buffer was decanted off and the 
remaining silica was washed with n-butanol (3 x 5 mL) and then washed again 






To a solution of the substrate (10.6 mg, 25 mmol) in the desired solvent (1 mL) 
was added the BREP (150 mg), followed by n-butanol (6.7 µL, 75 mmol) and 
the reaction was shaken at 37oC and monitored by chiral HPLC. 
 





To a solution of 112 (155 mg, 0.5 mmol)  in DCM (5 mL), was added potassium 
carbonate (100 mg, 0.7 mmol), TBAI (32 mg, 0.05 mmol) and benzyl bromide 
(72 µL, 0.6 mmol) and the reaction was refluxed until TLC showed complete 
conversion of the starting material. The reaction was then cooled to room 
temperature and washed with water (2.5 mL x 3) and brine (2.5 mL) and the 
organic layer dried over MgSO4, filtered and the solvent removed in-vacuo to 
leave a colourless solid which was purified by column chromatography (eluent: 
hexane:ethyl acetate; 60:40)  to give the title compound (91 mg, 46%) as a 
white solid. 1H NMR (CDCl3, 400 MHz) δ 4.91 (2H, s), 6.62 (1H, m), 6.86 (2H, 
d, J = 6.7 Hz), 6.90 (1H, dd, J = 8.1, 5.0 Hz), 6.95-7.10 (3H, m), 7.16-7.26 (3H, 
m), 7.32 (1H, ddd, J = 8.5, 2.6, 1.3 Hz), 7.42 (2H, td, J = 7.6, 3.1 Hz), 7.54 (2H, 
m), 7.64 (2H, m), 7.75 (1H, ddd, J = 14.0, 7.6, 1.7 Hz), 11.38 (1H, s, -OH). 13C 
NMR (CDCl3, 100 MHz) δ 70.3, 111.2 (d, J = 106.8 Hz), 118.3 (d, J = 7.7 Hz), 
118.5 (d, J = 12.8 Hz), 119.4 (d, J = 104.6 Hz), 121.0 (d, J = 12.1 Hz), 127.9 
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(d, J = 90.1 Hz), 128.0, 128.5 (d, J = 12.9 Hz), 131.2 (d, J = 10.9 Hz), 132.06, 
132.03, 132.5 (d, J = 10.5 Hz), 133.1, 133.9 (d, J = 2.2 Hz), 134.8 (d, J = 2.0 
Hz), 135.0 (d, J = 7.9 Hz), 135.4, 160.0 (d, J = 3.2 Hz), 164.0 (d, J = 3.2 Hz). 
31P NMR (CDCl3, 162 MHz) δ 38.15. HRMS: (ESI+) Calculated for C25H-
21O3PNa : 423.1121 Found [M+Na]+: 423.1116 (1.19 ppm) HPLC separation 
(DAICEL AD, hexane/isopropanol 80:20, 1.2 mL/min, UV = 210, 254 nm; tR 
(A) = 16.0 min, tR (B) = 16.2, e.e. = 0%. 
 




To a solution of hexanoic acid (0.125 mL, 1 mmol) in DCM (10 mL) was added 
thionyl chloride (87 µL, 1.2 mmol) dropwise at 0oC followed by a catalytic 
amount of DMF. The reaction was left to stir for 3 hours at room temperature 
after which the solvent and excess thionyl chloride was removed in-vacuo. The 
crude residue was then dissolved in DCM (10 mL) and 179 (320 mg, 0.8 mmol) 
was added followed by triethyl amine (0.2 mL, 1.4 mmol) and the reaction was 
left to stir at room temperature 5 hours. The reaction was then washed with 1 
M HCl sol. (5 mL), 1 M NaOH sol. (5 mL) and brine (5 mL) and the organic 
layer dried over MgSO4, filtered and the solvent removed in-vacuo to leave a 
clear oil which was purified by column chromatography (eluent: hexane:ethyl 
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acetate; 60:40)  to give the title compound (100 mg, 20%) as a clear oil. 1H 
NMR (CDCl3, 400 MHz) δ 0.86 (3H, t, J = 7.1 Hz), 1.20 (4H, m), 1.37 (2H, m), 
1.83 (2H, td, J = 7.3, 1.5 Hz), 4.81 (2H, m), 6.92 (3H, m), 7.08 (2H, m), 7.20 
(4H, m), 7.33 (3H, m), 7.46 (3H, m), 7.80 (2H, m), 7.95 (1H, ddd, J = 13.8, 7.6, 
1.6 Hz). 13C NMR (CDCl3, 100 MHz) δ 13.9, 22.2, 23.8, 31.1, 33.2, 70.2, 111.7 
(d, J = 6.6 Hz), 120.9 (d, J = 106 Hz), 121.1 (d, J = 11.8 Hz), 123.5 (d, J = 6.4 
Hz), 125.3 (d, J = 12.1 Hz),125.7 (d, J = 106.5 Hz), 127.9 (overlapping peaks), 
128.0 (d, J = 12.6 Hz), 127.8-128.3 (d, J = 48.3 Hz), 131.4 (d, J = 2.8 Hz), 
132.0 (d, J = 10.3 Hz), 132.4 (d, J = 109.7 Hz), 132.4 (d, J = 2.1 Hz), 133.6 (d, 
J = 8.9 Hz), 133.9 (d, J = 2.0 Hz), 134.4 (d, J = 6.9 Hz), 135.5, 153.3 (d, J = 
1.8 Hz), 159.4 (d, J = 3.4 Hz), 171.4. 31P NMR (CDCl3, 161 MHz) δ 22.68 (s). 
HRMS: (ESI+) Calculated for C31H31O4PNa: 521.1852 Found [M+Na]+: 
521.1857 (-1 ppm). HPLC separation (DAICEL AD, hexane/isopropanol 80:20, 
1.2 mL/min, UV = 210, 254 nm; tR (A) = 31.0 min, tR (B) = 39.6, e.e. = 0%. 
 




 To a solution 194 (21 mg, 0.053 mmol) in DCM (1 mL), was added triethyl 
amine (10.4 µL, 0.074 mmol) and AcCl (4.6 µL, 0.064 mmol) and the reaction 
was stirred at room temperature for 5 hours. The reaction was then washed 
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with 1 M HCl sol. (1 mL), 1 M NaOH sol. (1 mL) and brine (1 mL) and the 
organic layer dried over MgSO4, filtered and the solvent removed in-vacuo to 
give the title compound (21 mg, 97%) as a white solid. 1H NMR (CDCl3, 400 
MHz) δ 1.64 (3H, s), 4.82 (2H, AB, J = 11.1 Hz), 6.92 (3H, m), 7.05-7.23 (6H, 
m), 7.34 (3H, m), 7.47 (3H, m), 7.81 (2H, m), 7.97 (1H, ddd, J = 13.7, 7.6, 1.6 
Hz). 13C NMR (CDCl3, 100 MHz) δ 20.2, 70.2, 111.8 (d, J = 6.7 Hz), 120.8 (d, 
J = 106.1 Hz), 121.1 (d, J = 11.8 Hz), 123.5 (d, J = 6.3 Hz), 125.4 (d, J = 12.1 
Hz), 125.7 (d, J = 106.4 Hz), 127.1, 127.6, 128.9, 129.0 (d, J = 6.4 Hz), 131.3 
(d, J = 4.3 Hz), 132.1 (d, J = 2.3 Hz), 132.3 (d, J = 6.3 Hz), 132.7 (d, J = 2.2 
Hz), 135.3 (d, J = 4.5 Hz) 133.8 (d, J = 106.2 Hz), 134.2 (d, J = 1.3 Hz), 136.7, 
154.2 (d, J = 3.4 Hz), 160.0 (d, J = 3.2 Hz), 169.0 (d, J = 3.2 Hz). 31P NMR 
(CDCl3, 161 MHz) δ 22.69. HRMS: (ESI+) Calculated for C27H23O4PNa: 
465.1226 Found [M+Na]+: 465.1232 (-1.25 ppm). HPLC separation (DAICEL 
AD, hexane/isopropanol 80:20, 1.2 mL/min, UV = 210, 254 nm; tR (A) = 29.1 
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